| 91H | osteosarcoma | qPCR, Cell transfection, Flow cytometry assay, Cell proliferation assay etc. | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 27555785 | 2016 |
| A2M-AS1 | breast cancer | qPCR, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | 32352014 | 2020 |
| AB073614 | cervical cancer | qPCR | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30964162 | 2019 |
| AB073614 | colorectal cancer | qRT-PCR, Western blotting | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31934121 | 2019 |
| AB209630 | pancreatic cancer | qRT-PCR etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31147453 | 2019 |
| ABHD11-AS1 | endometrial cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29799152 | 2018 |
| ABHD11-AS1 | ovarian cancer | qRT-PCR , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31568657 | 2019 |
| ABHD11-AS1 | papillary thyroid cancer | qPCR, Western blot, Luciferase reporter assay, Other | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 31409775 | 2019 |
| AC007271.3 | oral squamous cell carcinoma | RT-qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31759044 | 2019 |
| AC008753.6 | acute myeloid leukemia | RNA-seq, qPCR | L | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31356197 | 2019 |
| AC009022.1 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31637768 | 2019 |
| AC020978 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, RIP etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32308748 | 2020 |
| AC091729.7 | sinonasal squamous cell carcinoma | qRT-PCR, microarray, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | 32039035 | 2020 |
| AC110491.1 | bladder cancer | qPCR | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31308745 | 2019 |
| AC114812.8 | bladder cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31706102 | 2020 |
| ACTN4 | renal cancer | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29901101 | 2018 |
| acv3UTR | gastric cancer | RT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32066878 | 2020 |
| ADAMTS9-AS1 | prostate cancer | qRT-PCR | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32153626 | 2019 |
| ADAMTS9-AS1 | bladder cancer | qPCR | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31308745 | 2019 |
| ADAMTS9-AS2 | gastric cancer | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32160650 | 2020 |
| ADAMTS9-AS2 | tongue squamous cell carcinoma | qPCR, microarray, Western blot | H | ✘ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✘ | ✘ | 30970517 | 2019 |
| ADAMTS9-AS2 | gastric cancer | qPCR, Western Blot | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30089248 | 2018 |
| ADAMTS9-AS2 | clear cell renal cell carcinoma | qPCR, Luciferase reporter assay, in vitro knockdown, RIP | L | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31400752 | 2019 |
| ADAMTS9-AS2 | glioblastoma | qPCR, Western blot, RIP, RNAi | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31632968 | 2019 |
| ADIPOQ | Colorectal carcinoma | qRT-PCR,Luciferase reporter assay,etc.. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32744690 | 2020 |
| ADPGK-AS1 | gastric cancer | qPCR, Luciferase reporter assay, Western blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30944080 | 2019 |
| ADPGK-AS1 | breast cancer | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31264061 | 2019 |
| AF119895 | hepatocellular carcinoma | Microarray, qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29274323 | 2017 |
| AFAP1-AS1 | gastric cancer | qRT-PCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32051698 | 2020 |
| AFAP1-AS1 | breast cancer | qPCR, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 29974352 | 2018 |
| AFAP1-AS1 | colorectal cancer | qPCR, Western blot, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29888110 | 2018 |
| AFAP1-AS1 | gastric cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 29805596 | 2018 |
| AFAP1-AS1 | non small cell lung cancer | RNA-seq, qPCR, Western blot, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29793547 | 2018 |
| AFAP1-AS1 | hepatocarcinoma | qPCR, Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32280542 | 2020 |
| AFAP1-AS1 | hepatocarcinoma | qPCR, Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32280542 | 2020 |
| AFAP1-AS1 | clear cell renal cell carcinoma | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30832752 | 2019 |
| AFAP1-AS1 | oral squamous cell carcinoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31875436 | 2019 |
| AFAP1-AS1 | non small cell lung cancer | RT-PCR, Luciferase Reporter Assay, RIP, Western Blot Analysis | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31696057 | 2019 |
| AFAP1-AS1 | prostate cancer | qRT-PCR, RIP, Luciferase reporter gene assay, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31669642 | 2020 |
| AFAP1-AS1 | prostate cancer | qRT-PCR , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31081081 | 2019 |
| AFAP1-AS1 | non small cell lung cancer | qRT-PCR , RIP , Western blot , RNAi , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31069893 | 2019 |
| AFAP1-AS1 | osteosarcoma | qRT-PCR , Western blot , RIP etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31002124 | 2019 |
| AFAP1-AS1 | pancreatic cancer | qPCR, Western blo, Luciferase reporter assay, Other | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30206930 | 2019 |
| AFAP1-AS1 | hepatocellular carcinoma | qPCR, Western blot, Flow cytometry assay etc. | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 26892468 | 2016 |
| AFAP1-AS1 | colorectal cancer | qPCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 27596298 | 2016 |
| AFAP1-AS1 | Breast cancer | Dual-luciferase reporter assay;qRT-PCR;etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32955920 | 2020 |
| AFAP1-AS1 | Lung cancer | Western blot;Flow Cytometry assay;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 33290312 | 2021 |
| AFDN-DT | gastric cancer | RT-qPCR | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31981317 | 2019 |
| AGAP2-AS1 | esophageal cancer | qPCR, Western blot, RIP, Luciferase reporter assay, in vitro knockdown etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32199129 | 2020 |
| AGAP2-AS1 | glioblastoma | qRT-PCR , Western blot , RIP etc. | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31186379 | 2019 |
| AGAP2-AS1 | hepatocellular carcinoma | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31088485 | 2019 |
| AGAP2-AS1 | breast cancer | qPCR, ChIP, RIP, Western blot, Fluorescence in situ hybridization analysis (FISH) | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30157918 | 2018 |
| AGAP2-AS1 | glioma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30684575 | 2019 |
| AGAP2-AS1 | ovarian cancer | qPCR | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31233485 | 2019 |
| AGAP2-AS1 | non small cell lung cancer | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28617550 | 2017 |
| AGPG | esophageal squamous cell carcinoma | qPCR, Western blot etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32198345 | 2020 |
| AK001058 | colorectal cancer | qPCR | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31632555 | 2019 |
| AK001796 | hepatocellular carcinoma | qPCR | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | 30915744 | 2019 |
| AK002107 | hepatocellular carcinoma | qPCR, Luciferase reporter assay, Western blot | H | ✘ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✘ | ✘ | 30943320 | 2019 |
| AK023507 | nasopharyngeal cancer | microarray, qPCR etc. | L | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 27886062 | 2016 |
| AK027294 | nasopharyngeal cancer | qRT-PCR , Western blot , RNAi , in vitro knockdown etc. | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31589096 | 2019 |
| AK027294 | gastric cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31298327 | 2019 |
| AK311218 | non small cell lung cancer | qPCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 27322209 | 2016 |
| AL121899.1 | oesophageal squamous cell carcinoma | qRT-PCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32164040 | 2020 |
| AL161431.1 | endometrial cancer | Western blot , luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32196580 | 2020 |
| ANCR | hepatocellular carcinoma | qRT-PCR, RIP, Western blotting, Dual-luciferase reporter gene assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31868085 | 2020 |
| ANCR | nasopharyngeal cancer | qPCR, Western blot, RIP, etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30568463 | 2018 |
| ANRIL | laryngeal squamous cell cancer | RT-qPCR, Western blot, Dual luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31960744 | 2020 |
| ANRIL | acute myeloid leukemia | qRT-PCR, Dual-luciferase reporter assay, Western blot analysis | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31830533 | 2020 |
| ANRIL | hepatocellular carcinoma | qRT-PCR, Western Blot, Luciferase Activity Assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31679275 | 2019 |
| ANRIL | hepatocellular carcinoma | qRT-PCR, Western blotting, Luciferase reporter analysis, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31670868 | 2020 |
| ANRIL | laryngeal squamous cell cancer | Dual luciferase reporter assay, qRT-PCR, Western blotting | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31667207 | 2019 |
| ANRIL | retinoblastoma | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31184221 | 2019 |
| ANRIL | hepatocellular carcinoma | qRT-PCR , Luciferase reporter assay , Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31609763 | 2019 |
| ANRIL | glioblastoma | microarray, qPCR | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30038703 | 2018 |
| ANRIL | colorectal cancer | qPCR, Luciferase reporter assay, Other | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30279206 | 2018 |
| ANRIL | oral squamous cell carcinoma | RNA-seq, qPCR, Western blot | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31364119 | 2019 |
| ANRIL | prostate cancer | RT-PCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29278879 | 2018 |
| ANRIL | Intracranial Aneurysms | RNA immunoprecipitation;Western blot;Luciferase reporter assay;RNA immunoprecipitation; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 34286462 | 2021 |
| AOC4P | non small cell lung cancer | qPCR, Western blot etc | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32325081 | 2020 |
| AOC4P | gastric cancer | qRT-PCR, Western Blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31696472 | 2019 |
| AP000221.1 | pancreatic cancer | microarray, qPCR etc. | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 25755691 | 2015 |
| AP002754.2 | colorectal cancer | qRT-PCR | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32127356 | 2020 |
| APOC1P1 | clear cell renal cell carcinoma | qRT-PCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31871500 | 2019 |
| APTR | osteosarcoma | qPCR, Western blot, Luciferase reporter assay, Other | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30317613 | 2019 |
| ARAP1-AS1 | cervical cancer | qRT-PCR, western blot, RIP, Luciferase reporter assay | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31953923 | 2020 |
| ARAP1-AS1 | bladder cancer | qPCR, Western blot, Luciferase reporter assay, RIP, Other | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30404578 | 2019 |
| ARHGAP27P1 | gastric cancer | RT-qPCR, Western blot, RIP | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31665700 | 2019 |
| ARHGAP42 | nasopharyngeal cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29936709 | 2018 |
| ARlnc1 | prostate cancer | RNA-seq, Microarray, qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RNAi, RIP | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29808028 | 2018 |
| ASB16-AS1 | cervical cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32058219 | 2020 |
| ASB16-AS1 | osteosarcoma | qPCR, Western blot, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32214826 | 2020 |
| ASB16-AS1 | glioma | qPCR, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 30949502 | 2019 |
| ASB16-AS1? | non small cell lung cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32141556 | 2020 |
| ASMTL-AS1 | papillary thyroid cancer | qRTPCR, RIP, Western blot, Luciferase reporter assay | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31953163 | 2020 |
| ATB | non small cell lung cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32092085 | 2020 |
| ATB | malignant melanoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29956757 | 2018 |
| ATB | hepatocellular carcinoma | qPCR, Western blot, RIP | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31558875 | 2019 |
| ATB | lung squamous cell carcinoma | Double-luciferase reporter assay, RT-qPCR, Western blotting analysis | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31934791 | 2020 |
| ATB | glioma | qRT-PCR, Western blot analysis etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31140621 | 2019 |
| ATB | cholangiocarcinoma | qRT-PCR, Western blotting, in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31571907 | 2019 |
| ATB | lung cancer | qPCR, Western Blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30128006 | 2018 |
| ATB | colorectal cancer | Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31222825 | 2019 |
| ATXN8OS | breast cancer | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31173245 | 2019 |
| AWPPH | colorectal adenocarcinoma | qRT-PCR , Western blot etc. | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31611981 | 2019 |
| AX800134 | hepatocellular carcinoma | qPCR, Western blot, in vitro knockdown, RNAi | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29789998 | 2018 |
| AY | hepatocellular carcinoma | Microarray, qPCR, Western blot, Luciferase reporter assay, RIP | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31285770 | 2019 |
| BALR-6 | B-lymphoblastic leukemia | qPCR, RNAi, Northern blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 26694754 | 2015 |
| BANCR | thyroid cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29917164 | 2018 |
| BANCR | pancreatic cancer | qPCR, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31769353 | 2019 |
| BANCR | non small cell lung cancer | PCR | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30980423 | 2019 |
| BANCR | non small cell lung cancer | RT-PCR , Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31114383 | 2019 |
| BANCR | colorectal cancer | qPCR, Western Blot, Luciferase assay | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30144787 | 2018 |
| BANCR | retinoblastoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31482398 | 2019 |
| BANCR | oral squamous cell carcinoma | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31654433 | 2019 |
| BANCR | gastric adenocarcinoma | qPCR, RNAi, Western blot, MTT assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 26248136 | 2015 |
| BANCR | thyroid cancer | Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29552216 | 2018 |
| BANCR | osteosarcoma | qPCR etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 27051014 | 2016 |
| BANCR | papillary thyroid cancer | qPCR, Western blot, Flow cytometry assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 25289082 | 2014 |
| BANCR | breast cancer | qPCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29805676 | 2018 |
| BANCR | Atherosclerosis | CCK-8 assay;qPCR;RT-qPCR;Western blot;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33151462 | 2021 |
| BBOX1-AS1 | colorectal cancer | RT-qPCR, Western bolt | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31984680 | 2020 |
| BC0209135 | colorectal cancer | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29949151 | 2018 |
| BC050642 | osteosarcoma | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31397185 | 2019 |
| BC200 | triple negative breast cancer | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31646972 | 2019 |
| BC200 | lung cancer | qPCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 28651607 | 2017 |
| BC200? | hepatocellular carcinoma | qPCR, Other | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30400024 | 2018 |
| BCAR4 | cervical cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 29937186 | 2018 |
| BCAR4 | gastric cancer | qPCR, Western blot etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32329841 | 2020 |
| BCAR4 | liver cancer | qPCR, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32319544 | 2020 |
| BCAR4 | bladder cancer | qPCR, Luciferase reporter assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32273720 | 2020 |
| BCAR4 | bladder cancer | RT-qPCR, western blotting, Dual luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31894304 | 2020 |
| BCAR4 | glioma | qRT-PCR, Western Blot, Dual-Luciferase Reporter Assays | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31849498 | 2019 |
| BCAR4 | prostate cancer | qPCR, Luciferase reporter assay, in vitro knockdown, etc. | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30513511 | 2018 |
| BCAR4 | breast cancer | qPCR etc. | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 21506106 | 2011 |
| BCAR4 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29615150 | 2018 |
| BCHE | breast cancer | Microarray, qPCR, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29948648 | 2018 |
| BCLIN25 | breast cancer | qPCR, Luciferase reporter assay, Western blot analysis | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31801944 | 2019 |
| BCYRN1 | glioma | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32104095 | 2020 |
| BCYRN1 | hepatocellular carcinoma | qRT-PCR, Dual luciferase reporter assay, Western bolt | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31920461 | 2020 |
| BCYRN1 | colorectal cancer | microarray, qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30114690 | 2018 |
| BCYRN1 | gastric cancer | qPCR, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31652309 | 2019 |
| BCYRN1 | gastric cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29435146 | 2017 |
| BDNF-AS | glioblastoma | qRT-PCR, microarray, RIP | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32015336 | 2020 |
| BDNF-AS | oesophageal cancer | qPCR, Western blot, Luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 29896888 | 2018 |
| BDNF-AS | colorectal cancer | qRT-PCR, Western blotting, RIP etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31062382 | 2019 |
| BLACAT1 | ovarian cancer | qRT-qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32095930 | 2020 |
| BLACAT1 | cervical cancer | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29863244 | 2018 |
| BLACAT1 | colorectal cancer | qPCR, Western blot, RIP | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✔ | ✘ | 31558855 | 2019 |
| BLACAT1 | prostate cancer | RT-PCR, Western Blotting, Luciferase Assays, RIP | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31957820 | 2020 |
| BLACAT1 | head and neck squamous cell carcinoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31944856 | 2020 |
| BLACAT1 | hepatocellular carcinoma | qRT-PCR , Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31174090 | 2019 |
| BlackMamba | anaplastic large cell lymphoma | qRT-PCR, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32123306 | 2020 |
| BRAF | breast cancer | qPCR, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✘ | ✘ | 29805676 | 2018 |
| BRE-AS1 | prostate cancer | qPCR | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30833361 | 2019 |
| BRE-AS1 | non small cell lung cancer | qPCR, Western blot, RIP, RNAi, Other | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30227111 | 2018 |
| BRM | papillary thyroid cancer | qPCR, Western blot etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32218861 | 2020 |
| BX111 | pancreatic cancer | Microarray, qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 29970904 | 2018 |
| BX357664 | colorectal cancer | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 29844809 | 2018 |
| BZRAP1-AS1 | hepatocellular carcinoma | RT-qPCR, Western blot analysis, RIP, Dual luciferase reporter gene assay | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31847842 | 2019 |
| C17orf91 | ovarian cancer | qPCR, RNAi, Western blot, Cell migration and invasion assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 27535740 | 2016 |
| C1QTNF1-AS1 | hepatocellular carcinoma | qRT-PCR , Luciferase reporter assay , Western blot etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31069760 | 2019 |
| C1QTNF1-AS1 | hepatocellular carcinoma | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31222560 | 2019 |
| C5orf66-AS1 | gastric cancer | qPCR etc. | L | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32308414 | 2020 |
| C5orf66-AS1 | oral squamous cell carcinoma | qPCR, Western blot, Other | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30280186 | 2018 |
| CACNA1G-AS1 | colorectal cancer | qRT-PCR, Western Blot, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31957825 | 2020 |
| CACS15 | oral squamous cell carcinoma | qPCR etc. | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31793142 | 2019 |
| CADM1-AS1 | hepatocellular carcinoma | Microarray , qRT-PCR , Western blot , in vitro knockdown etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31118799 | 2019 |
| CALIC | colon cancer | RNA-seq, qPCR, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31353791 | 2019 |
| CALML3-AS1 | bladder cancer | qPCR, Dual luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30177388 | 2018 |
| CALML3-AS1 | cervical cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31298313 | 2019 |
| CANT1 | retinoblastoma | qPCR, Western blot etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32366932 | 2020 |
| CAR10 | cervical cancer | RT-qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32025520 | 2020 |
| CASC11 | bladder cancer | qPCR | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30916832 | 2019 |
| CASC11 | esophageal cancer | qRT-PCR, Western Blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31696474 | 2019 |
| CASC11 | glioma | qRT-PCR , Luciferase reporter assay , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31121483 | 2019 |
| CASC11 | lung cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31378894 | 2019 |
| CASC11 | cervical cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31255182 | 2019 |
| CASC11 | neonatal neuroblastoma | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31645055 | 2019 |
| CASC11 | Colorectal cancer | Dual-luciferase reporter assay;qRT-PCR;Western blot;Immunohistochemistry;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33937069 | 2021 |
| CASC15 | cervical cancer | RT-qPCR, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32016962 | 2020 |
| CASC15 | melanoma | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30013768 | 2018 |
| CASC15 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29956772 | 2018 |
| CASC15 | tongue squamous cell carcinoma | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29804249 | 2018 |
| CASC15 | bladder cancer | qPCR, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31799648 | 2019 |
| CASC15 | melanoma | qRT-PCR, Luciferase Reporter Assay, Western Blotting | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31838468 | 2020 |
| CASC15 | nasopharyngeal cancer | RT-qPCR, Luciferase Reporter Gene Assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31696476 | 2019 |
| CASC15 | ovarian cancer | RT-qPCR, Dual-Luciferase Reporter Assay, Western Blot Analysis | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31695430 | 2019 |
| CASC15 | non small cell lung cancer | qRT-PCR , Luciferase reporter assay , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31599419 | 2019 |
| CASC15 | non small cell lung cancer | microarray, qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31396336 | 2019 |
| CASC19 | clear cell renal cell carcinoma | Western Blot, RIP, Luciferase Reporter Assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32273759 | 2020 |
| CASC19 | colorectal cancer | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31011255 | 2019 |
| CASC19 | non small cell lung cancer | qPCR, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31389608 | 2019 |
| CASC2 | pancreatic cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32104955 | 2020 |
| CASC2 | oral squamous cell carcinoma | RT-qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32009793 | 2019 |
| CASC2 | esophageal squamous cell carcinoma | qRT-PCR, Western blot, RIP | L | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31728180 | 2019 |
| CASC2 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay etc | L | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32271431 | 2020 |
| CASC2 | pancreatic cancer | Dual-luciferase reporter assay, RT-qPCR, Western blotting | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31894271 | 2020 |
| CASC2 | colorectal cancer | qRT-PCR , Western blot , RIP , in vitro knockdown etc. | H | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31173223 | 2019 |
| CASC2 | oral squamous cell carcinoma | qRT-PCR , Luciferase reporter assay , Western blot etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31123403 | 2019 |
| CASC2 | breast cancer | qPCR, Western Blot, Luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30106139 | 2018 |
| CASC2 | breast cancer | qPCR, Western blot, Luciferase reporter assay | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31352515 | 2019 |
| CASC2 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31301415 | 2019 |
| CASC2 | oral squamous cell carcinoma | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31210307 | 2019 |
| CASC2 | cervical cancer | qPCR, Western blot, Luciferase Reporter Assays | L | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 28495512 | 2017 |
| CASC2 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29476051 | 2018 |
| CASC2 | Glioblastoma | Luciferase reporter assay;RNA immunoprecipitation;etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32975234 | 2020 |
| CASC2 | Cholangiocarcinoma | qRT-PCR;Western blot;luciferase assay; | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32894543 | 2020 |
| CASC21 | colorectal cancer | RT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 31731190 | 2020 |
| CASC21 | colon cancer | qRT-PCR, RNA-seq, Western blotting assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31965704 | 2020 |
| CASC21 | Colorectal Cancer | RT-PCR;Western blot; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 34375566 | 2021 |
| CASC2c | non small cell lung cancer | qPCR, Western blot | L | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31300525 | 2019 |
| CASC7 | neuroblastoma | qRT-PCR, Western blot | L | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32101951 | 2019 |
| CASC9 | tongue squamous cell carcinoma | qRT-PCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32021442 | 2020 |
| CASC9 | hepatocellular carcinoma | qPCR, Western blot, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29790588 | 2018 |
| CASC9 | papillary thyroid cancer | dual-luciferase reporter assay, RIP, Western blot, RT-PCR | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31943867 | 2020 |
| CASC9 | lung cancer | Western Blot, RT-PCR, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31802910 | 2019 |
| CASC9 | laryngeal cancer | qRT-PCR | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31669650 | 2020 |
| CASC9 | colorectal cancer | qRT-PCR , Western blot , RIP , RNA-seq , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31186036 | 2019 |
| CASC9 | hemangioma | qPCR, Western blot, Luciferase reporter assay, etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30662268 | 2019 |
| CASC9 | gastric cancer | qPCR, Cell transfection, Western blot, Cell proliferation assay etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28146436 | 2017 |
| CASC9 | Breast cancer | qRT-PCR;Dual-luciferase reporter assay;MTT assay | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34084220 | 2021 |
| CASC9 | Colorectal cancer | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33298846 | 2020 |
| CASC9 | Colorectal Cancer | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34285188 | 2021 |
| CCAC1 | Adrenocortical carcinoma | Dual-luciferase reporter assay;qPCR;RT-qPCR;Luciferase reporter assay;Rescue assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33195693 | 2020 |
| CCAL | gastric cancer | qPCR, Western blot, Other | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30250169 | 2018 |
| CCAL | colorectal cancer | Microarray, qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31381140 | 2019 |
| CCAT1 | non small cell lung cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32084702 | 2020 |
| CCAT1 | oral squamous cell carcinoma | qRT-PCR, Western blot, RIP | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32009633 | 2020 |
| CCAT1 | nasopharyngeal cancer | qPCR, other | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30013670 | 2018 |
| CCAT1 | gastric cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29940756 | 2018 |
| CCAT1 | prostate cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29863242 | 2018 |
| CCAT1 | thyroid cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29791590 | 2018 |
| CCAT1 | non small cell lung cancer | qPCR, Western blot etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32323859 | 2020 |
| CCAT1 | colorectal cancer | qPCR, Western blot etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32256733 | 2020 |
| CCAT1 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 32227563 | 2020 |
| CCAT1 | acute myeloid leukemia | qPCR, Western blot, Luciferase reporter assay, RIP etc | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31790145 | 2019 |
| CCAT1 | colorectal cancer | qPCR, Western blot, RIP | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✔ | ✘ | 31558855 | 2019 |
| CCAT1 | colorectal cancer | qPCR, Western blot, RIP | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✔ | ✘ | 31558855 | 2019 |
| CCAT1 | cervical cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31935379 | 2020 |
| CCAT1 | colorectal cancer | RT-qPCR, Western Blotting, Luciferase Reporter Assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31807005 | 2019 |
| CCAT1 | breast cancer | microarray, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31695775 | 2019 |
| CCAT1 | cervical cancer | qRT-PCR , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31084453 | 2019 |
| CCAT1 | oral squamous cell carcinoma | qPCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31599709 | 2019 |
| CCAT1 | Colon Cancer | qRT-PCR, Western blotting etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31039730 | 2019 |
| CCAT1 | Colorectal cancer | qPCR, Western blot, etc. | H | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30633886 | 2019 |
| CCAT1 | prostate cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31387890 | 2019 |
| CCAT1 | triple negative breast cancer | qPCR, Luciferase reporter assay, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31310241 | 2019 |
| CCAT1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | 31218739 | 2019 |
| CCAT1 | gallbladder cancer | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 25569100 | 2015 |
| CCAT1 | retinoblastoma | qPCR, RNAi, Western blot, Cell migration and invasion assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28088735 | 2017 |
| CCAT1 | prostate cancer | qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29863242 | 2018 |
| CCAT1 | Non-small cell lung cancer | qPCR;RT-qPCR; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33325119 | 2021 |
| CCAT2 | gastric cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✔ | 32021279 | 2020 |
| CCAT2 | osteosarcoma | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29863240 | 2018 |
| CCAT2 | glioma | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32236863 | 2020 |
| CCAT2 | ovarian cancer | Western blot etc. | H | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32230936 | 2020 |
| CCAT2 | colorectal cancer | qPCR, Western blot, RIP | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✔ | ✘ | 31558855 | 2019 |
| CCAT2 | acute myeloid leukemia | qRT-PCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31949652 | 2018 |
| CCAT2 | triple negative breast cancer | RT-PCR, Western blot assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31904506 | 2020 |
| CCAT2 | osteosarcoma | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31322006 | 2019 |
| CCAT2 | cholangiocarcinoma | qPCR, Western blot, in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29329034 | 2018 |
| CCAT2 | small cell lung cancer | qPCR, Cell proliferation assay, Cell migration and invasion assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 27470400 | 2016 |
| CCAT2 | esophageal squamous cell carcinoma | qPCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 25919911 | 2015 |
| CCAT2 | hepatocellular carcinoma | qPCR, RNAi etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 27347113 | 2016 |
| CCAT2 | gastric cancer | qPCR, RNAi etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 25755774 | 2015 |
| CCAT2 | Prostate cancer | qRT-PCR;luciferase reporter assays;Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32831916 | 2020 |
| CCAT5 | colorectal adenocarcinoma | qRT-PCR , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31599415 | 2019 |
| CCDC26 | pancreatic cancer | qPCR, RNAi, Western blot, Cell proliferation assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 27470572 | 2016 |
| CCDC26 | Myeloid leukemia | RNA immunoprecipitation;Flow Cytometry assay;RNA immunoprecipitation;RNA pull-down; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33439746 | 2021 |
| CCEPR | colorectal adenocarcinoma | qRT-PCR , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31602230 | 2019 |
| CCHE1 | oral squamous cell carcinoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31981240 | 2020 |
| CCHE1 | gastric cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29771412 | 2018 |
| cCSC1 | Colorectal cancer | RT-PCR;Western blot;Flow Cytometry assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33887588 | 2021 |
| CDCA4P3 | acute myeloid leukemia | RNA-seq, qPCR | H | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31356197 | 2019 |
| CDKN2B-AS1 | laryngeal squamous cell cancer | qRT-PCR, Western blot, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31754305 | 2019 |
| CDKN2B-AS1 | osteosarcoma | PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31724892 | 2020 |
| CDKN2B-AS1 | ovarian cancer | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32305052 | 2020 |
| CDKN2B-AS1 | cervical cancer | qPCR, Luciferase reporter assay, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✔ | ✘ | 30884187 | 2019 |
| CDKN2B-AS1 | osteosarcoma | RT-qPCR, Western blot analysis, RIP, Luciferase reporter analysis | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31950433 | 2020 |
| CDKN2B-AS1 | hepatocellular carcinoma | qPCR, Western blot, RIP, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30165194 | 2018 |
| CDKN2B-AS1 | liver cancer | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31646789 | 2019 |
| CDKN2B-AS1 | In-stent restenosis | Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33603842 | 2021 |
| CDKN2BAS | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30510148 | 2018 |
| CEBPA-AS1 | liver cancer | qPCR, Western blot, in vitro knockdown, RNAi | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31646559 | 2019 |
| CERNA2 | gastric cancer | RT-PCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31949664 | 2018 |
| CERS6-AS1 | breast cancer | RT-qPCR, Western blotting, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31701672 | 2020 |
| CERS6-AS1 | Breast cancer | siRNA transfection;Dual-luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32808708 | 2020 |
| CES1P1 | acute myeloid leukemia | RNA-seq, qPCR | L | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31356197 | 2019 |
| Circ-0000212 | Colorectal cancer | RNA immunoprecipitation;RNA immunoprecipitation; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33649850 | 2021 |
| Circ-ASPH | Glioma | Luciferase reporter assay;RNA immunoprecipitation;etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33777211 | 2021 |
| Circ-DENND4C | Hepatocellular Carcinoma | FISH;qRT-PCR;RIP assay;Western blot;FISH;Luciferase reporter assay;Rescue assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 34233663 | 2020 |
| Circ-LDLRAD3 | Gastric cancer | qPCR;RT-qPCR;RIP assay;Rescue assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 33389349 | 2021 |
| circCLSPN | Glioblastoma Multiforme | CCK-8 assay;Dual-luciferase reporter assay;qRT-PCR;etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34269180 | 2021 |
| CircHECTD1 | Glioblastoma | qRT-PCR;luciferase reporter assays;Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34079759 | 2021 |
| CircHIPK3 | Breast cancer | luciferase reporter assays;qRT-PCR;Northern blot assay,RNA FISH | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 27050392 | 2016 |
| CircHIPK3 | Atherosclerosis | ChIP; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33659023 | 2021 |
| CircMTO1 | Atherosclerosis | qPCR;RT-qPCR;Western blot;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34238206 | 2021 |
| CircNEIL3 | Cervical cancer | RNA immunoprecipitation;Luciferase reporter assay;RNA immunoprecipitation; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33413360 | 2021 |
| circNEURL4 | Papillary Thyroid Carcinoma | microarray;qRT-PCR; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34306334 | 2021 |
| CircNFATC3 | Gastric cancer | qRT-PCR;RIP assay;Western blot; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33840258 | 2021 |
| circPVT1 | T Cell Acute Lymphoblastic Leukemia | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34237615 | 2021 |
| circRHOBTB3 | Pancreatic Ductal Adenocarcinoma | RIP assay;Western blot;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | 34416910 | 2021 |
| CircRNA8924 | Cervical cancer | qPCR, Western blot, Luciferase reporter assay etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30007986 | 2018 |
| CircTHBS1 | Primary cystitis glandularis | qPCR;luciferase reporter assays | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32820798 | 2020 |
| CircZFR | Thyroid cancer | qPCR, Luciferase reporter assay and CCK-8 assay | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29842886 | 2018 |
| Circ_0000735 | Bladder cancer | qRT-PCR;RIP assay;Flow Cytometry assay;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 33425100 | 2020 |
| Circ_0004913 | Hepatocellular carcinoma | qRT-PCR;RIP assay;RNA immunoprecipitation;etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 33021399 | 2020 |
| Circ_0005795 | Basal cell carcinoma | luciferase assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33433717 | 2021 |
| Circ_0005909 | Osteosarcoma | CCK-8 assay;qPCR;RT-qPCR;Western blot;luciferase assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33536787 | 2021 |
| Circ_0008039 | Breast cancer | qPCR, Luciferase reporter assay etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29807010 | 2018 |
| circ_0030586 | Bladder Cancer | qPCR;RT-qPCR;RACE;Western blot;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34175686 | 2021 |
| Circ_0057558 | Prostate cancer | luciferase assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33718387 | 2021 |
| Circ_C16orf62 | Gastric cancer | Dual-luciferase reporter assay;qPCR;RT-qPCR;Western blot;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33006960 | 2020 |
| cirRNA_0074027 | Colorectal cancer | Dual-luciferase reporter assay;Western blot;Flow Cytometry assay;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 33760126 | 2021 |
| CLRN1-AS1 | pituitary prolactinoma | qPCR, Western blot, Luciferase reporter assay, RIP | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | 31235696 | 2019 |
| CMPK2 | colorectal cancer | qPCR, Western blot etc | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32203166 | 2020 |
| COL1A1-014 | gastric cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31650323 | 2019 |
| CPS1-IT1 | hepatocellular carcinoma | qPCR, Western blot etc. | H | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 29137263 | 2017 |
| CR749391 | gastric cancer | RT-qPCR, Western blot, RIP, luciferase activity assay | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31853323 | 2020 |
| CRCAL-3 | Colorectal Cancer | qRT-PCR, in vitro knockdown etc. | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31038794 | 2019 |
| CRCAL1-4 | colorectal cancer | qPCR, Western blot, RIP | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✔ | ✘ | 31558855 | 2019 |
| CRNDE | wilms tumor | RT-qPCR | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32096178 | 2020 |
| CRNDE | medulloblastoma | RT-PCR, RIP | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31753063 | 2019 |
| CRNDE | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29864897 | 2018 |
| CRNDE | prostate cancer | qPCR, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32182608 | 2020 |
| CRNDE | colorectal cancer | qPCR, Western blot, RIP | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✔ | ✘ | 31558855 | 2019 |
| CRNDE | colorectal cancer | qPCR, Western blot, RIP | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✔ | ✘ | 31558855 | 2019 |
| CRNDE | osteosarcoma | qRT-PCR, Western blot analysis | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31898343 | 2020 |
| CRNDE | cervical cancer | qRT-PCR , Luciferase reporter assay , Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 31605132 | 2019 |
| CRNDE | Hepatocellular Carcinoma | qRT-PCR, Western blot analysis etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31099050 | 2019 |
| CRNDE | hepatocellular carcinoma | qPCR, Western blot, Other | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30430650 | 2018 |
| CRNDE | tongue squamous cell carcinoma | qPCR, Western blot, Other | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30242873 | 2019 |
| CRNDE | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30230527 | 2019 |
| CRNDE | cervical cancer | qPCR, Western blot, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31202167 | 2019 |
| CRNDE | non small cell lung cancer | qPCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 28477368 | 2017 |
| CRNDE | gastric cancer | qPCR, Western blot, RNAi, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 28490034 | 2017 |
| CRNDE | colorectal cancer | microarray, qPCR, RNAi etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 24184209 | 2014 |
| CRNDE | Chronic lymphocytic leukemia. | Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33857783 | 2021 |
| CRPAT4 | clear cell renal cell carcinoma | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30122945 | 2018 |
| CRYBG3 | lung cancer | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30026857 | 2018 |
| CRYBG3 | lung cancer | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31258784 | 2019 |
| CTC-497E21.4 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31451992 | 2020 |
| CYTOR | colorectal cancer | RIP, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✘ | ✘ | 30064438 | 2018 |
| DANCR | esophageal cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29997918 | 2018 |
| DANCR | glioma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 29940760 | 2018 |
| DANCR | non small cell lung cancer | qPCR , in vitro knockdown etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32196604 | 2020 |
| DANCR | cholangiocarcinoma | qPCR, Western blot, luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 32196584 | 2020 |
| DANCR | breast cancer | qPCR, Luciferase reporter assay, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | ✘ | 30910842 | 2019 |
| DANCR | osteosarcoma | qRT-PCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | 31918278 | 2020 |
| DANCR | colorectal cancer | qRT-PCR, RIP, Western blotting analysis | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31863900 | 2020 |
| DANCR | breast cancer | qRT-PCR, Western immunoblots, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31860165 | 2020 |
| DANCR | ovarian cancer | qRT-PCR, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31858532 | 2019 |
| DANCR | tongue squamous cell carcinoma | qRT-PCR, Luciferase reporter assay, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31827393 | 2019 |
| DANCR | pancreatic cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31804607 | 2019 |
| DANCR | ovarian cancer | qRT-PCR , Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31114986 | 2019 |
| DANCR | Hepatocellular Carcinoma | qRT-PCR, Western blotting, in vitro knockdown, RIP etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31038266 | 2019 |
| DANCR | colon cancer | qPCR, Western Blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30127873 | 2018 |
| DANCR | esophageal squamous cell carcinoma | qPCR, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31401160 | 2019 |
| DANCR | pancreatic cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 31267381 | 2019 |
| DANCR | Pancreatic Cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31213582 | 2019 |
| DANCR | malignant glioma | qPCR, Western blot, Luciferase reporter assays, in vitro knockdown etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29572052 | 2018 |
| DANCR | gastric cancer | qPCR, Luciferase reporter assay, Western blot, RNAi | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29416741 | 2017 |
| DANCR | Hepatocellular carcinoma | qRT-PCR;RACE;Western blot; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | 32964966 | 2020 |
| DARS-AS1 | ovarian cancer | qPCR, Luciferase reporter assay, RIP | H | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30964159 | 2019 |
| DARS-AS1 | thyroid cancer | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31841198 | 2019 |
| DBH-AS1 | large B-cell lymphoma | RT-qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32091157 | 2020 |
| DBH-AS1 | hepatocellular carcinoma | qPCR, Western Blot, Luciferase assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30142544 | 2018 |
| DCST1-AS1 | gastric cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32096164 | 2020 |
| DCST1-AS1 | triple negative breast cancer | Microarray, RT-qPCR, Luciferase reporter assay, Western blotting assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31897227 | 2020 |
| DCST1-AS1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30617187 | 2019 |
| DCST1-AS1 | hepatocellular carcinoma | Microarray, qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | 31371999 | 2019 |
| DCST1-AS1 | hepatocellular carcinoma | Microarray, qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | 31364110 | 2019 |
| DDX11-AS1 | osteosarcoma | RT-qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32014424 | 2020 |
| DDX11-AS1 | gastric cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29912172 | 2018 |
| DDX11-AS1 | non small cell lung cancer | qPCR, Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32298476 | 2020 |
| DDX11-AS1 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, RIP etc | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32271422 | 2020 |
| DDX11-AS1 | hepatocellular carcinoma | qRT-PCR , Western blot , RIP , RNAi , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 31097223 | 2019 |
| DDX11-AS1 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31298324 | 2019 |
| DDX11-AS1 | Esophageal Carcinoma | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34281459 | 2021 |
| DGCR5 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29790668 | 2018 |
| DGCR5 | non small cell lung cancer | qPCR, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31799664 | 2019 |
| DGCR5 | laryngeal cancer | qPCR, Western blot, Luciferase reporter assay, RNAi, RIP | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30980388 | 2019 |
| DGCR5 | hepatocellular carcinoma | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31538334 | 2019 |
| DGCR5 | glioblastoma multiforme | qRT-PCR | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31799672 | 2019 |
| DGCR5 | bladder cancer | qPCR, Western blot, RIP, RNAi, Other | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30238982 | 2019 |
| DGCR5 | hepatocellular carcinoma | qPCR, Western blot, Other | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30230592 | 2019 |
| DGCR5 | hepatocellular carcinoma | qPCR, Western blo, Luciferase reporter assay, RNAi, RIP, Other | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30216442 | 2018 |
| DGCR5 | thyroid cancer | qPCR, Luciferase reporter assay, etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30651878 | 2019 |
| DGCR5 | laryngeal cancer | qPCR, Luciferase reporter assay, in vitro knockdown, RIP, etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30549038 | 2018 |
| DGCR5 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31241800 | 2019 |
| DHRS4-AS4 | Neuroblastoma | qPCR, RNA-seq | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | 30886518 | 2019 |
| DICER1-AS1 | osteosarcoma | Microarray, qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | 29772430 | 2018 |
| DIO3OS | pancreatic cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31384177 | 2019 |
| DIRC3 | melanoma | RT-qPCR, Western blotting, RNA-seq | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31881017 | 2019 |
| DLEU1 | glioblastoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31713587 | 2019 |
| DLEU1 | nasopharyngeal cancer | qPCR, Western blot, Luciferase reporter assay etc | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32214823 | 2020 |
| DLEU1 | clear cell renal cell carcinoma | qRT-PCR, Dual-Luciferase Reporter Gene Assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31858537 | 2019 |
| DLEU1 | renal cell carcinoma | RT-qPCR, Western blot analysis | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 31702026 | 2019 |
| DLEU1 | bladder cancer | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30984249 | 2019 |
| DLEU1 | colorectal cancer | qPCR, ChIP, RIP, Northern blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30098595 | 2018 |
| DLEU1 | oral squamous cell carcinoma | microarray, qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30069008 | 2018 |
| DLEU1 | osteosarcoma | qPCR, Luciferase reporter assay | H | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31379208 | 2019 |
| DLEU1 | glioma | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31360066 | 2019 |
| DLEU1 | glioblastoma multiforme | qPCR, Western blot, RNAi | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31257517 | 2019 |
| DLEU1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31207081 | 2019 |
| DLEU2 | non small cell lung cancer | Western blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | 31721438 | 2019 |
| DLEU2 | gastric cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29912172 | 2018 |
| DLEU2 | osteosarcoma | qPCR, Western blot, RIP, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 32196715 | 2020 |
| DLEU2 | esophageal cancer | RT-PCR, Dual-luciferase reporter assay, Western blot assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31884338 | 2020 |
| DLEU2 | hepatocellular carcinoma | qPCR, Western blot, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31376657 | 2019 |
| DLGAP1-AS1 | hepatocellular carcinoma | qRT-PCR, Western blot (WB) analysis, RIP, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31949128 | 2020 |
| DLGAP1-AS1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31633236 | 2019 |
| DLGAP1-AS2 | glioma | qRT-PCR, western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31899508 | 2020 |
| DLX6-AS | non small cell lung cancer | qRT-PCR , in vitro knockdown , Luciferase reporter assay , Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31190891 | 2019 |
| DLX6-AS1 | esophageal squamous cell carcinoma | qRT-PCR, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32096208 | 2020 |
| DLX6-AS1 | cervical cancer | RT-qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 32077747 | 2020 |
| DLX6-AS1 | breast cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31705901 | 2019 |
| DLX6-AS1 | laryngeal cancer | qPCR, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32368147 | 2020 |
| DLX6-AS1 | neuroblastoma | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32289431 | 2020 |
| DLX6-AS1 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, RIP etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32239379 | 2020 |
| DLX6-AS1 | neuroblastoma | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31787850 | 2019 |
| DLX6-AS1 | nasopharyngeal cancer | qPCR, Western blot, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31782911 | 2019 |
| DLX6-AS1 | laryngeal squamous cell cancer | qRT-PCR | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31814904 | 2019 |
| DLX6-AS1 | liver cancer | Microarray , qRT-PCR , Luciferase reporter assay , Western blot , RIP etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31171015 | 2019 |
| DLX6-AS1 | pancreatic cancer | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31118816 | 2019 |
| DLX6-AS1 | colorectal cancer | qRT-PCR , Luciferase reporter assay , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31115000 | 2019 |
| DLX6-AS1 | ovarian cancer | qRT-PCR , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31081076 | 2019 |
| DLX6-AS1 | pancreatic cancer | qPCR, Western blot, Luciferase reporter assay, RNAi, Other | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30250401 | 2018 |
| DLX6-AS1 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31463827 | 2019 |
| DLX6-AS1 | ovarian cancer | qPCR, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31378881 | 2019 |
| DLX6-AS1 | colorectal cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31646562 | 2019 |
| DLX6-AS1 | adrenocortical carcinoma | microarray, qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 25595289 | 2015 |
| DLX6-AS1 | Prostate cancer | Rescue assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33035382 | 2021 |
| DMTF1v4 | colon cancer | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29949153 | 2018 |
| DNAH17-AS1 | pancreatic cancer | qPCR, Western blot, luciferase reporter assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32351291 | 2020 |
| DQ786243 | ovarian cancer | qPCR, Western Blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30105876 | 2018 |
| DRAIC | gastric cancer | qPCR, Western blot, RIP etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32351584 | 2020 |
| DSCAM-AS1 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32280246 | 2020 |
| DSCAM-AS1 | lung cancer | RNA-seq, qPCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30981459 | 2019 |
| DSCAM-AS1 | ovarian cancer | qRT-PCR , Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31173284 | 2019 |
| DSCAM-AS1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31396335 | 2019 |
| DSCAM-AS1 | Osteosarcoma | qRT-PCR,Luciferase reporter assay,etc.. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32744697 | 2020 |
| DSCAM-AS1 | Osteosarcoma | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32865178 | 2021 |
| DSCR8 | hepatocellular carcinoma | qPCR, Western blot, RIP, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30154476 | 2018 |
| DUBR | Neuroblastoma | qPCR, RNA-seq | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | 30886518 | 2019 |
| DUXAP10 | prostate cancer | qRT-PCR , Western blot , in vitro knockdown etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31114994 | 2019 |
| DUXAP10 | hepatocellular carcinoma | qRT-PCR, Western blotting etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31576658 | 2019 |
| DUXAP10 | pancreatic cancer | qPCR, in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29286182 | 2017 |
| DUXAP10 | non small cell lung cancer | qPCR, RNAi, RIP, western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 28029651 | 2017 |
| DUXAP8 | hepatocellular carcinoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32022476 | 2020 |
| DUXAP8 | bladder cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29917188 | 2018 |
| DUXAP8 | esophageal squamous cell carcinoma | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29771416 | 2018 |
| DUXAP8 | oral cancer | qPCR, RIP etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32304409 | 2020 |
| DUXAP8 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32271433 | 2020 |
| DUXAP8 | colorectal cancer | qPCR, RIP etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31786844 | 2019 |
| DUXAP8 | hepatocellular carcinoma | qRT-PCR , RIP etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31571902 | 2019 |
| DUXAP8 | renal cell carcinoma | qPCR, Western blot, Luciferase reporter assay, Other | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30317248 | 2018 |
| DUXAP8 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31364111 | 2019 |
| DUXAP8 | gastric cancer | qPCR, RNAi, Western blot, Cell proliferation assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 27507049 | 2016 |
| DUXAP8 | Papillary thyroid cancer | Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33522355 | 2021 |
| E330013P06 | breast cancer | qRT-PCR, Western blot assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31907990 | 2020 |
| EBIC | ovarian cancer | qPCR, Western blot | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30058681 | 2018 |
| EGFR-AS1 | renal cancer | qPCR, Western blot, RIP , microarray | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | 30770799 | 2019 |
| EGFR-AS1 | gastric cancer | qPCR, Western Blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30138934 | 2018 |
| EGOT | hepatocellular carcinoma | RT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32021242 | 2019 |
| ELF3-AS1 | osteosarcoma | qPCR, Western blot etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32194747 | 2020 |
| ELF3-AS1 | oral squamous cell carcinoma | RT-qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31686842 | 2019 |
| ELFN1-AS1 | colorectal cancer | qRT-PCR, microarray, Luciferase reporter assay, RIP, Western blotting | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31929141 | 2020 |
| ELFN1-AS1 | colon adenocarcinoma | qRT-PCR, Western blotting | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31814902 | 2019 |
| ELFN1-AS1 | Colon cancer | qRT-PCR; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33634016 | 2021 |
| ELFN1-AS1 | Colorectal Cancer | Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 34337713 | 2021 |
| EMX2OS | ovarian cancer | qPCR, Luciferase reporter assay, RIP etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32273754 | 2020 |
| ENSG00000254041.1 | pancreatic ductal adenocarcinoma | RT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32090981 | 2020 |
| ENST00000413528 | glioma | qPCR, microarray, Luciferase reporter assay, Western blot, RIP | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30924320 | 2019 |
| ENST00000425005 | liver cancer | RT-PCR, Western blot | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 31704308 | 2019 |
| ENST00000425295 | triple negative breast cancer | microarray, qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 25996380 | 2015 |
| ENST00000434223 | gastric cancer | qPCR, Western Blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30138664 | 2018 |
| ENST00000609220 | colon cancer | microarray, qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28160106 | 2017 |
| EPB41L4A-AS2 | ovarian cancer | qPCR, Western blot, Luciferase reporter assay, RIP | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31645082 | 2019 |
| EPIC1 | glioma | qPCR, Western blot etc. | L | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32322669 | 2020 |
| EPIC1 | pancreatic cancer | qRT-PCR, Western blotting, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31810603 | 2020 |
| EPIC1 | lung cancer | qPCR, Western blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30029875 | 2018 |
| EPIC1 | cholangiocarcinoma | qPCR, RIP, Other | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30205958 | 2018 |
| Erbb4-IR | prostate cancer | qPCR etc | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32269615 | 2020 |
| ERRLR01 | breast cancer | RNA-seq, qPCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28795861 | 2017 |
| ESCCAL-1 | esophageal squamous cell carcinoma | microarray, qPCR, RNAi etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 25885227 | 2015 |
| EWS | osteosarcoma | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32236759 | 2020 |
| EWSAT1 | nasopharyngeal cancer | qPCR, Western blot | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29966979 | 2018 |
| EWSAT1 | colorectal cancer | qPCR, Western blot, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30402843 | 2018 |
| EWSAT1 | osteosarcoma | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29243774 | 2017 |
| EZR-AS1 | colorectal cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31693738 | 2019 |
| EZR-AS1 | breast cancer | qPCR, Western blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30186463 | 2018 |
| F11-AS1 | hepatocellular carcinoma | RT-qPCR, RIP, Western blot analysis, Dual-luciferase reporter assay | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31880390 | 2020 |
| FAL1 | osteosarcoma | qPCR, Western blot, in vitro knockdown | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✘ | ✘ | 29987852 | 2018 |
| FAL1 | oesophageal cancer | qPCR, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30873881 | 2019 |
| FAL1 | esophageal cancer | qPCR, Luciferase reporter assay, ChIP, Western Blot | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30178844 | 2018 |
| FAL1 | colon cancer | qPCR, Western blot, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30290064 | 2018 |
| FAL1 | oral squamous cell carcinoma | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31298329 | 2019 |
| FALEC | endometrial cancer | qPCR | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31387003 | 2019 |
| FALEC | Tongue squamous cell carcinoma | qPCR, Western blot, in vitro knockdown, RIP | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31335317 | 2019 |
| FALEC | cervical cancer | qPCR | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31248657 | 2019 |
| FAM201A | lung squamous cell carcinoma | qPCR, Western Blotting Assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31841188 | 2019 |
| FAM201A | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, RNAi | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31298332 | 2019 |
| FAM201A | Triple negative breast cancer | ChIP;qPCR;RT-qPCR;RIP assay;Flow Cytometry assay;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33011533 | 2020 |
| FAM215A | liver cancer | qPCR, Western blot, RIP etc. | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | 32295144 | 2020 |
| FAM225A | nasopharyngeal cancer | Microarray, qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31331909 | 2019 |
| FAM83A-AS1 | hepatocellular carcinoma | qRT-PCR, RIP, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31696213 | 2019 |
| FAM83H-AS1 | triple negative breast cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32074085 | 2020 |
| FAM83H-AS1 | glioma | qPCR, Western blot, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29870057 | 2018 |
| FAM83H-AS1 | hepatocellular carcinoma | qRT-PCR , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31599410 | 2019 |
| FAM83H-AS1 | Intervertebral disc degeneration | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33313263 | 2020 |
| FAM99B | hepatocellular carcinoma | qPCR | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31243545 | 2019 |
| FAS-AS1 | non small cell lung cancer | qPCR, Luciferase Reporter Assay etc | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32329854 | 2020 |
| FBXL19-AS1 | breast cancer | qPCR, Luciferase reporter assay, RIP, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30886065 | 2019 |
| FBXL19-AS1 | breast cancer | qRT-PCR, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31696201 | 2019 |
| FBXL19-AS1 | lung adenocarcinoma | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31566718 | 2019 |
| FBXL19-AS1 | breast cancer | qRT-PCR, Western blot analysis, RIP assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31140103 | 2019 |
| FBXL19-AS1 | non small cell lung cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31210311 | 2019 |
| FENDRR | non small cell lung cancer | qRT-PCR, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31749883 | 2017 |
| FENDRR | colorectal cancer | qPCR | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31724220 | 2019 |
| FENDRR | non small cell lung cancer | qPCR, Luciferase reporter assay | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✘ | ✘ | 31545237 | 2019 |
| FENDRR | non small cell lung cancer | qPCR, Western blot, in vitro knockdown, etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30556873 | 2018 |
| FENDRR | Hepatocellular Carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP | L | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31351327 | 2019 |
| FENDRR | colon cancer | qPCR, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 31213846 | 2019 |
| FENDRR | Colorectal cancer | Dual-luciferase reporter assay;qRT-PCR;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33356998 | 2020 |
| FER1L4 | prostate cancer | RT-qPCR, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32140077 | 2020 |
| FER1L4 | esophageal squamous cell carcinoma | qPCR | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29771417 | 2018 |
| FER1L4 | lung cancer | qRT-PCR , Western blot etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31115514 | 2019 |
| FER1L4 | gastric cancer | microarray, qPCR, RNAi etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 25124853 | 2014 |
| FEZF1-AS1 | epithelial ovarian cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32135030 | 2019 |
| FEZF1-AS1 | hepatocellular carcinoma | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 29957463 | 2018 |
| FEZF1-AS1 | colorectal cancer | Microarray, qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29914894 | 2018 |
| FEZF1-AS1 | multiple myeloma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29864963 | 2018 |
| FEZF1-AS1 | breast cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29797562 | 2018 |
| FEZF1-AS1 | prostate cancer | qPCR, Western blot etc | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 32196579 | 2020 |
| FEZF1-AS1 | oral squamous cell carcinoma | qPCR, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31378890 | 2019 |
| FEZF1-AS1 | prostate cancer | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31298365 | 2019 |
| FEZF1-AS1 | osteosarcoma | RT-PCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29510778 | 2018 |
| FEZF1-AS1 | breast cancer | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29797562 | 2018 |
| FGD5-AS1 | non small cell lung cancer | qRT-PCR, Western blot, luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31919528 | 2020 |
| FGD5-AS1 | oral squamous cell carcinoma | qRT-PCR, Western Blot, Luciferase Reporter Assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31899825 | 2020 |
| FGD5-AS1 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31332696 | 2019 |
| FGD5-AS1 | Gastric cancer | qRT-PCR,luciferase reporter assay etc. | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32849774 | 2020 |
| FGD5-AS1 | Pancreatic cancer | Flow cytometry assay;qPCR;RT-qPCR;RIP assay;Western blot;Flow Cytometry assay;Rescue assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33794727 | 2021 |
| FGD5-AS1 | Osteosarcoma | Luciferase reporter assay;RNA immunoprecipitation;etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33891267 | 2021 |
| FGF13-AS1 | breast cancer | qPCR, Luciferase reporter assay, RIP, Western blot | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30771425 | 2019 |
| FIRRE-201 | colorectal cancer | RNA-seq, qPCR | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30039525 | 2018 |
| FLANC | colorectal cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31988194 | 2020 |
| FLVCR1-AS1 | glioma | qRT-PCR, Dual-luciferase reporter assay, RIP | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31699367 | 2020 |
| FLVCR1-AS1 | lung cancer | qPCR, Western blot, Luciferase reporter assay, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30309647 | 2018 |
| FLVCR1-AS1 | ovarian cancer | qPCR, Western blot, Other | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31412903 | 2019 |
| FOXC2-AS1 | non small cell lung cancer | qPCR, Western blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31396359 | 2019 |
| FOXCUT | gastric adenocarcinoma | qPCR | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31364114 | 2019 |
| FOXD1-AS1 | glioma | qRT-PCR, Western blotting, in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31102349 | 2019 |
| FOXD2-AS1 | cervical cancer | RT-qPCR, Western blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32082174 | 2020 |
| FOXD2-AS1 | gastric cancer | qPCR, Western blot, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29789713 | 2018 |
| FOXD2-AS1 | glioma | qPCR, Western blot etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 31770107 | 2019 |
| FOXD2-AS1 | glioma | qPCR, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✔ | ✘ | 30860979 | 2019 |
| FOXD2-AS1 | hepatocellular carcinoma | RT-qPCR, western blotting, Dual-luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31841454 | 2019 |
| FOXD2-AS1 | cervical cancer | qRT-PCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31841177 | 2019 |
| FOXD2-AS1 | osteosarcoma | qRT-PCR , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31115575 | 2019 |
| FOXD2-AS1 | thyroid cancer | qRT-PCR , Western blot , RIP etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | 31024447 | 2019 |
| FOXD2-AS1 | hepatocellular carcinoma | qRT-PCR , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31004581 | 2019 |
| FOXD2-AS1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP, RNAi, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30272362 | 2018 |
| FOXD2-AS1 | glioma | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31347720 | 2019 |
| FOXD2-AS1 | osteosarcoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31228799 | 2019 |
| FOXD2-AS1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31210410 | 2019 |
| FOXD2-AS1 | esophageal squamous cell carcinoma | qRT-PCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29286915 | 2018 |
| FOXD2-AS1 | colorectal cancer | qPCR, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28925486 | 2017 |
| FOXD2-AS1 | Rheumatoid arthritis | qRT-PCR;luciferase reporter assays;Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34030529 | 2021 |
| FOXD3-AS1 | nasopharyngeal cancer | RT-qPCR, Western blot, microarray | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32073875 | 2020 |
| FOXD3-AS1 | melanoma | qPCR, RIP, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32354225 | 2020 |
| FOXD3-AS1 | non small cell lung cancer | qPCR, Western blot, luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32196603 | 2020 |
| FOXD3-AS1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32191537 | 2020 |
| FOXD3-AS1 | thyroid cancer | qRT-PCR, Western blot analysis, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31678422 | 2020 |
| FOXD3-AS1 | colorectal cancer | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31058315 | 2019 |
| FOXD3-AS1 | breast cancer | qRT-PCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31017311 | 2019 |
| FOXO1 | lung cancer | qPCR, Western blot, in vitro knockdown | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31217928 | 2019 |
| FOXP4-AS1 | osteosarcoma | qPCR, Western blot, in vitro knockdown, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29859193 | 2018 |
| FOXP4-AS1 | cervical cancer | qPCR, Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32256085 | 2020 |
| FOXP4-AS1 | prostate cancer | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31209207 | 2019 |
| FOXP4-AS1 | gastric cancer | qPCR, Western blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31646567 | 2019 |
| FTH1P3 | cervical cancer | qPCR, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31789421 | 2019 |
| FTH1P3 | esophageal squamous cell carcinoma | qPCR, Western Blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30119232 | 2018 |
| FTH1P3 | oral squamous cell carcinoma | qPCR, Cell transfection, Western blot, Luciferase reporter assay, RNA pull-down assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28093311 | 2017 |
| FTX | non small cell lung cancer | qRT-PCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 32176463 | 2019 |
| FTX | gastric cancer | qRT-PCR, Western blot, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32021248 | 2019 |
| FTX | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29925853 | 2018 |
| FTX | hepatocellular carcinoma | qPCR, Western blot, in vitro knockdown, RNAi | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29845188 | 2018 |
| FTX | colorectal cancer | qPCR, Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32280242 | 2020 |
| FTX | gastric cancer | qPCR, Western blot etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32271421 | 2020 |
| FTX | lung adenocarcinoma | qPCR, RIP etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 32226311 | 2020 |
| FTX | osteosarcoma | qRT-PCR, Western blotting, Dual-luciferase reporter analysis, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31920141 | 2020 |
| FTX | renal cell carcinoma | qPCR, Cell proliferation assay, Cell cycle assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 27983937 | 2017 |
| FUNDC2P4 | hepatocellular carcinoma | Microarray, qRT-PCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29295626 | 2018 |
| GAB2 | ovarian cancer | qPCR, Western Blot | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30093110 | 2018 |
| GABPB1-IT1 | Hepatocellular carcinoma | Luciferase activity assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33664823 | 2021 |
| GACAT1 | breast cancer | qPCR, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32194758 | 2020 |
| GACAT1 | gastric cancer | qPCR, Luciferase reporter assay, Western blot, Other | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30405842 | 2018 |
| GACAT3 | breast cancer | qRT-PCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31983109 | 2019 |
| GACAT3 | liver cancer | Western blot etc | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32266036 | 2020 |
| GACAT3 | gastric cancer | qPCR, Western Blot, Dual luciferase assay | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30098426 | 2018 |
| GACAT3 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, RNAi, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30317610 | 2019 |
| GACAT3 | non small cell lung cancer | qPCR, Western blot, Luciferase reporting assay etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29565489 | 2018 |
| GALNT5 | gastric cancer | Microarray, RIP etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29743591 | 2018 |
| GAPDH | bladder cancer | qPCR | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31308745 | 2019 |
| GAPLINC | gastric cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29785127 | 2018 |
| GAPLINC | perihilar cholangiocarcinoma | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30128015 | 2018 |
| GAPLINC | glioblastoma multiforme | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30657584 | 2019 |
| GAS5 | cervical cancer | qRT-PCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32105659 | 2020 |
| GAS5 | bladder cancer | qRT-PCR, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32069387 | 2019 |
| GAS5 | liver cancer | qRT-qPCR, Western blot | L | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31705194 | 2019 |
| GAS5 | esophageal squamous cell carcinoma | Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 30008868 | 2018 |
| GAS5 | breast cancer | qPCR, Western blot, Luciferase reporter assay, RIP | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | 30007957 | 2018 |
| GAS5 | breast cancer | Microarray, qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | L | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29969658 | 2018 |
| GAS5 | ovarian cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29896229 | 2018 |
| GAS5 | renal cell carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29895198 | 2018 |
| GAS5 | triple negative breast cancer | qPCR, Western blot, Luciferase reporter assay | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29793177 | 2018 |
| GAS5 | melanoma | qPCR, Western blot, Luciferase reporter assay, RIP, in vitro knockdown etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32308561 | 2020 |
| GAS5 | gastric cancer | qRT-PCR, Western Blotting, Dual Luciferase Report | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31910411 | 2020 |
| GAS5 | glioma | qRT-PCR, Western blot assay | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31889362 | 2019 |
| GAS5 | gastric cancer | qRT-PCR , Luciferase reporter assay , Western blot etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31182630 | 2019 |
| GAS5 | glioma | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31172354 | 2019 |
| GAS5 | oral squamous cell carcinoma | qRT-PCR , Luciferase reporter assay , RNAi , in vitro knockdown etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31583913 | 2019 |
| GAS5 | laryngeal squamous cell cancer | qRT-PCR, Western blotting etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31572003 | 2019 |
| GAS5 | glioma | microarray, qPCR | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30078184 | 2018 |
| GAS5 | colorectal cancer | qPCR, Dual-Luciferase reporter assay, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30066886 | 2018 |
| GAS5 | osteosarcoma | Microarray, qPCR, Western blot, in vitro knockdown | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31337976 | 2019 |
| GAS5 | Breast Cancer | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31326549 | 2019 |
| GAS5 | Ovarian Cancer | qPCR, Western blot, Luciferase reporter assay, RIP | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31314588 | 2019 |
| GAS5 | triple negative breast cancer | qPCR | L | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31282278 | 2019 |
| GAS5 | hepatocellular carcinoma | qPCR, Luciferase reporter assay | L | ✔ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31235746 | 2019 |
| GAS5 | cervical cancer | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31206689 | 2019 |
| GAS5 | bladder cancer | Microarray, qPCR etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 29516641 | 2018 |
| GAS5 | colorectal cancer | qPCR etc. | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29630521 | 2018 |
| Gas5 | Pulmonary hypertension | qRT-PCR; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33010302 | 2020 |
| GAS5-AS1 | glioma | qRT-qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32072565 | 2020 |
| GAS6-AS1 | hepatocellular carcinoma | RT-qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32089066 | 2020 |
| GAS6-AS2 | osteosarcoma | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 32269179 | 2020 |
| GAS6-AS2 | hepatocellular carcinoma | qRT-PCR, luciferase reporter analysis, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31933797 | 2019 |
| GAS6-AS2 | breast cancer | RT-qPCR, RIP, luciferase reporter assay, western blotting | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31839366 | 2020 |
| GAS6-AS2 | melanoma | q-PCR , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31162889 | 2019 |
| GAS6-AS2 | Non-small-cell lung cancer | Dual-luciferase reporter assay;qRT-PCR;Western blot;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33459113 | 2021 |
| GAS8-AS1 | osteosarcoma | RT-qPCR | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32013985 | 2020 |
| GAS8-AS1 | papillary thyroid cancer | qPCR, Western blot, Luciferase reporter assay, Other | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30429236 | 2019 |
| GAS8-AS1 | hepatocellular carcinoma | qPCR, RIP, RNAi, Other | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 30228180 | 2018 |
| GASL1 | prostate cancer | RT-qPCR, Western blotting etc. | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31186749 | 2019 |
| GASL1 | Gastric cancer | Cell transfection;Cell transfection;qPCR;RT-qPCR;Western blot;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32897806 | 2020 |
| GATA2-AS1 | non small cell lung cancer | qRT-PCR , Western blot , RNAi , RIP etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31607132 | 2019 |
| GATA3-AS1 | hepatocellular carcinoma | RT-qPCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31871924 | 2019 |
| GATA6-AS | glioma | RT-qPCR | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31809214 | 2019 |
| GATA6-AS | mantle cell lymphoma | qPCR, Western blot | L | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31402946 | 2019 |
| GATA6-AS | Cervical cancer | qPCR;RT-qPCR; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 33167959 | 2020 |
| GATA6-AS1 | gastric cancer | qRT-PCR, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31981860 | 2019 |
| GBCDRlnc1 | gallbladder cancer | qPCR, microarray, Western blot, RIP, RNAi | H | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30953511 | 2019 |
| GCASPC | gallbladder cancer | qPCR, RIP, RNA pull-down assay, Mass Spetcrometry etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 27450454 | 2016 |
| GClnc1 | osteosarcoma | qPCR, Western blot assay, Luciferase reporter assay, Other | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30454890 | 2018 |
| GClnc1 | bladder cancer | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31298933 | 2019 |
| GClnc1 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31298323 | 2019 |
| GCRL1 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29789536 | 2018 |
| GEHT1 | ovarian cancer | qRT-PCR , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30988076 | 2019 |
| GHET1 | osteosarcoma | qPCR, Western blot etc | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 32319657 | 2020 |
| GHET1 | gastric cancer | qPCR, Western blot etc | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32176622 | 2020 |
| GHET1 | cervical cancer | qRT-PCR, Western blot, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31682716 | 2020 |
| GHET1 | gastric cancer | qPCR | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30066922 | 2018 |
| GHRLOS | Non-small cell lung cancer | ChIP;Dual-luciferase reporter assay;qRT-PCR;etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 33968785 | 2021 |
| GIAT4RA | non small cell lung cancer | qPCR, Western blot, RIP, RNAi, Other | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 31417184 | 2019 |
| GIHCG | tongue squamous cell carcinoma | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29953645 | 2018 |
| GIHCG | Cervical Cancer | qPCR | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30719165 | 2019 |
| GIHCG | breast cancer | qRT-PCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31858553 | 2019 |
| GLCC1 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RNAi, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31375671 | 2019 |
| GMDS-AS1 | lung adenocarcinoma | RT-qPCR, Western blot, Luciferase assay | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31860169 | 2020 |
| GNAS-AS1 | nasopharyngeal cancer | qPCR, Western blot etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32271425 | 2020 |
| GNAS-AS1 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31267263 | 2019 |
| GPC3-AS1 | cervical cancer | in vitro knockdown , Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31168873 | 2019 |
| H19 | chronic myeloid leukemia | qRT-PCR, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32160707 | 2020 |
| H19 | T cell acute lymphoblastic leukemia | qPCR, Western blot, microarray | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32146726 | 2020 |
| H19 | prostate cancer | qPCR, Western blot, microarray | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32146726 | 2020 |
| H19 | multiple myeloma | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31712391 | 2019 |
| H19 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay | L | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29968942 | 2018 |
| H19 | melanoma | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 29950863 | 2018 |
| H19 | lung cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29950144 | 2018 |
| H19 | retinoblastoma | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29805578 | 2018 |
| H19 | breast cancer | qPCR, Western blot etc. | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32345117 | 2020 |
| H19 | gastric cancer | qPCR, Western blot etc. | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31787851 | 2019 |
| H19 | glioma | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31777264 | 2019 |
| H19 | gastric cancer | qPCR | H | ✘ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✘ | 30945348 | 2019 |
| H19 | lung cancer | qRT-PCR , Luciferase reporter assay , Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31187349 | 2019 |
| H19 | glioma | qRT-PCR , Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31173296 | 2019 |
| H19 | pancreatic neuroendocrine tumor | qRT-PCR , RNA-seq , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31117050 | 2019 |
| H19 | uterine leiomyoma | qRT-PCR , in vitro knockdown etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31089260 | 2019 |
| H19 | gastric cancer | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31081061 | 2019 |
| H19 | gastric cancer | qPCR, Western blot, Cell invasion assay, Cell migration assay Animal experiments | H | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30192003 | 2018 |
| H19 | endometrial cancer | qPCR, Western blot, Dual Luciferase Reporter Gene Assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30070313 | 2018 |
| H19 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, RNAi, RIP, Other | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 30362512 | 2019 |
| H19 | breast cancer | qPCR, Other | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31436255 | 2019 |
| H19 | acute myeloid leukemia | qPCR, Western blot | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31389605 | 2019 |
| H19 | pituitary adenoma | qPCR, Western blot | L | ✔ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31369093 | 2019 |
| H19 | lung adenocarcinoma | qPCR, Western blot, Luciferase reporter assay, RNA interference | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31317666 | 2019 |
| H19 | anaplastic thyroid cancer | qPCR | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31299871 | 2019 |
| H19 | hepatocellular carcinoma | qPCR, Western blot, in vitro knockdown | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31298392 | 2019 |
| H19 | colorectal cancer | qPCR | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31232113 | 2019 |
| H19 | cervical cancer | qPCR | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31229557 | 2019 |
| H19 | non small cell lung cancer | qPCR, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31219199 | 2019 |
| H19 | breast cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31217890 | 2019 |
| H19 | rectal cancer | Western blot | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31638183 | 2019 |
| H19 | oral squamous cell carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29344674 | 2018 |
| H19 | tongue squamous cell carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29523225 | 2018 |
| H19 | ovarian cancer | qPCR, RNAi etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 19656414 | 2009 |
| H19 | hepatocellular carcinoma | qPCR, Western blot, RIP, RNA pull-down assay etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 23811339 | 2013 |
| H19 | glioma | microarray, qPCR, RNAi, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 24466011 | 2014 |
| H19 | gastric cancer | qPCR, Western blot, Luciferase reporter assay | H | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 28848149 | 2017 |
| H19 | breast cancer | qPCR, Western blot, Luciferase report assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28544374 | 2017 |
| H19 | lung cancer | qPCR, etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29950144 | 2018 |
| H19 | hepatocellular carcinoma | qPCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 26378581 | 2015 |
| H19 | Endometriosis | qRT-PCR;Western blot assay | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 26089099 | 2015 |
| H19 | Lung cancer | Dual-luciferase reporter assay;Western blot;Flow Cytometry assay;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33527767 | 2021 |
| H19 | Atherosclerosis | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33235026 | 2021 |
| H19 | Glioma | qPCR;RT-qPCR;Western blot;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33161527 | 2020 |
| H22954 | acute myeloid leukemia | qPCR, Luciferase reporter assay, Western blot | L | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30959078 | 2019 |
| HAGLR | lung adenocarcinoma | Microarray, qPCR , in vitro knockdown , Western blot , RIP etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31194977 | 2019 |
| HAGLROS | lung cancer | qPCR, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31378893 | 2019 |
| HAL | serous ovarian cancer | qRT-PCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 32039453 | 2020 |
| HAND2-AS1 | gastric cancer | qPCR, RIP etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32368078 | 2020 |
| HAND2-AS1 | cervical cancer | Microarray, qPCR, Western blot, Luciferase reporter assay, RIP etc | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32314545 | 2020 |
| HAND2-AS1 | hepatocellular carcinoma | Western blot, RIP etc | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32224127 | 2020 |
| HAND2-AS1 | triple negative breast cancer | qPCR, Western blot etc | L | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31788122 | 2019 |
| HAND2-AS1 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, RIP etc | L | ✔ | ✘ | ✔ | ✘ | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | 31760170 | 2019 |
| HAND2-AS1 | cervical cancer | Microarray, Dual luciferase reporter assay, RIP, RT-qPCR, Western blot analysis | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31889905 | 2019 |
| HAND2-AS1 | breast cancer | RT-qPCR, Western blot analysis, Dual luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31683462 | 2020 |
| HAND2-AS1 | colorectal cancer | qPCR, Luciferase assay | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30078677 | 2018 |
| HAND2-AS1 | ovarian cancer | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31222748 | 2019 |
| HANR | non small cell lung cancer | qRT-PCR | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32016972 | 2020 |
| HAS2-AS1 | non small cell lung cancer | qPCR, Western blot, RIP etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32269726 | 2020 |
| HAS2-AS1 | ovarian cancer | RT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31082772 | 2019 |
| HAS2-AS1 | glioblastoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31385362 | 2019 |
| HCCL5 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30482773 | 2018 |
| HCG11 | laryngeal cancer | qPCR, Western blot, Luciferase reporter assay, RIP etc | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32271435 | 2020 |
| HCG11 | gastric cancer | qRT-PCR, Western blot, RIP, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31889902 | 2019 |
| HCG11 | hepatocellular carcinoma | qRT-PCR, Western Blot Assay, Dual-Luciferase Reporter Assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | 31858580 | 2019 |
| HCG11 | glioma | qPCR, Luciferase reporter assay, in vitro knockdown, RIP, etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30706982 | 2019 |
| HCG11 | glioma | qPCR, Western blot, Luciferase reporter assay, RIP | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31310044 | 2019 |
| HCG11 | prostate cancer | qPCR, Western blot, Luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31228307 | 2019 |
| HCG11 | Oral squamous cell carcinoma | MTT assay;Western blot;Flow Cytometry assay;Luciferase reporter assay;MTT assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33151000 | 2021 |
| HCG15 | glioma | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32346611 | 2020 |
| HCG18 | gastric cancer | qPCR, Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32256081 | 2020 |
| HCG18 | colorectal cancer | RT-qPCR, Dual-luciferase reporter assay, Western blot analysis | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31854468 | 2020 |
| HCG18 | nasopharyngeal cancer | RT-PCR, Western Blot, Luciferase Reporter Assays | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31841193 | 2019 |
| HCG22 | bladder cancer | qPCR, Western blot, RIP | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31304601 | 2019 |
| HCP5 | non small cell lung cancer | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32104093 | 2020 |
| HCP5 | prostate cancer | RT-qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31746434 | 2020 |
| HCP5 | gastric cancer | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32357145 | 2020 |
| HCP5 | clear cell renal cell carcinoma | qPCR, Luciferase reporter assay, RIP etc | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32271414 | 2020 |
| HCP5 | oral squamous cell carcinoma | RT-qPCR, Western Blot Analysis, Dual-Luciferase Reporter Assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31849534 | 2019 |
| HCP5 | acute myeloid leukemia | qRT-PCR, Western blotting | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31836918 | 2020 |
| HCP5 | lung adenocarcinoma | qRT-PCR, in vitro knockdown, Western blot analysis, Chromatin immunoprecipitation etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31131047 | 2019 |
| HCP5 | cervical cancer | qPCR, Western blot, Luciferase Reporter Gene Assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30070314 | 2018 |
| HCP5 | triple negative breast cancer | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31215169 | 2019 |
| HCP5 | Hepatocellular carcinoma | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 34148029 | 2021 |
| HEIH | liver cancer | RT-PCR , Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31144384 | 2019 |
| HEIH | non small cell lung cancer | qPCR, Western blot, Other | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30230600 | 2019 |
| HEIH | Endometrial Cancer | qPCR, Western blot | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31650338 | 2019 |
| HEIH | Ovarian cancer | RNA immunoprecipitation;Western blot;RNA immunoprecipitation;Rescue assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33110047 | 2020 |
| HGBC | gallbladder cancer | RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31752906 | 2019 |
| HHIP-AS1 | hepatocellular carcinoma | qRT-PCR , Western blot , RIP , in vitro knockdown etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31604528 | 2019 |
| HIF1A-AS2 | osteosarcoma | RT-PCR, Western blotting, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31866584 | 2019 |
| HIF2PUT | osteosarcoma | qPCR, Western blot | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✔ | ✘ | 30966832 | 2019 |
| HIPK1-AS | cervical cancer | Microarray, qPCR, in vitro knockdown | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29901171 | 2018 |
| HKLINCR1 | lung cancer | qRT-PCR , RNA-seq , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31089191 | 2019 |
| HLA-F-AS1 | colorectal cancer | qRT-PCR, Dual luciferase reporter gene assay, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31863778 | 2019 |
| HLA-F-AS1 | Triple negative breast cancer | Western blot;Flow Cytometry assay;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33618253 | 2021 |
| HMGA2 | pancreatic cancer | qRT-PCR | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 32010621 | 2020 |
| HMMR-AS1 | lung adenocarcinoma | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31128573 | 2019 |
| HMMR-AS1 | breast cancer | qPCR, RNAi, Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 27920576 | 2016 |
| HNF1A-AS1 | gastric cancer | qPCR, Western blot, RIP, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32336754 | 2020 |
| HNF1A-AS1 | cervical cancer | Dual luciferase reporter gene assay, RIP, RT-qPCR, Western blot assay | H | ✔ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31827397 | 2019 |
| HNF1A-AS1 | gastric cancer | qPCR, Western blot, Dual-luciferase reporter assays, ChIP, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30185552 | 2018 |
| HNF1A-AS1 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31243821 | 2019 |
| HNRNPU-AS1 | Cervical Cancer | qPCR;RT-qPCR;Flow Cytometry assay;luciferase assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 34309414 | 2021 |
| HORAS5 | prostate cancer | qPCR, Western blot, RNA-seq | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | 30776192 | 2019 |
| HOST2 | triple negative breast cancer | qPCR, Western blot, Luciferase reporter assay, RIP etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32248842 | 2020 |
| HOST2 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31799663 | 2019 |
| HOST2 | ovarian cancer | RT-qPCR, Western blot analyses | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31701766 | 2019 |
| HOST2 | hepatocellular carcinoma | qPCR, Western blot, Other | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30453302 | 2018 |
| HOST2 | pancreatic cancer | qPCR, Other | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30406400 | 2020 |
| HOTAIR | medulloblastoma | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31986414 | 2020 |
| HOTAIR | liver cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29849802 | 2018 |
| HOTAIR | colorectal cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29808247 | 2018 |
| HOTAIR | renal cell carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29789714 | 2018 |
| HOTAIR | prostate cancer | qPCR, Western blot, Luciferase reporter assay | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29807357 | 2018 |
| HOTAIR | gastric cancer | qPCR, Western blot, Luciferase reporter assay etc. | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32364078 | 2020 |
| HOTAIR | glioblastoma | qPCR, Western blot etc. | L | ✔ | ✘ | ✔ | ✘ | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | 32279420 | 2020 |
| HOTAIR | lung cancer | qPCR, Luciferase reporter assay, RIP etc. | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 32248643 | 2020 |
| HOTAIR | gastric cancer | Luciferase reporter assay, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30810117 | 2019 |
| HOTAIR | non small cell lung cancer | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30720199 | 2019 |
| HOTAIR | small cell lung cancer | qRT-PCR, Western blotting analysis, Luciferase reporter assays | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31934137 | 2019 |
| HOTAIR | hepatocellular carcinoma | qRT-PCR, Western blot, Luciferase assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31933720 | 2019 |
| HOTAIR | breast cancer | RT-PCR, Western blot analysis | H | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31882666 | 2019 |
| HOTAIR | gastric cancer | qRT-PCR, Western Blot Assay, Dual-Luciferase Reporter Assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31819516 | 2019 |
| HOTAIR | Acute myeloid leukemia | qPCR, Western blot, ChIP | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30172749 | 2018 |
| HOTAIR | renal cell carcinoma | qPCR, Fluorescent in situ hybridization, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30105850 | 2018 |
| HOTAIR | lung cancer | qPCR, Western blot, Luciferase reporter assay | H | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30047193 | 2018 |
| HOTAIR | colorectal cancer | qPCR, RIP, Other | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30362162 | 2019 |
| HOTAIR | nasopharyngeal cancer | qPCR, Luciferase reporter assay, Other | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30314699 | 2018 |
| HOTAIR | lung cancer | qPCR, Western blot, RIP, Other | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30223276 | 2018 |
| HOTAIR | gastric cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30557546 | 2018 |
| HOTAIR | lung cancer | qPCR, Western blot, Luciferase reporter assay, RIP, etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31475459 | 2019 |
| HOTAIR | oesophageal cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31389660 | 2019 |
| HOTAIR | breast cancer | qPCR, Western blot, RIP | L | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31367244 | 2019 |
| HOTAIR | Breast Cancer | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31326549 | 2019 |
| HOTAIR | colon cancer | qPCR, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31298326 | 2019 |
| HOTAIR | head and neck squamous cell carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31297902 | 2019 |
| HOTAIR | gastric cancer | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31281667 | 2019 |
| HOTAIR | breast cancer | qPCR, Western blot, RNAi | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31281438 | 2019 |
| HOTAIR | esophageal squamous cell carcinoma | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31207321 | 2019 |
| HOTAIR | cutaneous squamous cell carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31649487 | 2019 |
| HOTAIR | gastrointestinal stromal tumor | qPCR, RNAi, Western blot, RIP, Cell proliferation assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 27659532 | 2016 |
| HOTAIR | nasopharyngeal cancer | qPCR, Western Blotting etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29228426 | 2017 |
| HOTAIR | glioblastoma | qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 27306825 | 2016 |
| HOTAIR | head and neck squamous cell carcinoma | qPCR, Western blot, Flow cytometry assay etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 26592246 | 2015 |
| HOTAIR | prostate cancer | qPCR, RNAi, Western blot, Flow cytometry assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | 26962687 | 2016 |
| HOTAIR | pancreatic cancer | qPCR etc. | L | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 28476883 | 2017 |
| HOTAIR | pancreatic cancer | qPCR, RNAi, Luciferase reporter assay, in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 22614017 | 2013 |
| HOTAIR | bladder cancer | qPCR, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 25030736 | 2014 |
| HOTAIR | non small cell lung cancer | qPCR, RNAi, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 24103700 | 2013 |
| HOTAIR | cervical cancer | qPCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 24748337 | 2014 |
| HOTAIR | breast cancer | RC-PCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29325547 | 2018 |
| HOTAIR | breast cancer | qPCR, Luciferase reporter assay, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29222472 | 2017 |
| HOTAIR | colorectal cancer | qPCR, western blot etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29808247 | 2018 |
| HOTAIR | Cholangiocarcinoma | qRT-PCR,Western blot,RIP etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | 32755793 | 2020 |
| HOTAIR | Glioma | Dual-luciferase reporter assay;Flow Cytometry assay;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 33425098 | 2020 |
| HOTAIRM1 | head and neck cancer | qPCR, Western blot, Luciferase reporter assay | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29905017 | 2018 |
| HOTAIRM1 | breast cancer | qPCR, RIP etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32284737 | 2020 |
| HOTAIRM1 | papillary thyroid cancer | qPCR, Luciferase reporter assay etc | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32269214 | 2020 |
| HOTAIRM1 | glioma | qPCR, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32180085 | 2020 |
| HOTAIRM1 | ovarian cancer | qRT-PCR, Western blot, RIP, Luciferase activity assay | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31935390 | 2020 |
| HOTAIRM1 | type I endometrial cancer | qRT-PCR, Western Blot Assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31853186 | 2019 |
| HOTAIRM1 | glioblastoma multiforme | qPCR, RNAi, Other | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 30376874 | 2018 |
| HOTAIRM1 | Pancreatic ductal adenocarcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdow, etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30613920 | 2019 |
| HOTAIRM1 | Thyroid cancer | MTT assay;qPCR;RT-qPCR;Western blot;luciferase assay;MTT assay; | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 33650656 | 2021 |
| HOTTIP | prostate cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 29884766 | 2018 |
| HOTTIP | papillary thyroid cancer | qPCR, Western blot, Luciferase reporter assay etc | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | 32335029 | 2020 |
| HOTTIP | pancreatic cancer | qPCR, Western blot, Luciferase reporter assay, RIP etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32280243 | 2020 |
| HOTTIP | papillary thyroid cancer | qPCR etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32194727 | 2020 |
| HOTTIP | colorectal cancer | qRT-PCR, Western Blotting Assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31945724 | 2020 |
| HOTTIP | oral tongue squamous cell carcinoma | qRT-PCR, Dual-luciferase reporter assay, Western blot assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31910357 | 2020 |
| HOTTIP | gastric cancer | Western Blot, qRT-PCR, Dual-Luciferase Reporter Assay, RIP | H | ✔ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31908497 | 2019 |
| HOTTIP | acute myeloid leukemia | qRT-PCR , Luciferase reporter assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31002141 | 2019 |
| HOTTIP | renal cell carcinoma | qPCR, RIP, ChIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30021349 | 2018 |
| HOTTIP | renal cell carcinoma | qPCR, Western blot, Luciferase reporter assay, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30226576 | 2018 |
| HOTTIP | laryngeal cancer | qPCR, Western blot, Luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31328440 | 2019 |
| HOTTIP | tongue squamous cell carcinoma | qPCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 26058875 | 2015 |
| HOTTIP | non small cell lung cancer | qPCR, RNAi, Flow cytometry assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 27347311 | 2016 |
| HOTTIP | hepatocellular carcinoma | qPCR, RNAi, Dual-luciferase reporter assay, Cell proliferation assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 26710269 | 2015 |
| HOXA-AS2 | acute myeloid leukemia | qPCR, Western blot etc. | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32369230 | 2020 |
| HOXA-AS2 | osteosarcoma | qRT-PCR, Luciferase Reporter Assay, RIP, Western Blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31853184 | 2019 |
| HOXA-AS2 | glioma | qRT-PCR, Western Blot Analysis, Dual-Luciferase Reporter Assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31819475 | 2019 |
| HOXA-AS2 | osteosarcoma | qPCR, Luciferase assay, Western Blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30081707 | 2018 |
| HOXA-AS2 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, Other | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30415263 | 2018 |
| HOXA-AS2 | papillary thyroid cancer | qPCR, Western blot, Luciferase reporter assay, RIP, RNAi, Other | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30384358 | 2018 |
| HOXA-AS2 | papillary thyroid cancer | qPCR, Western blot, RNAi, Luciferase reporter assay, RIP, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30375256 | 2019 |
| HOXA-AS2 | non small cell lung cancer | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31389597 | 2019 |
| HOXA-AS2 | malignant glioma | qPCR, Luciferase reporter assay, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29310118 | 2018 |
| HOXA-AS3 | lung adenocarcinoma | qPCR, Western blot, in vitro knockdown, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29899328 | 2018 |
| HOXA-AS3 | hepatocellular carcinoma | qPCR, Luciferase reporter assay, RIP, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30963785 | 2019 |
| HOXA10-AS | acute myeloid leukemia | qRT-PCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31867596 | 2019 |
| HOXA10-AS | glioma | qPCR, Western Blot | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30132568 | 2018 |
| HOXA11-AS | hypopharyngeal squamous cell carcinoma | qRT-PCR | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31987067 | 2020 |
| HOXA11-AS | glioma | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31737190 | 2019 |
| HOXA11-AS | oral squamous cell carcinoma | qRT-PCR, Western blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 31731187 | 2020 |
| HOXA11-AS | clear cell renal cell carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 29953617 | 2018 |
| HOXA11-AS | non small cell lung cancer | RT-qPCR, Western Blot Assay, Luciferase Reporter Assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31908486 | 2019 |
| HOXA11-AS | colorectal cancer | qRT-PCR , Luciferase reporter assay , Western blot etc. | L | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31013434 | 2019 |
| HOXA11-AS | oral squamous cell carcinoma | qRT-PCR, Western blot analysis etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31139017 | 2019 |
| HOXA11-AS | lung adenocarcinoma | qPCR, Western Blot, RIP, Dual-luciferase reporter assay | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30099826 | 2018 |
| HOXA11-AS | glioma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30657566 | 2019 |
| HOXA11-AS | Oral Squamous Cell Carcinoma | qPCR, Luciferase reporter assay | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31275988 | 2019 |
| HOXA11-AS | gastric cancer | qPCR, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31235999 | 2019 |
| HOXA11-AS | laryngeal squamous cell cancer | Microarray, qPCR, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29511452 | 2018 |
| HOXA11-AS | esophageal squamous cell carcinoma | qPCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29575836 | 2018 |
| HOXA11-AS | Prostate Cancer | Flow cytometry assay;MTT assay;Flow Cytometry assay;MTT assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34337714 | 2021 |
| HOXA6-HOXA5 | colon cancer | q-PCR , Western blot , RNAi , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31159758 | 2019 |
| HOXB-AS1 | multiple myeloma | qRT-PCR, Western blot analysis, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31886581 | 2019 |
| HOXB-AS3 | lung cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32039488 | 2020 |
| HOXB-AS3 | acute myeloid leukemia | qPCR, Western blot etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31767858 | 2019 |
| HOXB-AS3 | acute myeloid leukemia | qPCR | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31234830 | 2019 |
| HOXB-AS3 | Endometrial Carcinoma | CCK-8 assay;qPCR;RT-qPCR;RNA pull-down assay;Flow Cytometry assay;RNA pull-down; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 34187214 | 2021 |
| HOXB13-AS1 | glioma | qPCR, Western Blot, ChIP, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30105866 | 2018 |
| HOXC-AS1 | gastric cancer | qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 32307743 | 2020 |
| HOXC-AS1 | gastric cancer | Microarray, qRT-PCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31870402 | 2019 |
| HOXC-AS3 | invasive mucinous adenocarcinoma | qRT-PCR, Western blot assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31925650 | 2020 |
| HOXC-AS3 | glioblastoma | qRT-PCR, Western blotting, in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31062400 | 2019 |
| HOXC13-AS | breast cancer | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31066051 | 2019 |
| HOXC13-AS | Oral squamous cell cancer | qRT-PCR,Western blot,luciferase reporter assay,RIP,FISH etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32763778 | 2020 |
| HOXD-AS1 | cervical cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29896986 | 2018 |
| HOXD-AS1 | Colorectal cancer | qPCR, Western blot | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | 30823921 | 2019 |
| HOXD-AS1 | ovarian cancer | qPCR, Luciferase reporter assay, RIP | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30823895 | 2019 |
| HOXD-AS1 | osteosarcoma | qPCR, Western Blot, RIP, ChIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30119259 | 2018 |
| HOXD-AS1 | hepatocellular carcinoma | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31231887 | 2019 |
| HOXD-AS1 | bladder cancer | qPCR, RNAi, Cell proliferation assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 27328915 | 2016 |
| HOXD-AS2 | glioma | qPCR, Western blot, in vitro knockdown, etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30485495 | 2018 |
| HRCEG | gastric cancer | qRT-PCR, RNAi, Western Blot | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 31964588 | 2020 |
| hsa_circ_0000700 | Esophageal squamous cell carcinoma | qPCR;RT-qPCR;RNA immunoprecipitation;Flow Cytometry assay;RNA immunoprecipitation; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33854621 | 2021 |
| hsa_circ_0006168 | Glioblastoma | qRT-PCR;luciferase reporter assays;Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34024251 | 2021 |
| Hsa_circ_0043265 | Tongue Squamous Cell Carcinoma | qRT-PCR;Western blot;luciferase assay;RNA pull-down; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34257535 | 2021 |
| hsa_circ_0049055 | thyroid cancer | Luciferase reporter assay;RNA immunoprecipitation;etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34108309 | 2021 |
| hsa_circ_0053063 | Breast cancer | Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33744861 | 2021 |
| hsa_circ_0058107 | Nasopharyngeal cancer | qRT-PCR;Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 26390174 | 2015 |
| hsa_circ_0080145 | Chronic myeloid leukemia | qPCR etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30205959 | 2018 |
| HSPC324 | lung adenocarcinoma | RT-qPCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 32068121 | 2020 |
| HULC | ovarian cancer | RT-qPCR | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32046413 | 2019 |
| HULC | large B-cell lymphoma | qRT-PCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32010942 | 2020 |
| HULC | gastric cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 31726371 | 2020 |
| HULC | pancreatic ductal adenocarcinoma | PCR | H | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31715081 | 2019 |
| HULC | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RNAi, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | 29895332 | 2018 |
| HULC | hepatocellular carcinoma | qPCR, Western blot | H | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30981758 | 2019 |
| HULC | pancreatic cancer | qRT-PCR, Western blot assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31857775 | 2019 |
| HULC | breast cancer | qRT-PCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31824174 | 2019 |
| HULC | bone neoplasms | qPCR, Western Blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30120220 | 2018 |
| HULC | colon cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30551459 | 2019 |
| HULC | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31645479 | 2019 |
| HULC | Ewing sarcoma | qPCR, Western blot | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31639426 | 2019 |
| HULC | glioma | qPCR, Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 26894862 | 2016 |
| HULC | osteosarcoma | qPCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 26045809 | 2015 |
| HULLK | prostate cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31253147 | 2019 |
| HUR1 | hepatocellular carcinoma | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29790592 | 2018 |
| IDH1-AS1 | prostate cancer | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | 31570703 | 2019 |
| IGF2-AS | Recurrent miscarriage | CCK-8 assay;Dual-luciferase reporter assay;RT-qPCR;RNA immunoprecipitation;Western blot; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34109707 | 2021 |
| IGF2AS | gastric cancer | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31183590 | 2019 |
| IGFL2-AS1 | gastric cancer | RT-qPCR, Western blot analysis, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31943339 | 2020 |
| IGFL2-AS1 | breast cancer | RNA-seq, qPCR, in vitro knockdown | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 28488769 | 2017 |
| IHS | hepatocellular carcinoma | qRT-PCR , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31128422 | 2019 |
| ILF3-AS1 | Cervical cancer | qRT-PCR;luciferase reporter assays;Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 34080029 | 2021 |
| ILF3-AS1 | Breast cancer | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 33525948 | 2021 |
| INHBA-AS1 | oral squamous cell carcinoma | RT-qPCR | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32141551 | 2020 |
| INHBA-AS1 | Colorectal cancer | qRT-PCR;RIP assay;RNA immunoprecipitation;RNA immunoprecipitation; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33090398 | 2020 |
| INHBA-AS1 | Oral squamous cell carcinoma | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33015761 | 2020 |
| IQCJ-SCHIP1-AS1 | colorectal cancer | RNA-seq, qPCR | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31205916 | 2019 |
| IRAIN | multiple myeloma | qPCR, Luciferase reporter assay etc | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31788123 | 2019 |
| IRF1-AS | esophageal squamous cell carcinoma | qRT-PCR , Luciferase reporter assay , RIP , RNAi RNA-seq , Western blot etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31173852 | 2019 |
| ITGB2-AS1 | pancreatic ductal adenocarcinoma | Dual luciferase reporter assay, RIP, qRT-PCR, Western blot analysis | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31957875 | 2020 |
| ITIH4-AS1 | colorectal cancer | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31557619 | 2019 |
| JHDM1D-AS1 | non small cell lung cancer | PCR, Western blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31739208 | 2019 |
| JPX | lung cancer | RT-qPCR, Luciferase reporter assay, western blotting | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31941509 | 2020 |
| JPX | hepatocellular carcinoma | qPCR, Dual luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30091314 | 2018 |
| JPX | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31253987 | 2019 |
| kcna3 | colorectal cancer | qPCR, Western Blot | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30099342 | 2018 |
| KCNK15-AS1 | lung cancer | qPCR, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31788071 | 2019 |
| KCNMA1-AS1 | epithelial ovarian cancer | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31210304 | 2019 |
| KCNQ1DN | renal cell carcinoma | qPCR | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31528231 | 2019 |
| KCNQ1OT1 | hepatocellular carcinoma | RT-qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32124966 | 2018 |
| KCNQ1OT1 | maxillary sinus squamous cell carcinoma | RT-qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31709597 | 2019 |
| KCNQ1OT1 | tongue squamous cell carcinoma | Microarray, qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29970910 | 2018 |
| KCNQ1OT1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29966655 | 2018 |
| KCNQ1OT1 | osteosarcoma | qPCR, Western blot, RIP, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32332718 | 2020 |
| KCNQ1OT1 | tongue squamous cell carcinoma | qRT-PCR, Western Blot Analysis, Dual-Luciferase Reporter Assays, RIP | H | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31957833 | 2020 |
| KCNQ1OT1 | gastric cancer | qPCR, Luciferase reporter assay, Western blotting | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31915311 | 2020 |
| KCNQ1OT1 | ovarian cancer | qRT-PCR, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31909901 | 2020 |
| KCNQ1OT1 | acute myeloid leukemia | qRT-PCR, Western blot, dual-luciferase reporter assay, RIP | H | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31837329 | 2020 |
| KCNQ1OT1 | bladder cancer | qRT-PCR, Western blot, RIP, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31827399 | 2019 |
| KCNQ1OT1 | ovarian cancer | Western Blotting | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31696465 | 2019 |
| KCNQ1OT1 | osteosarcoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31392505 | 2019 |
| KCNQ1OT1 | acute myeloid leukemia | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31390869 | 2019 |
| KCNQ1OT1 | Glioma | Dual-luciferase reporter assay;Western blot;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32996777 | 2020 |
| KCNQ1OT1 | Retinoblastoma | qPCR;RT-qPCR;Western blot;Flow Cytometry assay;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33345272 | 2021 |
| KIAA0125 | colorectal cancer | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31228314 | 2019 |
| KIF2C | hepatocellular carcinoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32056305 | 2020 |
| KRT19P3 | gastric cancer | qPCR, Western blot, RNAi, Microarray, Luciferase reporter assays, Other | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31409899 | 2019 |
| KTN1-AS1 | head and neck squamous cell carcinoma | qPCR, Western blot, Luciferase reporter assay, etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32267161 | 2020 |
| LBCS | prostate cancer | qPCR, Western blot, RIP | L | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31221168 | 2019 |
| LBX2-AS1 | gastric cancer | qPCR, Western blot, RIP, Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32351330 | 2020 |
| LBX2-AS1 | gastric cancer | qRT-PCR, Luciferase reporter assay, RIP, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31673844 | 2020 |
| LBX2-AS1 | Colorectal cancer | Dual-luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34080639 | 2021 |
| LCAT1 | lung cancer | qPCR, Western blot, Luciferase reporter assay, RNA-seq etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31779616 | 2019 |
| LEF-AS1 | colorectal cancer | qPCR, Luciferase reporter assay, in vitro knockdown etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31773695 | 2019 |
| LEF1-AS1 | hepatocellular carcinoma | RT-qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32068261 | 2020 |
| LEF1-AS1 | retinoblastoma | RT-qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31990064 | 2020 |
| LEF1-AS1 | colon cancer | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | 32308428 | 2020 |
| LEF1-AS1 | colorectal cancer | qPCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32248974 | 2020 |
| LEF1-AS1 | hepatocellular carcinoma | qPCR, Western blot, RIP, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32178558 | 2020 |
| LEF1-AS1 | oral squamous cell carcinoma | qRT-PCR , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30983488 | 2019 |
| LEF1-AS1 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31386568 | 2019 |
| LFAR1 | intrahepatic cholangiocarcinoma | western blot, RT-PCR | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31934072 | 2019 |
| LIFR-AS1 | colorectal cancer | Microarray, qPCR, Luciferase reporter assay, RNAi | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29807108 | 2018 |
| LIFR-AS1 | breast cancer | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31127025 | 2019 |
| LIFR-AS1 | Gastric cancer | Western blot; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33355363 | 2021 |
| LIMD1-AS1 | non small cell lung cancer | qPCR, RIP etc. | L | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32239804 | 2020 |
| LIN28B-AS1 | lung adenocarcinoma | qPCR, Microarray, RIP, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30353165 | 2019 |
| LINC-OIP5 | breast cancer | RT-qPCR, Western blotting | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31897120 | 2020 |
| LINC-PINT | lung cancer | qRT-PCR, Western blot, RIP | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31981466 | 2019 |
| LINC-PINT | melanoma | qRT-PCR, Western Blot, RIP, Microarray | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31921860 | 2020 |
| LINC-PINT | osteosarcoma | qRT-PCR etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31070482 | 2019 |
| LINC-PINT | colorectal cancer | microarray, qPCR, RIP etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 24070194 | 2014 |
| LINC-ROR | breast cancer | qPCR, Western Blot | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30145819 | 2018 |
| LINC-ROR | hepatocellular carcinoma | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31082791 | 2019 |
| LINC-ROR | liver cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31400406 | 2019 |
| LINC-UBC1 | colorectal cancer | qPCR, RNAi, Western blot, Flow cytometry assay, Cell proliferation assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28260919 | 2017 |
| LINC00052 | hepatocellular carcinoma | mircoarray, qPCR, Western Blot, Luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30098428 | 2018 |
| LINC00052 | glioma | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31210314 | 2019 |
| LINC00052 | cervical cancer | qPCR, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31210293 | 2019 |
| LINC00052 | head and neck squamous cell carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31639333 | 2019 |
| LINC00052 | hepatocellular carcinoma | qPCR, Western blot, RIP etc, | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28969024 | 2017 |
| LINC000607 | hepatocellular carcinoma | qPCR, Western blot, ChIP | L | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30169594 | 2018 |
| LINC00096 | triple negative breast cancer | Microarray, qRT-PCR, Western Blot, Dual-Luciferase Reporter Assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 31819536 | 2019 |
| LINC00114 | nasopharyngeal cancer | qPCR, Western blot, luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32196600 | 2020 |
| LINC00114 | colorectal cancer | Western Blotting, Luciferase Reporter Assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31921641 | 2020 |
| LINC00115 | glioma | qPCR , Luciferase reporter assay , Western blot , RIP , RNA-seq , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 31599491 | 2019 |
| LINC00152 | colorectal cancer | RT-qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32042551 | 2020 |
| LINC00152 | breast cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 29863253 | 2018 |
| LINC00152 | colorectal cancer | qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32307642 | 2020 |
| LINC00152 | laryngeal squamous cell cancer | qPCR, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32266320 | 2020 |
| LINC00152 | gastric cancer | qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32210577 | 2020 |
| LINC00152 | tongue squamous cell carcinoma | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32194700 | 2020 |
| LINC00152 | esophageal cancer | qPCR, Western blot etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32190735 | 2020 |
| LINC00152 | ovarian cancer | qPCR, Microarray etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31799647 | 2019 |
| LINC00152 | esophageal squamous cell carcinoma | qRT-PCR, Dual-Luciferase Reporter Assay, RIP, Western Blot Assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31802892 | 2019 |
| LINC00152 | osteosarcoma | qRT-PCR , Luciferase reporter assay , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31579407 | 2019 |
| LINC00152 | papillary thyroid cancer | qPCR, luciferase reporter assay, Western Blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30146756 | 2018 |
| LINC00152 | ovarian cancer | qPCR, Western blot, luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30030896 | 2018 |
| LINC00152 | colorectal cancer | qPCR, Western blot etc, | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29180678 | 2017 |
| LINC00152 | gallbladder cancer | qPCR, RNAi, Western blot, ChIP, Luciferase reporter assay, Cell proliferation assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 27829993 | 2016 |
| LINC00152 | lung cancer | qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 28787699 | 2017 |
| LINC00160 | clear cell renal cell carcinoma | qPCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32315986 | 2020 |
| LINC00161 | osteosarcoma | microarray, qPCR, RNAi, RIP, Dual-luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 27609068 | 2016 |
| LINC00162 | pancreatic ductal adenocarcinoma | RNA-seq, in vitro knockdown etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32364285 | 2020 |
| LINC00163 | lung cancer | qPCR, Western blot, in vitro knockdown, RIP, etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30662806 | 2018 |
| LINC00173 | triple negative breast cancer | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | 32058222 | 2020 |
| LINC00173 | esophageal squamous cell carcinoma | qPCR | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29891973 | 2018 |
| LINC00174 | hepatocellular carcinoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32128852 | 2019 |
| LINC00174 | glioma | qRT-qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31713817 | 2019 |
| LINC00174 | glioma | qPCR, Western blot, etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31791014 | 2019 |
| LINC00174 | Osteosarcoma | RIP assay;Rescue assay;RNA pull-down; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34222341 | 2021 |
| LINC00176 | hepatocellular carcinoma | RNA-seq, Microarray, qPCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28869604 | 2017 |
| LINC00205 | hepatocellular carcinoma | qPCR, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31272761 | 2019 |
| LINC00210 | non small cell lung cancer | Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32266029 | 2020 |
| LINC00210 | thyroid cancer | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31240707 | 2019 |
| LINC00221 | acute lymphoblastic leukemia | qPCR, Luciferase reporter assay, RNAi, RIP etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32297639 | 2020 |
| LINC00222 | lung adenocarcinoma | qPCR, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | 29990868 | 2018 |
| LINC00243 | non small cell lung cancer | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31595421 | 2019 |
| LINC00261 | non small cell lung cancer | qPCR, Western blot etc | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31772674 | 2019 |
| LINC00261 | cholangiocarcinoma | qRT-PCR, western blot assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 31812439 | 2020 |
| LINC00261 | colon cancer | qRT-PCR , Western blot , RIP etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31183860 | 2019 |
| LINC00261 | non small cell lung cancer | qRT-PCR , Western blot , RIP , in vitro knockdown etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31115010 | 2019 |
| LINC00261 | Osteosarcoma | qPCR;RT-qPCR;RIP assay;Western blot;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34424120 | 2021 |
| LINC00265 | colorectal cancer | qRT-PCR, Western Blot Analysis | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31824175 | 2019 |
| LINC00277 | non small cell lung cancer | microarray, qPCR, RNAi, Cell proliferation assay etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 28040594 | 2017 |
| LINC00284 | Oral squamous cell carcinoma | qPCR;RT-qPCR;Rescue assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33618612 | 2021 |
| LINC00284 | Papillary Thyroid Cancer | qRT-PCR; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34226533 | 2021 |
| LINC00304 | prostate cancer | qRT-PCR , RNAi etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31012142 | 2019 |
| LINC00310 | breast cancer | qPCR, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29993199 | 2018 |
| LINC00311 | papillary thyroid cancer | qRT-PCR, Western blot assay, Dual-luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31894666 | 2020 |
| LINC00312 | ovarian cancer | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29952351 | 2018 |
| LINC00312 | colorectal cancer | qPCR, Western Blot, luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30134003 | 2018 |
| LINC003121 | thyroid cancer | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29969438 | 2018 |
| LINC00313 | papillary thyroid cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29940766 | 2018 |
| LINC00319 | bladder cancer | qPCR, Western blot, Luciferase reporter assay, RIP etc | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32194636 | 2020 |
| LINC00319 | bladder cancer | qRT-PCR , Luciferase reporter assay , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31608995 | 2019 |
| LINC00319 | nasopharyngeal cancer | qPCR, Luciferase reporter assay, Other | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30243935 | 2019 |
| LINC00319 | acute myeloid leukemia | qPCR, Western blot, Luciferase reporter assay, RIP, etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30587342 | 2019 |
| LINC00319 | glioma | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31325436 | 2019 |
| LINC00324 | gastric cancer | qPCR, Western blot, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29915327 | 2018 |
| LINC00324 | breast cancer | RNA-seq, qPCR | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30981459 | 2019 |
| LINC00324 | colorectal cancer | Western Blot Analysis, qRT-PCR, Dual-Luciferase Assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31858541 | 2019 |
| LINC00324 | lung adenocarcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30556874 | 2018 |
| LINC00324 | osteosarcoma | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31225659 | 2019 |
| LINC00324 | gastric cancer | qPCR, Western blot, RIP, etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29915327 | 2018 |
| LINC00324 | Papillary thyroid cancer | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33318312 | 2020 |
| LINC00336 | lung cancer | qPCR, Luciferase reporter assay, RIP, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30787392 | 2019 |
| LINC00337 | gastric cancer | qPCR, RIP, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31217892 | 2019 |
| LINC00337 | non small cell lung cancer | qPCR, Western blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31632575 | 2019 |
| LINC00339 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29906749 | 2018 |
| LINC00339 | hepatocellular carcinoma | qPCR, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31239716 | 2019 |
| LINC00339 | Hepatocellular carcinoma | qRT-PCR,Western blot,Luciferase reporter assay etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31081143 | 2019 |
| LINC00341 | colorectal cancer | RT-PCR, Western blot, microarray | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 32067238 | 2019 |
| LINC00341 | gastric cancer | qPCR | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31949815 | 2018 |
| LINC00346 | pancreatic cancer | qPCR, Luciferase reporter assay, RIP, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30728036 | 2019 |
| LINC00346 | cutaneous squamous cell carcinoma | RT-qPCR, Western blot analysis, RNA-seq, | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31837949 | 2020 |
| LINC00346 | hepatocellular carcinoma | RT-qPCR, Luciferase reporter assay, Western blotting | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31691159 | 2020 |
| LINC00346 | pancreatic ductal adenocarcinoma | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31391552 | 2019 |
| LINC00355 | lung adenocarcinoma | Dual luciferase reporter gene assay, RIP, RT-qPCR, Western blot analysis | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31689506 | 2020 |
| LINC0036 | gastric cancer | qPCR, microarray | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32095316 | 2020 |
| LINC00365 | gastric cancer | qPCR | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32095083 | 2020 |
| LINC00423 | retroperitoneal liposarcoma | qPCR , RNA-seq , RIP , in vitro knockdown etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31160581 | 2019 |
| LINC00449 | acute myeloid leukemia | microarray, qRT-PCR, Luciferase reporter assay, RIP, Western blotting assay | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31960456 | 2020 |
| LINC00459 | melanoma | Microarray, qRT-PCR, Western blotting, Luciferase reporter assay, RIP | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31844121 | 2019 |
| LINC00460 | gastric cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32059342 | 2019 |
| LINC00460 | papillary thyroid cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32021436 | 2020 |
| LINC00460 | head and neck squamous cell carcinoma | qRT-PCR, Western blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31737186 | 2019 |
| LINC00460 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32184630 | 2020 |
| LINC00460 | lung adenocarcinoma | qPCR, Western blot etc | H | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 31789388 | 2019 |
| LINC00460 | bladder cancer | qPCR | H | ✘ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | 30881506 | 2019 |
| LINC00460 | papillary thyroid cancer | qRT-PCR, Western blot assay, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31870440 | 2019 |
| LINC00460 | colorectal cancer | qPCR | H | ✘ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✘ | ✘ | 30123352 | 2018 |
| LINC00460 | colorectal cancer | qPCR, Western Blot, Luciferase reporter assay, ChIP, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30092404 | 2018 |
| LINC00460 | lung adenocarcinoma | qPCR, Luciferase reporter assay, Other | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30359741 | 2019 |
| LINC00460 | head and neck squamous cell carcinoma | qPCR, Western blot, RNAi, RIP, Other | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31429766 | 2019 |
| LINC00460 | papillary thyroid cancer | qPCR, Western blot, Luciferase reporter assay, etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30478856 | 2018 |
| LINC00460 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31376654 | 2019 |
| LINC00460 | breast cancer | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31308741 | 2019 |
| LINC00460 | non small cell lung cancer | qPCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29409808 | 2018 |
| LINC00460 | esophageal cancer | qPCR, etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29926523 | 2018 |
| LINC00460 | Head and neck squamous cell carcinoma | Dual-luciferase reporter assay;qRT-PCR;etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 33833526 | 2021 |
| LINC00461 | rectal cancer | RT-qPCR, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31972361 | 2020 |
| LINC00461 | lung adenocarcinoma | Dual-luciferase reporter gene assay, RIP, RT-qPCR, Western blot analysis | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31967713 | 2020 |
| LINC00461 | non small cell lung cancer | qRT-PCR, Dual-luciferase reporter assay, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31934717 | 2020 |
| LINC00461 | colorectal cancer | qRT-PCR, Dual-luciferase reporter assay, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31908480 | 2019 |
| LINC00462 | pancreatic cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29899418 | 2018 |
| LINC00466 | Glioma | qRT-PCR;RIP assay; | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 33642868 | 2021 |
| LINC00467 | head and neck squamous cell carcinoma | RT-qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 32159247 | 2020 |
| LINC00467 | glioma | qPCR, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32226508 | 2020 |
| LINC00467 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP etc | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32221502 | 2020 |
| LINC00467 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 31772673 | 2019 |
| LINC00467 | hepatocellular carcinoma | qRT-PCR, Western blot analysis, Dual-luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31916278 | 2020 |
| LINC00467 | lung adenocarcinoma | RT-PCR, Western blot analysis, Luciferase assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31686834 | 2019 |
| LINC00467 | lung adenocarcinoma | RT-qPCR, Western blot analysis, RIP, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31680321 | 2019 |
| LINC00467 | hepatocellular carcinoma | RT-qPCR, Western blot assay, RIP, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31656043 | 2020 |
| LINC00467 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31480990 | 2019 |
| LINC00470 | gastric cancer | qRT-PCR, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31711642 | 2019 |
| LINC00470 | glioblastoma | qPCR, Western blot, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | 29866190 | 2018 |
| LINC00470 | hepatocellular carcinoma | qRT-PCR , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31612313 | 2019 |
| LINC00472 | gastric cancer | qRT-PCR etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31570433 | 2019 |
| LINC00472 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30522853 | 2018 |
| LINC00472 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31382188 | 2019 |
| LINC00473 | hepatocellular carcinoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32021265 | 2020 |
| LINC00473 | abdominal aortic aneurysm | RT-qPCR, RIP, Western blotting, Dual-Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31954705 | 2020 |
| LINC00473 | glioma | Dual-luciferase reporter assay, RIP, RT-qPCR, Western blotting | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31894297 | 2020 |
| LINC00473 | head and neck squamous cell carcinoma | qPCR, Western blot, Microarray, Other | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30468475 | 2018 |
| LINC00473 | pancreatic cancer | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31206665 | 2019 |
| LINC00473 | Colorectal Cancer | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34306345 | 2021 |
| LINC00477? | gastric cancer | RT-PCR , RIP , RNAi etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31191018 | 2019 |
| LINC00483 | gastric cancer | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32293550 | 2020 |
| LINC00485 | lung adenocarcinoma | qPCR, western blot | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31528122 | 2019 |
| LINC00488 | hepatocellular carcinoma | qRT-PCR , Luciferase reporter assay , Western blot , RIP etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31005556 | 2019 |
| LINC00504 | ovarian cancer | qRT-PCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31691157 | 2020 |
| LINC00511 | cervical cancer | RT-qPCR, Western blot, microarray | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | 32067228 | 2020 |
| LINC00511 | gastric cancer | RT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32042282 | 2020 |
| LINC00511 | hepatocellular carcinoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31731191 | 2020 |
| LINC00511 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, RIP etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32368318 | 2020 |
| LINC00511 | T cell acute lymphoblastic leukemia | qPCR, Western blot etc. | L | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32242897 | 2020 |
| LINC00511 | ovarian cancer | qRT-PCR, Western Blot Analysis, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31920390 | 2019 |
| LINC00511 | papillary thyroid cancer | qRT-PCR, Western blotting | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31897240 | 2020 |
| LINC00511 | gastric cancer | qRT-PCR, Western blot, RIP, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31889903 | 2019 |
| LINC00511 | bladder cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30042171 | 2018 |
| LINC00511 | osteosarcoma | qPCR, Western blot, etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30592325 | 2018 |
| LINC00511 | breast cancer | qPCR, Western blot, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31395854 | 2019 |
| LINC00511 | osteosarcoma | Microarray, qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31386627 | 2019 |
| LINC00511 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31646568 | 2019 |
| LINC00514 | Triple negative breast cancer | qPCR;RT-qPCR;Flow Cytometry assay;Luciferase reporter assay;Rescue assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33757509 | 2021 |
| LINC00514 | Gastric cancer | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 33888645 | 2021 |
| LINC00515 | glioma | RT-PCR , Luciferase reporter assay , Western blot , RNAi , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31114220 | 2019 |
| LINC00518 | breast cancer | qPCR, Western blot, Luciferase reporter assay, RIP, etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30611858 | 2019 |
| LINC00518 | bladder cancer | qPCR | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31308745 | 2019 |
| LINC00519 | lung squamous cell carcinoma | qPCR, Luciferase reporter assay, in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32297697 | 2020 |
| LINC00520 | papillary thyroid cancer | RT-qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32075502 | 2020 |
| LINC00525 | non small cell lung cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31991382 | 2020 |
| LINC00525 | bladder cancer | qPCR | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31308745 | 2019 |
| LINC00525 | Colorectal Cancer | qPCR, Western blot, Luciferase reporter assay | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31242722 | 2019 |
| LINC00526 | glioma | qPCR, Western blot, RIP | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31240814 | 2019 |
| LINC00565 | ovarian cancer | qRT-PCR, Western Blot Analysis | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31819497 | 2019 |
| LINC00588 | osteosarcoma | qPCR, Western blot, Luciferase reporter assay, RIP etc | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 32265694 | 2020 |
| LINC00607 | non small cell lung cancer | PCR | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30980423 | 2019 |
| LINC00612 | osteosarcoma | qPCR, Western blot, Luciferase reporter assay, RNAi etc | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 32311343 | 2020 |
| LINC00612 | bladder cancer | qPCR, Luciferase reporter assay, Western blot, RNAi, RIP | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✔ | ✘ | 30940184 | 2019 |
| LINC00619 | gastric cancer | qPCR, Western blot etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32359894 | 2020 |
| LINC00628 | lung adenocarcinoma | qPCR, Luciferase reporter assay, Western blot, RIP | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31557618 | 2019 |
| LINC00629 | gastric cancer | Microarray, Dual-luciferase reporter gene assay, Western blot analysis, RIP, RT-qPCR | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31674022 | 2020 |
| LINC00641 | bladder cancer | qPCR, Luciferase reporter assay | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30060954 | 2018 |
| LINC00641 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, RIP | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31322545 | 2019 |
| LINC00657 | pancreatic ductal adenocarcinoma | RT-qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32116086 | 2019 |
| LINC00657 | breast cancer | qPCR, in vitro knockdown, MTT assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 26942882 | 2016 |
| LINC00662 | hepatocellular carcinoma | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31959915 | 2020 |
| LINC00662 | colon cancer | luciferase reporter assay, Western-blot analysis, qRT-PCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31900207 | 2020 |
| LINC00662 | prostate cancer | qRT-PCR , Luciferase reporter assay , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31114993 | 2019 |
| LINC00662 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, Other | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30297104 | 2018 |
| LINC00662 | oral squamous cell carcinoma | qPCR, Western blot, in vitro knockdown, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30705593 | 2019 |
| LINC00662 | acute myeloid leukemia | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31306637 | 2019 |
| LINC00662 | Cervical cancer | qPCR;RT-qPCR;Rescue assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 33819358 | 2021 |
| linc00662 | Lung cancer | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33108738 | 2021 |
| LINC00662 | Skin cancer | MTT assay;qPCR;RT-qPCR;Luciferase reporter assay;MTT assay;Rescue assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32894549 | 2020 |
| LINC00663 | glioblastoma | qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 26743782 | 2016 |
| LINC00665 | gastric cancer | RT-PCR, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31736127 | 2019 |
| LINC00665 | prostate cancer | qPCR, Luciferase reporter assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32273723 | 2020 |
| LINC00665 | breast cancer | qPCR, Western blot etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32271427 | 2020 |
| LINC00665 | non small cell lung cancer | qPCR, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30889481 | 2019 |
| LINC00665 | breast cancer | Western blotting, RT-qPCR, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31907362 | 2020 |
| LINC00665 | gastric cancer | qRT-PCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31695413 | 2019 |
| LINC00665 | Melanoma | qRT-PCR; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33247967 | 2020 |
| LINC00667 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, RIP etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32281700 | 2020 |
| LINC00667 | glioma | qPCR, Luciferase reporter assay, RIP, Western blot | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30743215 | 2019 |
| LINC00668 | glioma | qPCR, Western blot, Luciferase reporter assay, RIP etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32279214 | 2020 |
| LINC00668 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 32249890 | 2020 |
| LINC00673 | non small cell lung cancer | PCR | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30980423 | 2019 |
| LINC00673 | prostate cancer | RT-qPCR, Western blot analysis, Dual-luciferase reporter gene assay, RIP | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31881124 | 2020 |
| LINC00673 | thyroid cancer | qPCR, Western Blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30106140 | 2018 |
| LINC00673 | breast cancer | qPCR, Western Blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30094100 | 2018 |
| LINC00675 | clear cell renal cell carcinoma | qPCR, Western blot etc | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32196582 | 2020 |
| LINC00675 | gastric cancer | qPCR, Western blot, RIP | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29107103 | 2018 |
| LINC00680 | glioblastoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31999854 | 2019 |
| LINC00680 | glioblastoma | PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32000032 | 2019 |
| LINC00682 | gastric cancer | qPCR, luciferase reporter assay, Western blotting | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31822638 | 2019 |
| LINC00689 | glioma | qRT-PCR , Luciferase reporter assay , in vitro knockdown , Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31181442 | 2019 |
| LINC00691 | gastric cancer | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32330554 | 2020 |
| LINC00703 | gastric cancer | qRT-PCR, RIP, Western blot analysis | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31897348 | 2019 |
| LINC00704 | thyroid cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 29923329 | 2018 |
| LINC00707 | colorectal cancer | RT-qPCR, Western blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32010320 | 2020 |
| LINC00707 | colorectal cancer | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31115001 | 2019 |
| LINC00707 | gastric cancer | qPCR, Western blot, in vitro knockdown, RIP, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30502359 | 2018 |
| LINC00707 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31213848 | 2019 |
| LINC00707 | Osteosarcoma | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34316513 | 2021 |
| LINC00857 | gastric cancer | Microarray, qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30008909 | 2018 |
| LINC00857 | lung adenocarcinoma | qRT-PCR, Dual luciferase assay, Western blot analysis | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31667785 | 2020 |
| LINC00858 | osteosarcoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29944887 | 2018 |
| LINC00858 | colorectal cancer | qPCR, Western blot, RIP etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32323793 | 2020 |
| LINC00858 | colorectal cancer | Dual luciferase reporter assay, RIP, qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31902050 | 2020 |
| LINC00858 | colon cancer | RT-qPCR, Western blot analysis, RIP, Dual-luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31884577 | 2020 |
| LINC00858 | osteosarcoma | qPCR, Western blot, RIP, etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29944887 | 2018 |
| LINC00899 | breast cancer | qPCR, | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31739288 | 2019 |
| LINC00908 | prostate cancer | Microarray, RT-qPCR, Western blot analysis, Dual-luciferase reporter assay, RIP | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31938018 | 2020 |
| LINC00909 | glioma | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31132669 | 2019 |
| LINC00958 | lung adenocarcinoma | qRT-qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 31997940 | 2020 |
| LINC00958 | hepatocellular carcinoma | RIP, RNA-seq, RT-qPCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31915027 | 2020 |
| LINC00958 | non small cell lung cancer | qRT-PCR, western blot analysis, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31855084 | 2019 |
| LINC00958 | nasopharyngeal cancer | RT-qPCR, Luciferase Reporter Assay, RIP, Western Blot Analysis | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31819474 | 2019 |
| LINC00958 | cervical cancer | RT-qPCR, Luciferase reporter assay, RIP, Western blot analysis | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31691355 | 2020 |
| LINC00958 | oral squamous cell carcinoma | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31161900 | 2019 |
| LINC00958 | pancreatic cancer | qPCR, Western blot, Luciferase reporter assay, RIP, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30639194 | 2019 |
| LINC00961 | non small cell lung cancer | Microarray, qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30010215 | 2018 |
| LINC00961 | glioma | qPCR, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30070327 | 2018 |
| LINC00963 | ovarian cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32021459 | 2020 |
| LINC00963 | breast cancer | RT-PCR, Western Blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31751910 | 2019 |
| LINC00963 | glioma | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32273770 | 2020 |
| LINC00963 | melanoma | qPCR, Dual luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30180950 | 2018 |
| Linc00963 | Prostate cancer | Rescue assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33643926 | 2021 |
| LINC00968 | osteosarcoma | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29904919 | 2018 |
| LINC00968 | breast cancer | qPCR, Luciferase reporter assay, RIP, Western blot | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | 30791958 | 2019 |
| LINC00968 | breast cancer | qPCR, Western blot, Luciferase reporter assay, RIP | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31213129 | 2019 |
| LINC00973 | colorectal cancer | qPCR | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30848094 | 2019 |
| LINC00976 | pancreatic cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31747939 | 2019 |
| LINC00978 | hepatocellular carcinoma | RNAi, RT-qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32077915 | 2020 |
| LINC00978 | hepatocellular carcinoma | qRT-PCR , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31582742 | 2019 |
| LINC00982 | papillary thyroid cancer | qPCR, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31262968 | 2019 |
| LINC00993 | triple negative breast cancer | qRT-PCR, Western Blot | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31921620 | 2019 |
| LINC00994 | gastric cancer | qRT-PCR | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31737214 | 2019 |
| LINC00994 | pancreatic cancer | qPCR, microarray, Luciferase reporter assay, western blot | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30739523 | 2019 |
| LINC01006 | pancreatic cancer | Microarray, RT-qPCR, Western blot, RIP, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31827394 | 2019 |
| LINC01006 | Lung cancer | qPCR;RT-qPCR;RIP assay;Western blot;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 33753463 | 2021 |
| LINC01006 | Prostate cancer | Luciferase reporter assay;RNA immunoprecipitation;etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33088221 | 2020 |
| LINC01023 | glioma | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31281473 | 2019 |
| LINC01048 | cutaneous squamous cell carcinoma | qPCR, Luciferase reporter assay, Western blot, microarray, RIP | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | 30931936 | 2019 |
| LINC01060 | pancreatic cancer | qPCR, Western blot, in vitro knockdown, RIP | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29913236 | 2018 |
| LINC01061 | papillary thyroid cancer | qPCR, Western blot, luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30029886 | 2018 |
| LINC01082 | colon cancer | qPCR, Other | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31432387 | 2019 |
| LINC01088 | non small cell lung cancer | RT-qPCR, western blot, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31811854 | 2020 |
| LINC01089 | Lung Adenocarcinoma | Rescue assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34281560 | 2021 |
| LINC01093 | non small cell lung cancer | qRT-PCR, Western Blotting | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31957835 | 2020 |
| LINC01094 | clear cell renal cell carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31767633 | 2019 |
| LINC01111 | pancreatic cancer | Microarray, qPCR, Western blot etc. | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31767833 | 2019 |
| LINC01116 | glioma | qRT-PCR, in vitro knockdown, Western blot analysis, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31144303 | 2019 |
| LINC01116 | oral squamous cell carcinoma | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31308744 | 2019 |
| LINC01121 | pancreatic cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29843149 | 2018 |
| LINC01123 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31488218 | 2019 |
| LINC01123 | Osteosarcoma | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33837611 | 2021 |
| LINC01123 | Carotid Atherosclerosis | qRT-PCR;Western blot; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34403009 | 2021 |
| LINC01125 | breast cancer | qPCR, microarray, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30867411 | 2019 |
| LINC01125 | ovarian cancer | qRT-PCR, Dual-luciferase reporter assay, RIP | L | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31865363 | 2019 |
| LINC01133 | esophageal squamous cell carcinoma | qPCR | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30007982 | 2018 |
| LINC01133 | breast cancer | qPCR, Western blot, RIP | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31557401 | 2019 |
| LINC01133 | nasopharyngeal cancer | qRT-PCR , Western blot , RIP , RNAi , in vitro knockdown etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31106003 | 2019 |
| LINC01133 | gastric cancer | qPCR, Luciferase assay | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30134915 | 2018 |
| LINC01133 | cervical cancer | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31390932 | 2019 |
| LINC01134 | hepatocellular carcinoma | qPCR, Western blot, RIP etc | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 32272940 | 2020 |
| LINC01140 | glioma | qPCR, Western blot, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32184618 | 2020 |
| Linc01152 | hepatocellular carcinoma | RT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31054511 | 2019 |
| LINC01189 | Hcv-hepatocellular carcinoma | qRT-PCR;luciferase assay; | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33059056 | 2021 |
| LINC01194 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32346298 | 2020 |
| LINC01207 | pancreatic cancer | qRT-PCR, Western blotting, Microarray data analysis, RIP etc. | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | 30991076 | 2019 |
| LINC01207 | Colon cancer | Rescue assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33299853 | 2020 |
| LINC01224 | hepatocellular carcinoma | qRT-PCR, Western Blot Analysis, Dual-Luciferase Reporter Assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31902747 | 2020 |
| LINC01224 | Endometrial Carcinoma | Flow cytometry assay;RNA pull-down assay;Western blot;Flow Cytometry assay;RNA pull-down; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 34278482 | 2021 |
| LINC01234 | oral squamous cell carcinoma | RT-qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32041570 | 2020 |
| LINC01234 | multiple myeloma | qRT-PCR, Western blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31737211 | 2019 |
| LINC01234 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32246902 | 2020 |
| LINC01234 | colon cancer | qPCR, Luciferase reporter assay, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | 30755591 | 2019 |
| LINC01234 | non small cell lung cancer | qRT-PCR, Luciferase reporter assays, RIP, Western blot analysis | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31959200 | 2020 |
| LINC01234 | colorectal cancer | Dual-luciferase reporter assay, qRT-PCR.RIP, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31904146 | 2020 |
| LINC01234 | hepatocellular carcinoma | qPCR, Western Blot Analysis, Dual-Luciferase Reporter Assay, RIP | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31838274 | 2020 |
| LINC01234 | non small cell lung cancer | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31106421 | 2019 |
| LINC01234 | esophageal cancer | qPCR, in vitro knockdown, etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30519325 | 2018 |
| LINC01234 | Colorectal Cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31650732 | 2019 |
| LINC01234 | Triple-Negative Breast Cancer | qPCR;RT-qPCR;Rescue assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34173712 | 2021 |
| LINC01260 | spinal cord glioma | qPCR, Western blot, Dual-luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30071522 | 2018 |
| LINC01278 | osteosarcoma | qRT-PCR, Western blot, microarray, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31994731 | 2020 |
| LINC01287 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RNAi, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30001751 | 2018 |
| LINC01287 | breast cancer | qRT-PCR , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31173295 | 2019 |
| LINC01287 | hepatocellular carcinoma | qPCR, Western Blot, luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30133116 | 2018 |
| LINC01288 | non small cell lung cancer | qRT-PCR , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31054777 | 2019 |
| LINC01296 | breast cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29981416 | 2018 |
| LINC01296 | thyroid cancer | RT-qPCR, Dual luciferase reporter gene assay, RIP, Western blot analysis | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31693087 | 2019 |
| LINC01296 | hepatocellular carcinoma | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30988624 | 2019 |
| LINC01296 | esophageal squamous cell carcinoma | RIP, qPCR, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30416853 | 2018 |
| LINC01296 | pancreatic Ductal adenocarcinoma | qPCR, Western blot, RNAi, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30203487 | 2019 |
| LINC01296 | gastric cancer | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29091895 | 2017 |
| LINC01303 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31497936 | 2019 |
| LINC01314 | gastric cancer | qRT-PCR , Luciferase reporter assay , Western blot , RNAi etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31007611 | 2019 |
| LINC01314 | hepatoblastoma | Microarray, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29571247 | 2018 |
| LINC01352 | hepatocellular carcinoma | qRT-PCR, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32157216 | 2020 |
| LINC01354 | colorectal cancer | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30987669 | 2019 |
| LINC01355 | breast cancer | qPCR, Western blot, RIP | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31243265 | 2019 |
| LINC01385 | nasopharyngeal cancer | qPCR, Western blot, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32264733 | 2020 |
| LINC01391 | hepatocellular carcinoma | qPCR, Western blot, in vitro knockdown, RIP | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31207322 | 2019 |
| LINC01410 | endometrial cancer | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32314193 | 2020 |
| LINC01410 | cholangiocarcinoma | RT-qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31951299 | 2020 |
| LINC01413 | colorectal cancer | Microarray, qRT-PCR, Western Blot, RIP, Luciferase Reporter Assay, In Vivo Assays | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31927328 | 2020 |
| LINC01419 | esophageal squamous cell carcinoma | qRT-PCR , Luciferase reporter assay , Western blot , RIP etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31019568 | 2019 |
| LINC01419 | lung adenocarcinoma | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31582214 | 2019 |
| LINC01420 | pancreatic cancer | qPCR, Luciferase reporter assay, Western blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31562613 | 2019 |
| LINC01420 | thyroid cancer | RT-qPCR | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31897152 | 2020 |
| LINC01436 | gastric cancer | qRT-PCR, Luciferase assay, RIP, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31829474 | 2020 |
| LINC01436 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30614188 | 2019 |
| LINC01446 | glioblastoma | qPCR, Western blot, luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30029885 | 2018 |
| LINC01503 | gastric cancer | qPCR etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32207034 | 2020 |
| LINC01510 | papillary thyroid cancer | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31590919 | 2019 |
| LINC01518 | oesophageal squamous cell carcinoma | qRT-PCR, Luciferase reporter assay, Western blot analysis | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31810385 | 2019 |
| LINC01535 | cervical cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31273925 | 2019 |
| LINC01537 | Lung Cancer | RNA-seq, qPCR | L | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31374807 | 2019 |
| LINC01551 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31270840 | 2019 |
| LINC01554 | Melanoma | qRT-PCR; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33378013 | 2020 |
| LINC01559 | pancreatic cancer | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31608998 | 2019 |
| LINC01561 | non small cell lung cancer | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32003010 | 2020 |
| LINC01561 | breast cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29890225 | 2018 |
| LINC01605 | bladder cancer | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30054424 | 2018 |
| LINC01614 | non small cell lung cancer | PCR | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30980423 | 2019 |
| LINC01617 | esophageal cancer | qPCR, Western Blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30120975 | 2018 |
| LINC01638 | triple negative breast cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30002443 | 2018 |
| LINC01638 | breast cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29992881 | 2018 |
| LINC01638 | colorectal adenocarcinoma | qRT-PCR , Western blot , in vitro knockdown etc. | H | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31059049 | 2019 |
| LINC01667 | Gastric cancer | RT-PCR;Western blot;Flow Cytometry assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33390953 | 2020 |
| LINC01714 | cholangiocarcinoma | RNA-seq, qRT-PCR, Western Blot Assays, RNAi, RIP | L | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31902744 | 2020 |
| LINC01783 | cervical cancer | qRT-PCR, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32021449 | 2020 |
| LINC01787 | breast cancer | qRT-PCR, Western Blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31750242 | 2019 |
| LINC01857 | glioma | qRT-PCR , Luciferase reporter assay , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31049960 | 2019 |
| LINC01857 | Diffuse large b-cell lymphoma | Flow cytometry assay;Flow Cytometry assay;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 33311569 | 2020 |
| LINC01980 | esophageal squamous cell carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✔ | ✘ | 32325088 | 2020 |
| LINC01980 | esophageal squamous cell carcinoma | qPCR, microarray, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30935686 | 2019 |
| LINC02042 | esophageal squamous cell carcinoma | qRT-PCR, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32161513 | 2020 |
| LINC02095 | triple negative breast cancer | RT-qPCR | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31690584 | 2020 |
| LINC02163 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 29893595 | 2018 |
| LINC02381 | colorectal cancer | Western blot | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32092325 | 2020 |
| LINC02418 | non small cell lung cancer | RT-qPCR, Western Blot, Luciferase Activity Reporter Assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31841189 | 2019 |
| LINC02418 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31358735 | 2019 |
| LINC02465 | gastric cancer | qPCR, Western blot, in vitro knockdown, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30632400 | 2018 |
| LINC02476 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32280244 | 2020 |
| LINC02499 | hepatocellular carcinoma | qRT-PCR | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32039538 | 2019 |
| LINC02582 | breast cancer | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31601781 | 2019 |
| LINC02595 | colorectal cancer | qRT-PCR, Western blot, microarray | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32064615 | 2020 |
| LINC0638 | melanoma | qPCR | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | 31289478 | 2019 |
| LINC81507 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, RIP | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31296840 | 2019 |
| LINCRNA-p21 | breast cancer | RT-qPCR, Western blot, microarray | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32062693 | 2020 |
| LINCRNA-p21 | glioma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29981322 | 2018 |
| LINCRNA-p21 | bladder cancer | qPCR | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30902882 | 2019 |
| LINCRNA-p21 | gastric cancer | qPCR, Western blot, etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30484893 | 2018 |
| LINCRNA-p21 | Breast Cancer | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31326549 | 2019 |
| LINCRNA-p21 | esophageal squamous cell carcinoma | Microarray, qPCR, Western blot | L | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31308755 | 2019 |
| LINCRNA00494 | non small cell lung cancer | RT-qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32117734 | 2020 |
| LINCRNA02471 | thyroid cancer | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 32194901 | 2020 |
| LINP1 | cervical Cancer | qPCR, Western blot, RIP etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32348690 | 2020 |
| LINP1 | gastric cancer | RT-PCR, Western Blot Analysis | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31957826 | 2020 |
| LINP1 | ovarian cancer | qRT-PCR, Western Blot Analysis | H | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31957816 | 2020 |
| LINP1 | breast cancer | Microarray, qRT-PCR, Western blot assay | H | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31927036 | 2020 |
| LINP1 | prostate cancer | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30058678 | 2018 |
| LINP1 | acute myeloid leukemia | RNA-seq, qPCR, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31325181 | 2019 |
| LINP1 | wilms tumor | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31298321 | 2019 |
| LINP1 | breast cancer | qPCR, RNAi, Western blot, Northern blot, RIP, RNA pull-down assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 27111890 | 2016 |
| LINRIS | colon cancer | qPCR, RNAi, RIP etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31791342 | 2019 |
| LL22NC03-N64E9.1 | lung cancer | qPCR, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29935018 | 2018 |
| LMCD1-AS1 | osteosarcoma | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32248969 | 2020 |
| LMCD1-AS1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay | L | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31278071 | 2019 |
| LNAPPCC | colon cancer | qPCR, Western blot, RIP, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | 32330872 | 2020 |
| lnc-BMP1-1 | lung cancer | qRT-PCR, Western blotting | L | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31901898 | 2020 |
| lnc-CCDST | cervical cancer | qPCR, Western blot, in vitro knockdown, RIP, etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30518908 | 2018 |
| lnc-DILC | bladder cancer | qRT-PCR , Luciferase reporter assay , Western blot etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31176734 | 2019 |
| lnc-DILC | renal cell carcinoma | qRT-PCR , Western blot , RIP , in vitro knockdown etc. | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31592114 | 2019 |
| lnc-DILC | liver cancer | microarray, Luciferase reporter assay etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 26812074 | 2016 |
| lnc-HC | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32278306 | 2020 |
| lnc-LIF-AS | cervical cancer | RT-PCR , Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31085454 | 2019 |
| lnc-NA | endometrioid endometrial cancer | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31050196 | 2019 |
| lnc-p23154 | oral squamous cell carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30026052 | 2018 |
| lnc-PCDH9-13:1 | hepatocellular carcinoma | qPCR | H | ✘ | ✔ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | 30045829 | 2018 |
| lnc-SNHG1 | pituitary cancer | qPCR, Western blot | H | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30048990 | 2018 |
| Lnc-STYK1-2 | Bladder Cancer | Dual-luciferase reporter assay;Western blot;Luciferase reporter assay;RNA sequencing; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34332611 | 2021 |
| lnc-TALC | glioblastoma | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | L | ✔ | ✘ | ✔ | ✘ | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | 31053733 | 2019 |
| lnc-THOR | glioma | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31727877 | 2019 |
| lnc-THOR | renal cell carcinoma | qPCR, Western blot etc. | H | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29752937 | 2018 |
| lnc-THOR | nasopharyngeal cancer | qPCR, Western blot, RIP, Luciferase reporter assay, etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29959065 | 2018 |
| lnc-TLN2-4:1 | gastric cancer | qPCR etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32256587 | 2020 |
| lnc00152 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 29956750 | 2018 |
| lnc00673 | pancreatic cancer | qRT-PCR, Luciferase reporter assay, Western blotting | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31949497 | 2020 |
| lnc01133 | ovarian cancer | qRT-PCR, Western blot assays | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31949667 | 2018 |
| lnc712 | breast cancer | Microarray, RT-qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31892853 | 2020 |
| lncAGER | colorectal cancer | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32031046 | 2020 |
| lncAPP | prostate cancer | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31107971 | 2019 |
| lncAROD | head and neck squamous cell carcinoma | qPCR, Western blot, RIP etc | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32216017 | 2020 |
| lncARSR | hepatocellular carcinoma | RT-qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32169080 | 2020 |
| lncARSR | non small cell lung cancer | qPCR, Western blot etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 32269718 | 2020 |
| lncARSR | bladder cancer | qRT-PCR, Western blotting analysis, Dual-luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31892841 | 2020 |
| lncARSR | epithelial ovarian cancer | qPCR, Luciferase reporter assays, Western blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30034936 | 2018 |
| lncMX1-215 | head and neck squamous cell carcinoma | qRT-PCR, Dual-luciferase reporter assay, Western blotting, RIP, In vivo analysis | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31907020 | 2020 |
| lncPARP1 | hepatocellular carcinoma | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | 29776974 | 2018 |
| lncPARP1 | hepatocellular carcinoma | qPCR, western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29776974 | 2018 |
| lncRNA-AC078883.3 | non small cell lung cancer | qRT-PCR , Luciferase reporter assay , Western blot etc. | L | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31111480 | 2019 |
| lncRNA-APC1 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30511962 | 2018 |
| lncRNA-ATB | ovarian cancer | qRT-PCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 32021299 | 2020 |
| lncRNA-ATB | colorectal cancer | qPCR, Western blot etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32256798 | 2020 |
| lncRNA-ATB | lung adenocarcinoma | qPCR, Western blot, Luciferase reporter assay etc. | L | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32256108 | 2020 |
| lncRNA-cCSC1 | colorectal cancer | qRT-PCR, Western blot assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31680315 | 2020 |
| lncRNA-CF129 | pancreatic cancer | qPCR, Western blot, Luciferase reporter assay, RIP | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31367258 | 2019 |
| lncRNA-CIR | osteosarcoma | RT-qPCR, Western blot analysis | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31889901 | 2019 |
| lncRNA-HAL | Triple negative breast cancer | qPCR, in vitro knockdown, RNAi | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31401107 | 2019 |
| lncRNA-Hpvt1 | hepatocellular carcinoma | microarray, qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 27894309 | 2016 |
| lncRNA-LET | clear cell renal cell carcinoma | qPCR, Western blot, Luciferase reporter assay etc | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31768131 | 2019 |
| lncRNA-LET | esophageal squamous cell carcinoma | RT-PCR , Western blot , RIP etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31602267 | 2019 |
| lncRNA-NUTF2P3-001 | pancreatic cancer | microarray, qPCR, RNAi, Western blot, Luciferase reporter assay, MTT assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 26755660 | 2016 |
| lncRNA-p21 | prostate cancer | qRT-PCR , Western blot , RIP , Luciferase reporter assay , in vitro knockdown etc. | H | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31189930 | 2019 |
| lncRNA-PDPK2P | hepatocellular carcinoma | Microarray, qPCR, Western blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31368655 | 2019 |
| lncRNA-RP1-13P20.6 | colorectal cancer | qPCR etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 27596299 | 2016 |
| lncRNA-RP11-317J10.2 | colorectal cancer | qPCR | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29073791 | 2017 |
| lncRNA-Saf | Hepatocellular carcinoma | qPCR, Western blot, in vitro knockdown, etc. | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30632031 | 2019 |
| lncRNA-UCA1 | hepatocellular carcinoma | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31354286 | 2019 |
| lncRNA-ZNF281 | glioma | qPCR, Western blot, etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30509101 | 2018 |
| lncRNA00544 | breast cancer | Microarray, qPCR | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28959047 | 2017 |
| LNMAT2 | bladder cancer | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31593555 | 2019 |
| lnPTENP1 | osteosarcoma | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29805503 | 2018 |
| LNRRIL6 | colorectal cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31246342 | 2019 |
| LOC100133669 | oesophageal squamous cell carcinoma | RT-qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32130753 | 2019 |
| LOC101928316 | gastric cancer | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31207155 | 2019 |
| LOC101928963 | glioma | qRT-PCR, Western Blot, Dual Luciferase Reporter Gene Assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31670198 | 2019 |
| LOC105372579 | hepatocellular carcinoma | qRT-PCR , Luciferase reporter assay, in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31114338 | 2019 |
| LOC283070 | prostate cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29956684 | 2018 |
| LOC285194 | gastric cancer | qRT-PCR, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31991056 | 2019 |
| LOC285194 | non small cell lung cancer | qPCR, Western blot, in vitro knockdown, etc. | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30542733 | 2019 |
| LOC285194 | breast cancer | qPCR, RNAi, Western blot, ChIP, Luciferase reporter assay, Cell proliferation assay, ISH etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 23558749 | 2013 |
| LOC285194 | colon cancer | qPCR, RNAi, Western blot, ChIP, Luciferase reporter assay, Cell proliferation assay, ISH etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 23558749 | 2013 |
| LOC389332 | gastric cancer | qRT-PCR, microarray | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31884510 | 2019 |
| LOC441242 | triple negative breast cancer | microarray, qPCR etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 26910840 | 2016 |
| LOC554202 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay etc | H | ✔ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31762810 | 2019 |
| LOC554202 | breast cancer | qPCR etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 22289355 | 2012 |
| Loc680254 | Sciatic nerve injury | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34115425 | 2021 |
| LOC728196 | glioma | qPCR, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30179681 | 2018 |
| LOC730101 | osteosarcoma | qRT-PCR, Western blot, RNAi | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29253564 | 2017 |
| LOXL1-AS1 | ovarian cancer | qRT-PCR, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32058209 | 2020 |
| LOXL1-AS1 | endometrial cancer | qPCR, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32006897 | 2020 |
| LOXL1-AS1 | lung adenocarcinoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31758653 | 2019 |
| LOXL1-AS1 | non small cell lung cancer | qRT-PCR | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 31737192 | 2019 |
| LOXL1-AS1 | pancreatic cancer | RT-qPCR, Western blot, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31732974 | 2019 |
| LOXL1-AS1 | gastric cancer | qRT-PCR, Luciferase Reporter Assay, Western Blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31908498 | 2019 |
| LOXL1-AS1 | breast cancer | qRT-PCR, Western Blot, Luciferase Reporter Assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31841194 | 2019 |
| LOXL1-AS1 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, RIP, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31468594 | 2019 |
| LOXL1-AS1 | Liver Cancer | Western blot;Luciferase reporter assay;Rescue assay;RNA pull-down; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34267816 | 2021 |
| LRB1 | hepatocellular carcinoma | Microarray, qPCR | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30008842 | 2018 |
| LRRC75A-AS1 | Triple Negative breast cancer | qRT-PCR;luciferase reporter assays;Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32811810 | 2020 |
| LSINCT5 | non small cell lung cancer | qPCR, Western blot, in vitro knockdown, RNAi, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29883241 | 2018 |
| LSINCT5 | bladder cancer | qPCR, Western blot, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 29772237 | 2018 |
| LSINCT5 | osteosarcoma | RNAi, qPCR, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30420287 | 2018 |
| LUADT1 | melanoma | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32191497 | 2020 |
| LUCAT1 | renal cell carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29932248 | 2018 |
| LUCAT1 | cervical cancer | qPCR, Western blot, RIP, Luciferase reporter assay etc | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32207530 | 2020 |
| LUCAT1 | pancreatic cancer | qPCR, Western blot, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31789465 | 2019 |
| LUCAT1 | Cervical Cancer | qPCR, RNA-seq | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30831032 | 2019 |
| LUCAT1 | choroidal melanoma | qRT-PCR, Western blot, luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31968402 | 2020 |
| LUCAT1 | colorectal cancer | qPCR, RT-PCR, RNA-seq | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31964396 | 2020 |
| LUCAT1 | ovarian cancer | qPCR, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30107913 | 2018 |
| LUCAT1 | clear cell renal cell carcinoma | microarray, qPCR, Western blot | H | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30032137 | 2018 |
| LUCAT1 | hepatoblastoma | qPCR, Western blot, Luciferase reporter assay, RIP, etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | ✘ | 30479162 | 2018 |
| LUCAT1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30588744 | 2019 |
| LUCAT1 | cervical cancer | qPCR, Western blot, etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31486481 | 2019 |
| LUCAT1 | triple negative breast cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31399501 | 2019 |
| LUCAT1 | breast cancer | Microarray, qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31300015 | 2019 |
| LUCAT1 | oral squamous cell carcinoma | qPCR, Western blot, in vitro knockdown | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31210306 | 2019 |
| LUCAT1 | breast cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31635802 | 2019 |
| LUCAT1 | Chronic obstructive pulmonary disease | ELISA;qRT-PCR;RNA pull-down assay;Western blot;Rescue assay;RNA pull-down; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 34125980 | 2021 |
| LUCRC | colorectal cancer | RT-qPCR | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32082365 | 2020 |
| MACC1-AS1 | cervical squamous cell carcinoma | qPCR, Western blot etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32194733 | 2020 |
| MACC1-AS1 | gastric cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | 30742067 | 2019 |
| MACC1-AS1 | hepatocellular carcinoma | qRT-PCR, Western blotting | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 31915309 | 2020 |
| MACC1-AS1 | pancreatic cancer | qPCR;Western blot;etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31391063 | 2019 |
| MAFG-AS1 | breast cancer | qRT-PCR , Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31002134 | 2019 |
| MAFG-AS1 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, Other | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30348529 | 2018 |
| MAFG-AS1 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 30599080 | 2019 |
| MAFG-AS1 | Lung adenocarcinoma | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31211984 | 2019 |
| MAGI1-IT1 | epithelial ovarian cancer | Microarray , qRT-PCR , Western blot , in vitro knockdown etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31122127 | 2019 |
| MAGI2-AS3 | colorectal cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31709544 | 2019 |
| MAGI2-AS3 | non small cell lung cancer | qRT-PCR, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31910343 | 2020 |
| MAGI2-AS3 | cervical squamous cell carcinoma | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31832086 | 2019 |
| MAGI2-AS3 | non small cell lung cancer | qPCR, etc. | L | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29922089 | 2018 |
| MALAT1 | cervical cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32152961 | 2020 |
| MALAT1 | glioma | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32117213 | 2020 |
| MALAT1 | gastric cancer | qRT-PCR, Western blot | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32104001 | 2020 |
| MALAT1 | colorectal cancer | qPCR, Western blot, in vitro knockdown, RNAi | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29964337 | 2018 |
| MALAT1 | ovarian cancer | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29949143 | 2018 |
| MALAT1 | lung adenocarcinoma | qPCR, Western blot, in vitro knockdown, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29928414 | 2018 |
| MALAT1 | breast cancer | Microarray, qPCR | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | 29912916 | 2018 |
| MALAT1 | glioma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29808528 | 2018 |
| MALAT1 | non small cell lung cancer | qPCR | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | 29805668 | 2018 |
| MALAT1 | esophageal squamous cell carcinoma | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31938345 | 2018 |
| MALAT1 | ovarian cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29874124 | 2018 |
| MALAT1 | colorectal cancer | qPCR, Luciferase reporter assay etc | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32349546 | 2020 |
| MALAT1 | retinoblastoma | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32336590 | 2020 |
| MALAT1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP etc | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 32220970 | 2020 |
| MALAT1 | gastric cancer | qPCR, Western blot etc | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32214850 | 2020 |
| MALAT1 | prostate cancer | qPCR etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 32210615 | 2020 |
| MALAT1 | colorectal cancer | qPCR, Western blot, RIP, Luciferase reporter assay etc | L | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32209115 | 2020 |
| MALAT1 | laryngeal and hypopharyngeal Carcinoma | qPCR, RNAi etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31792655 | 2019 |
| MALAT1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31777593 | 2019 |
| MALAT1 | multiple myeloma | qRT-PCR, Western blot, Dual-luciferase reporter assay | H | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31953613 | 2020 |
| MALAT1 | prostate cancer | RT-qPCR, Western blot assay, Luciferase assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31935634 | 2020 |
| MALAT1 | lung adenocarcinoma | RT-qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 31933847 | 2019 |
| MALAT1 | gastric cancer | RT-qPCR, Western blottin | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | 31897197 | 2020 |
| MALAT1 | non small cell lung cancer | qRT-PCR, Western blot assay, Dual-luciferase reporter gene assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31863664 | 2020 |
| MALAT1 | laryngeal squamous cell cancer | RT-PCR, Western blotting | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31837057 | 2020 |
| MALAT1 | hepatocellular carcinoma | qRT-PCR, Western blot, Dual-luciferase reporting assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31693399 | 2020 |
| MALAT1 | gallbladder cancer | qRT-PCR , Western blot , RIP etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31174563 | 2019 |
| MALAT1 | hepatocellular carcinoma | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31168355 | 2019 |
| MALAT1 | esophageal squamous cell carcinoma | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31116509 | 2019 |
| MALAT1 | breast cancer | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31105998 | 2019 |
| MALAT1 | adrenocortical carcinoma | qRT-PCR , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31085769 | 2019 |
| MALAT1 | infantile hemangioma | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31610202 | 2019 |
| MALAT1 | colon cancer | qPCR, Western blot, Dual-luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30154407 | 2018 |
| MALAT1 | osteosarcoma | qPCR, Luciferase assay, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30076726 | 2018 |
| MALAT1 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, RNAi, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30285605 | 2018 |
| MALAT1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, Other | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30278452 | 2018 |
| MALAT1 | hepatocellular carcinoma | qPCR, Western blot, in vitro knockdown, RIP, etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30546959 | 2018 |
| MALAT1 | ovarian cancer | qPCR, Western blot, Luciferase reporter assay, RNAi, etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31496733 | 2019 |
| MALAT1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31466138 | 2019 |
| MALAT1 | Multiple myeloma | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31397203 | 2019 |
| MALAT1 | breast cancer | qPCR, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31382922 | 2019 |
| MALAT1 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | 31372165 | 2019 |
| MALAT1 | oral squamous cell carcinoma | qPCR | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31360193 | 2019 |
| MALAT1 | Hepatocellular Carcinoma | qPCR, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31347327 | 2019 |
| MALAT1 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, RIP | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31311811 | 2019 |
| MALAT1 | renal cell carcinoma | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31250518 | 2019 |
| MALAT1 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31240979 | 2019 |
| MALAT1 | Glioblastoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31648104 | 2019 |
| MALAT1 | diffuse large B-cell lymphoma | qPCR, RNAi, Western blot, Flow cytometry assay etc. | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28292022 | 2017 |
| MALAT1 | uveal melanoma | qPCR, Western blot, Cell proliferation assay, Cell migration and invasion assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 27725873 | 2017 |
| MALAT1 | retinoblastoma | qPCR, Western blot, Luciferase Reporter Assays | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28550678 | 2017 |
| MALAT1 | bladder cancer | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 22722759 | 2012 |
| MALAT1 | gastric cancer | qPCR, Western blot etc. | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29162158 | 2017 |
| MALAT1 | multiple myeloma | in vitro knockdown, RIP etc. | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29632340 | 2018 |
| MALAT1 | prostate cancer | qPCR, Northern blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 23726266 | 2013 |
| MALAT1 | cervical cancer | qPCR, Northern blot etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 22491206 | 2010 |
| MALAT1 | ovarian cancer | qPCR, Western blot, RIP etc. | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29548748 | 2018 |
| MALAT1 | hepatocellular carcinoma | qPCR, RNAi, Western blot, Dual-luciferase reporter assay etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 27524242 | 2016 |
| MALAT1 | gastric cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 28396617 | 2017 |
| MALAT1 | gastric cancer | qPCR, RNAi, Western blot, Cell proliferation assay, ISH etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28268166 | 2017 |
| MALAT1 | cervical cancer | qPCR, Cell proliferation assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 26854446 | 2015 |
| MALAT1 | ovarian cancer | qPCR, Luciferase reporter assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | 29874124 | 2018 |
| MALAT1 | Oral squamous cell cancer | qRT-PCR,Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32879299 | 2020 |
| MALAT1 | Parkinsons disease | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 33726823 | 2021 |
| MALAT1 | Thymic cancer | Western blot;Flow Cytometry assay;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 34122636 | 2021 |
| MALAT1 | Prostate Cancer | qRT-PCR;Western blot;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34295718 | 2021 |
| MALAT1 | Glioma | qRT-PCR;RT-PCR; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34268963 | 2021 |
| MALAT1 | Laryngocarcinoma | qPCR;RT-qPCR;Western blot; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34183954 | 2021 |
| MANCR | hepatocellular carcinoma | qPCR, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31788100 | 2019 |
| MANCR | gastric cancer | RT-qPCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31807188 | 2019 |
| MAP3K1-2 | gastric cancer | qPCR, Western Blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30122954 | 2018 |
| MATN1-AS1 | glioma | qRT-PCR, Luciferase reporter assay, RIP, Western blot assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31667976 | 2020 |
| MBNL1-AS1 | non small cell lung cancer | qRT-PCR, RIP | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32092823 | 2020 |
| MBNL1-AS1 | bladder cancer | qPCR, Western blot, Luciferase reporter assay etc | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32194406 | 2020 |
| MBNL1-AS1 | bladder cancer | qPCR, Luciferase reporter assay etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31769229 | 2019 |
| MBNL1-AS1 | colon cancer | qPCR, Western blot, Luciferase reporter assay, RIP | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31255531 | 2019 |
| MBNL1-AS1 | Prostate cancer | qPCR;RT-qPCR;Western blot;luciferase assay;Rescue assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33648424 | 2021 |
| MBNL3 | hepatocellular carcinoma | qPCR, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28553938 | 2017 |
| MCM3AP-AS1 | cervical squamous cell carcinoma | RT-qPCR | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31985002 | 2020 |
| MCM3AP-AS1 | gastric cancer | qPCR, Western blot, luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32196596 | 2020 |
| MCM3AP-AS1 | prostate cancer | qPCR, Western blot, RIP etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | 32193153 | 2020 |
| MCM3AP-AS1 | pancreatic cancer | qRT-PCR, Western blot analysis, Dual luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31830901 | 2019 |
| MCM3AP-AS1 | Colorectal cancer | CCK-8 assay;qPCR;RT-qPCR;Western blot;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 33686713 | 2021 |
| MEF2C-AS1 | gastric cancer | RNA-seq, qPCR, Western blot, in vitro knockdown | L | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30005210 | 2018 |
| MEG3 | osteosarcoma | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32016959 | 2020 |
| MEG3 | clear cell renal cell carcinoma | qPCR, Luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29968912 | 2018 |
| MEG3 | malignant melanoma | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29781534 | 2018 |
| MEG3 | chronic myeloid leukemia | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29772439 | 2018 |
| MEG3 | acute myeloid leukemia | qPCR, Western blot, RIP etc. | L | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32359033 | 2020 |
| MEG3 | head and neck squamous cell carcinoma | qPCR, Western blot, Luciferase reporter assay etc | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 32277605 | 2020 |
| MEG3 | glioma | qPCR, Western blot, Luciferase reporter assay etc | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32271438 | 2020 |
| MEG3 | colorectal cancer | Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32219064 | 2020 |
| MEG3 | prostate cancer | qPCR, Western blot, RIP etc | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31790140 | 2019 |
| MEG3 | Neuroblastoma | qPCR, RNA-seq | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | 30886518 | 2019 |
| MEG3 | glioma | qPCR, western blot | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31545491 | 2019 |
| MEG3 | melanoma | RT-PCR, Western blot (WB) analysis, Dual luciferase array | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31938020 | 2020 |
| MEG3 | clinical nonfunctioning pituitary adenoma | qRT-PCR, Luciferase Reporter Assay, Western Blot Analysis | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31899875 | 2020 |
| MEG3 | choriocarcinoma | qRT-PCR , Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31124134 | 2019 |
| MEG3 | cholangiocarcinoma | qRT-PCR , Western blot , in vitro knockdown etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31119760 | 2019 |
| MEG3 | renal cell carcinoma | Luciferase reporter assay , RIP etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31071531 | 2019 |
| MEG3 | cervical cancer | qPCR | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30174437 | 2018 |
| MEG3 | multiple myeloma | microarray, qPCR, RIP, Dual-Luciferase reporter assay | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30134227 | 2018 |
| MEG3 | chronic myeloid leukemia | qPCR, Luciferase assay, Western blot, RIP | L | ✔ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30072211 | 2018 |
| MEG3 | colorectal cancer | qPCR, Western blot, Other | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31413531 | 2019 |
| MEG3 | T-cell lymphoblastic lymphoma | qPCR, Western blot, in vitro knockdown, etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✘ | ✘ | 30556337 | 2018 |
| MEG3 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31396320 | 2019 |
| MEG3 | Breast Cancer | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31326549 | 2019 |
| MEG3 | cervical cancer | qPCR, Western blot, Luciferase reporter assay, RIP | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31320837 | 2019 |
| MEG3 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31251997 | 2019 |
| MEG3 | gastric adenocarcinoma | qPCR, Western blot, Luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31650535 | 2019 |
| MEG3 | ovarian cancer | Microarray, qPCR, Western blot, Luciferase reporter assay, RIP | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31638182 | 2019 |
| MEG3 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31632544 | 2019 |
| MEG3 | tongue squamous cell carcinoma | microarray, MSP-PCR, RNAi, Western blot etc. | L | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 24343426 | 2014 |
| MEG3 | osteosarcoma | qPCR, Western blot, Northern blot, ChIP etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 17569660 | 2007 |
| MEG3 | endometrial cancer | qPCR, Western blot, RIP | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29094270 | 2017 |
| MEG3 | non-functioning pituitary adenoma | qPCR, ISH etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 18628527 | 2008 |
| MEG3 | glioma | qPCR etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 25645334 | 2015 |
| MEG3 | hepatocellular carcinoma | qPCR, Western blot, Cell proliferation assay, Cell invasion assay etc. | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 26992211 | 2016 |
| MEG3 | glioma | qPCR, RNAi, Western blot, MTT assay etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 26676363 | 2016 |
| MEG3 | gastric cancer | qPCR, Luciferase reporter assay, RNA pull-down assay etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 26253106 | 2015 |
| MEG3 | glioma | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29027534 | 2017 |
| MEG3 | Pituitary adenoma | Flow cytometry assay;Western blot;Flow Cytometry assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 33649837 | 2021 |
| MEG3 | Breast cancer | Dual-luciferase reporter assay;qRT-PCR;Western blot;Flow Cytometry assay;Luciferase reporter assay; | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 33121324 | 2020 |
| MEG3 | Hepatocellular carcinoma | Western blot;Flow Cytometry assay;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 33747202 | 2021 |
| MEG4 | gastric cancer | qRT-PCR , Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31584879 | 2019 |
| METTL14 | colorectal cancer | RT-PCR, Western blot, RNA immunoprecipitation | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | 32111213 | 2020 |
| MFI2 | cervical cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31210294 | 2019 |
| MFI2-AS1 | glioma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31298339 | 2019 |
| MHRT | gastric cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31273599 | 2019 |
| MIAT | cholangiocarcinoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32064660 | 2020 |
| MIAT | breast cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29792859 | 2018 |
| MIAT | pancreatic cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29772434 | 2018 |
| MIAT | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32345777 | 2020 |
| MIAT | melanoma | qPCR, Western blot etc. | H | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32300960 | 2020 |
| MIAT | gastric cancer | qPCR, Western blot etc | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | 32274858 | 2020 |
| MIAT | esophageal cancer | qPCR, Western blot, in vitro knockdown etc | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32266022 | 2020 |
| MIAT | cervical cancer | qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32239132 | 2020 |
| MIAT | esophageal squamous cell carcinoma | Dual luciferase reporter assay, qRT-PCR, Western blot analysis, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31943174 | 2020 |
| MIAT | non small cell lung cancer | RT-qPCR, RNAi, Dual-luciferase reporter assay, Western blot analysis | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31897168 | 2020 |
| MIAT | wilms tumor | RT-qPCR, Western Blot Analysis | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31841180 | 2019 |
| MIAT | acute myeloid leukemia | qRT-PCR, Western blot analysis, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31698307 | 2019 |
| MIAT | non small cell lung cancer | qRT-PCR , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31081093 | 2019 |
| MIAT | clear cell renal cell carcinoma | qPCR, Luciferase assays | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30041179 | 2018 |
| MIAT | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30551417 | 2019 |
| MIAT | papillary thyroid cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31372094 | 2019 |
| MIAT | Atherosclerosis | qRT-PCR;luciferase reporter assays;Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32833904 | 2020 |
| MIAT | NA | qRT-PCR;luciferase reporter assays;Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34016053 | 2021 |
| MIAT | Atherosclerosis | RNA immunoprecipitation;RNA pull-down assay;Western blot;RNA immunoprecipitation;RNA pull-down; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33165137 | 2020 |
| MIAT | Colorectal cancer | RNA pull-down assay;Western blot;RNA pull-down; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33085926 | 2020 |
| MIF-AS1 | ovarian cancer | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32196575 | 2020 |
| MINCR | glioma | qPCR, Luciferase reporter assay, RIP etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32333234 | 2020 |
| MINCR | nasopharyngeal cancer | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31760895 | 2019 |
| miR-183 sponge | Breast cancer | luciferase reporter assays;qRT-PCR;Western blot assay | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 25394902 | 2014 |
| MIR100HG | triple negative breast cancer | RNA-seq, qPCR, Western Blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30042378 | 2018 |
| MIR100HG | osteosarcoma | qPCR, Western blot, Luciferase reporter assay, RIP, etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30551532 | 2019 |
| MIR137HG | bladder cancer | qPCR | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31308745 | 2019 |
| miR143HG | hepatocellular carcinoma | qPCR, Luciferase reporter assay, Western blot | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | 30945380 | 2019 |
| MIR155HG | clear cell renal cell carcinoma | Western blot, qRT-PCR | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31889587 | 2020 |
| MIR155HG | pancreatic cancer | q-PCR , Luciferase reporter assay , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31161625 | 2019 |
| MIR155HG | laryngeal squamous cell cancer | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31081043 | 2019 |
| MIR17HG | glioma | qPCR, Western blot, Luciferase reporter assay, RIP, etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30691465 | 2019 |
| MIR181A2HG | NA | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33537821 | 2021 |
| MIR194-2HG | Liver cancer | qPCR;RT-qPCR;Western blot; | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 33116574 | 2020 |
| MIR2052HG | breast cancer | qPCR, Luciferase reporter assay, RIP, Western blot | L | ✔ | ✔ | ✔ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | 30944027 | 2019 |
| MIR205HG | cervical cancer | qRT-PCR, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31655037 | 2019 |
| MIR205HG | cervical cancer | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31023531 | 2019 |
| MIR210HG | cervical cancer | RT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32087604 | 2020 |
| MIR22HG | colorectal cancer | qRT-PCR, Western blot | L | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32127004 | 2020 |
| MIR22HG | cervical cancer | qRT-PCR | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32099468 | 2020 |
| MIR22HG | endometrial cancer | qPCR, Western blot, Luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29775889 | 2018 |
| MIR22HG | glioblastoma | other | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31891366 | 2020 |
| MIR22HG | hepatocellular carcinoma | qPCR, RIP, Western Blot | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30083257 | 2018 |
| MIR22HG | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP, etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30680848 | 2019 |
| MIR22HG | esophageal adenocarcinoma | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31291201 | 2019 |
| MIR22HG | Adenomyosis | Cell proliferation assay;qPCR;RT-qPCR;Luciferase report assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33624428 | 2021 |
| MIR31HG | osteosarcoma | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31564967 | 2019 |
| MIR31HG | hepatocellular carcinoma | qPCR, Dual luciferase reporter assay, Western blot, RIP | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30176933 | 2018 |
| MIR31HG | esophageal cancer | qPCR etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 28975978 | 2017 |
| MIR4435-2HG | colorectal cancer | RT-qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32154166 | 2020 |
| MIR4435-2HG | oral squamous cell carcinoma | RT-qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32016787 | 2020 |
| MIR4435-2HG | lung cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 29872866 | 2018 |
| MIR4435-2HG | melanoma | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32196611 | 2020 |
| MIR4435-2HG | colorectal cancer | RNA-seq, microarray | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | 30972258 | 2019 |
| MIR4435-2HG | non small cell lung cancer | qRT-PCR, Western blot, Luciferase reporter analysis, RIP, RNA-seq | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31875359 | 2020 |
| MIR4435-2HG | gastric cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31484163 | 2019 |
| MIR4697HG | glioma | qPCR, Luciferase reporter analysis, RIP | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31884342 | 2020 |
| MIR503HG | non small cell lung cancer | qPCR, Western blot etc | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32184667 | 2020 |
| MIR503HG | non small cell lung cancer | qRT-PCR, Western Blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31858550 | 2019 |
| MIR503HG | choriocarcinoma | qPCR, Cell transfection, Cell cycle assay etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 27023770 | 2016 |
| MIR503HG | Tnbc | RNA immunoprecipitation;Flow Cytometry assay;RNA immunoprecipitation; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 33869743 | 2021 |
| MIR570MG | colon cancer | Western blot, Luciferase reporter assay etc | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32195190 | 2020 |
| MIR600HG | colorectal cancer | qPCR, Western blot, Luciferase reporter assay etc | L | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 32270866 | 2020 |
| MLK7-AS1 | ovarian cancer | qPCR, Western blot, Luciferase reporter assay, RIP, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30249278 | 2018 |
| MNX1-AS1 | gastric cancer | qRT-PCR, Western blotting, Luciferase assays, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31924214 | 2020 |
| MNX1-AS1 | bladder cancer | RT-PCR, Dual-luciferase reporter assay, Western blot analysis | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31843814 | 2020 |
| MNX1-AS1 | breast cancer | qPCR, Western blot, etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 30697072 | 2019 |
| MORT | mantle cell lymphoma | qPCR etc. | L | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32280273 | 2020 |
| MPPED2-AS1 | breast cancer | qRT-PCR , Western blot , RIP , Microarray etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31181813 | 2019 |
| MRPL39 | gastric cancer | qPCR, Luciferase reporter assay, Other | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30452299 | 2018 |
| MRVI1-AS1 | nasopharyngeal cancer | qPCR, Western blot, Luciferase reporter assay | L | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31273338 | 2019 |
| MSC-AS1 | osteosarcoma | RT-qPCR, Western blot | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 32155139 | 2020 |
| MSC-AS1 | pancreatic cancer | qPCR, Luciferase reporter assay, RIP | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30915884 | 2019 |
| MSC-AS1 | kidney renal clear cell carcinoma | RT-qPCR, Western blot analysis, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31916281 | 2020 |
| MSC-AS1 | Glioma | qRT-PCR;RIP assay;RNA immunoprecipitation;etc. | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33106913 | 2021 |
| MSC-AS1 | Gastric cancer | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33819916 | 2021 |
| MST1P2 | bladder cancer | PCR | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32052927 | 2020 |
| MT1JP | breast cancer | RT-qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32039825 | 2020 |
| MT1JP | glioma | qRT-PCR , Western blot etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31066040 | 2019 |
| MT1JP | Lung Cancer | qPCR, Western blot, Luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31342947 | 2019 |
| MTX2-6 | Esophageal squamous cell carcinoma | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33869216 | 2021 |
| MVIH | acute myeloid leukemia | RT-qPCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31724217 | 2019 |
| MVIH | gastric cancer | qPCR, Western blot etc | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31773716 | 2019 |
| MVIH | non small cell lung cancer | qPCR, Western Blot analysis | H | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31942179 | 2020 |
| MYCNOS | hepatocellular carcinoma | qPCR etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31776854 | 2019 |
| MYCNOS | Glioblastoma | CCK-8 assay;Cell proliferation assay;qPCR;RT-qPCR;Western blot;Luciferase activity assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33871770 | 2021 |
| Myd88 | hepatocellular carcinoma | qPCR, Western blotting etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29022910 | 2017 |
| MYMLR | lung adenocarcinoma | Microarray, qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31361039 | 2019 |
| MYOSLID | osteosarcoma | qRT-PCR, Dual-Luciferase Reporter Assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31849524 | 2019 |
| MYOSLID | gastric cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31497917 | 2019 |
| MYU | prostate cancer | qPCR, ChIP, Dual-luciferase activity assay, Western blot | H | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30132573 | 2018 |
| n384546 | papillary thyroid cancer | qRT-PCR , Luciferase reporter assay , Western blot , RNA-seq , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31160577 | 2019 |
| NAP1L6 | prostate cancer | Microarray, qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✘ | ✘ | 30154665 | 2018 |
| NBAT1 | glioblastoma | qPCR, Western blot, in vitro knockdown | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29771423 | 2018 |
| NBAT1 | renal cancer | qPCR, Western blot, Luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31298469 | 2019 |
| NBAT1 | esophageal cancer | qPCR, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31632565 | 2019 |
| NBR2 | colorectal cancer | Western Blotting, RT-PCR | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31888414 | 2019 |
| NBR2 | non small cell lung cancer | qRT-PCR , Western blot etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31599420 | 2019 |
| NBR2 | Hepatocellular carcinoma | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33651649 | 2021 |
| NCK-AS1 | osteosarcoma | qRT-PCR, Western Blot Analysis, Dual Luciferase Reporter Assay, RIP | H | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31908475 | 2019 |
| NCK1-AS1 | urinary bladder cancer | qPCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32184669 | 2020 |
| NCK1-AS1 | ovarian cancer | qPCR, Western blot, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31761329 | 2019 |
| NCK1-AS1 | Melanoma | qPCR;RT-qPCR;RIP assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34247598 | 2021 |
| ncRAB31 | renal cell carcinoma | microarray, qPCR, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 24238219 | 2013 |
| ncRAN | neuroblastoma | qPCR, RNAi, Northern blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 19287950 | 2009 |
| NEAT1 | malignant melanoma | RT-qPCR, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32096166 | 2020 |
| NEAT1 | pancreatic cancer | qRT-PCR, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32064164 | 2020 |
| NEAT1 | endometrial cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31747378 | 2019 |
| NEAT1 | cholangiocarcinoma | qPCR, Western blot, in vitro knockdown, RNAi, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 29970216 | 2018 |
| NEAT1 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 29864936 | 2018 |
| NEAT1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29797561 | 2018 |
| NEAT1 | lung adenocarcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29788922 | 2018 |
| NEAT1 | cervical cancer | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32368085 | 2020 |
| NEAT1 | lung cancer | qPCR, Western blot, RIP etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32296457 | 2020 |
| NEAT1 | acute myeloid leukemia | qPCR, Western blot, Luciferase reporter assay etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32280304 | 2020 |
| NEAT1 | breast cancer | qPCR, Western blot etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32273717 | 2020 |
| NEAT1 | diffuse large B-cell lymphoma | qPCR, Western blot, RIP, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32206038 | 2020 |
| NEAT1 | acute myeloid leukemia | qPCR, Western blot, Luciferase reporter assay etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32179410 | 2020 |
| NEAT1 | Neuroblastoma | qPCR, RNA-seq | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | 30886518 | 2019 |
| NEAT1 | colorectal cancer | qPCR, Western blot, RIP | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✔ | ✘ | 31558855 | 2019 |
| NEAT1 | bladder cancer | RNA-seq, Western blot assay, RT-PCR | H | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31933859 | 2019 |
| NEAT1 | hepatocellular carcinoma | qRT-PCR, Western Blot Analysis, The Assay of Luciferase | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31819522 | 2019 |
| NEAT1 | hepatocellular carcinoma | qRT-PCR, Western blot, dual-luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31819486 | 2019 |
| NEAT1 | hepatocellular carcinoma | RT-PCR, Luciferase Reporter Assay, Western Blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31802908 | 2019 |
| NEAT1 | colorectal cancer | Western blotting, qRT-PCR, Dual Luciferase assay | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | 31802650 | 2020 |
| NEAT1 | colon cancer | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31173354 | 2019 |
| NEAT1 | melanoma | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31173352 | 2019 |
| NEAT1 | colorectal cancer | qPCR, Western blot, RIP, Dual-Luciferase Assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30185232 | 2018 |
| NEAT1 | ovarian cancer | qPCR, Western blot, RIP, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30154460 | 2018 |
| NEAT1 | osteosarcoma | qPCR | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30123061 | 2018 |
| NEAT1 | cervical cancer | qPCR, Western Blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30096244 | 2018 |
| NEAT1 | glioma | microarray, qPCR, Western blot, Dual luciferase reported assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30053878 | 2018 |
| NEAT1 | cervical cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30024596 | 2018 |
| NEAT1 | hepatocellular carcinoma | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30021196 | 2018 |
| NEAT1 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30407674 | 2019 |
| NEAT1 | osteosarcoma | qPCR, Western blot, Luciferase reporter assay, RNAi, Other | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30203547 | 2019 |
| NEAT1 | multiple myeloma | qPCR, Western blot, Other | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31427718 | 2020 |
| NEAT1 | osteosarcoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30485482 | 2018 |
| NEAT1 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31486491 | 2019 |
| NEAT1 | prostate cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31481527 | 2019 |
| NEAT1 | Breast Cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31344855 | 2019 |
| NEAT1 | endometrial cancer | Microarray, qPCR, Western blot, Luciferase reporter assay, RIP | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31287002 | 2019 |
| NEAT1 | lung cancer | qPCR, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31646570 | 2019 |
| NEAT1 | leukemia | qPCR, RNAi, Western blot, Flow cytometry assay etc. | L | ✔ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 27446393 | 2016 |
| NEAT1 | bladder cancer | qPCR, RNAi, Flow cytometry assay, MTT assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 27384674 | 2016 |
| NEAT1 | gastric adenocarcinoma | qPCR, RNAi, Cell proliferation assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 26911892 | 2016 |
| NEAT1 | nasopharyngeal cancer | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 27020592 | 2016 |
| NEAT1 | lung cancer | qPCR, Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29152741 | 2018 |
| NEAT1 | lung cancer | RNAi, qPCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28615056 | 2017 |
| NEAT1 | non small cell lung cancer | qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 25854373 | 2015 |
| NEAT1 | nasopharyngeal cancer | qPCR, Luciferase reporter assay, Western blot, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29270022 | 2017 |
| NEAT1 | breast cancer | qPCR, RNAi, ChIP etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 27556296 | 2016 |
| NEAT1 | non small cell lung cancer | qPCR, RNAi, Western blot, RNA pull-down assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 27351135 | 2016 |
| NEAT1 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 28762332 | 2017 |
| NEAT1 | hepatocellular carcinoma | qPCR, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 29764424 | 2018 |
| NEAT1 | breast cancer | qPCR, RNAi, Western blot, Luciferase reporter assay, MTT assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28034643 | 2017 |
| NEAT1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28783584 | 2017 |
| NEAT1 | Endometrial cancer | qRT-PCR,Luciferase reporter assay,Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32882142 | 2020 |
| NEAT1 | Glioma | Luciferase reporter assay;RNA immunoprecipitation;etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 33982764 | 2021 |
| NEAT1 | Gastric cancer | Dual-luciferase reporter assay;Western blot;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 33982777 | 2021 |
| NEAT1 | Cholangiocarcinoma | Western blot;Flow Cytometry assay;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33502823 | 2021 |
| NEAT1 | Neuroblastoma | RACE; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32693640 | 2020 |
| NIFK-AS1 | endometrial cancer | qPCR, Western blot, Northern blot, Dual-luciferase report system assays, RIP | L | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30176290 | 2018 |
| NKILA | cervical squamous cell carcinoma | RT-qPCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31950510 | 2020 |
| NKILA | non small cell lung cancer | RT-qPCR, Western blotting | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31934087 | 2019 |
| NKILA | breast cancer | qRT-PCR, Western blotting analysis | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31862380 | 2020 |
| NKILA | osteosarcoma | qPCR , Western blot , RIP , in vitro knockdown etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31173281 | 2019 |
| NKILA | rectal cancer | qPCR, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30171719 | 2018 |
| NKILA | breast cancer | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31282094 | 2019 |
| NKILA | breast cancer | qPCR, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29761481 | 2018 |
| NKX2-1-AS1 | lung cancer | RNA-seq, qPCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30981459 | 2019 |
| NKX2-1-AS1 | lung cancer | qPCR, Western blot, Luciferase reporter assay, RIP, RNAi, Microarray, Other | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30258080 | 2018 |
| NNT-AS1 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30006956 | 2018 |
| NNT-AS1 | lung cancer | qPCR, in vitro knockdown, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29857296 | 2018 |
| NNT-AS1 | ovarian cancer | qPCR, in vitro knockdown | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29805655 | 2018 |
| NNT-AS1 | bladder cancer | qPCR, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 31782983 | 2019 |
| NNT-AS1 | non small cell lung cancer | qRT-PCR, DualLuciferase Reporter Assay, Western Blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31957837 | 2020 |
| NNT-AS1 | non small cell lung cancer | qRT-PCR, Western blot assay, Dual-luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31923353 | 2020 |
| NNT-AS1 | non small cell lung cancer | qPCR, Western blot | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30070323 | 2018 |
| NNT-AS1 | gastric cancer | qPCR, Luciferase reporter assay, Other | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30324628 | 2019 |
| NONHSAT066293 | esophageal squamous cell carcinoma | microarray, qPCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 27035335 | 2016 |
| NONHSAT105177 | pancreatic Ductal adenocarcinoma | qPCR, Western blot, Microarray, Other | H | ✔ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30237397 | 2018 |
| NONHSAT112228.2 | lung cancer | RT-qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32141418 | 2020 |
| NONHSAT141924 | breast cancer | qPCR, Western blot, Microarray etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32284761 | 2020 |
| NORAD | ovarian cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 32141533 | 2020 |
| NORAD | lung cancer | qPCR, Luciferase reporter assay, RIP | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30967631 | 2019 |
| NORAD | breast cancer | qPCR, Luciferase reporter assay, RIP | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30967631 | 2019 |
| NORAD | breast cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30930692 | 2019 |
| NORAD | Neuroblastoma | qPCR, RNA-seq | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | 30886518 | 2019 |
| NORAD | thyroid cancer | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 30787987 | 2019 |
| NORAD | gastric cancer | qRT-PCR, Luciferase Reporter Gene Assay, Western Blot Assays | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31802897 | 2019 |
| NORAD | osteosarcoma | qRT-PCR , Luciferase reporter assay , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31169973 | 2019 |
| NORAD | cervical cancer | qPCR, RIP, Dual Luciferase Reporter Assay, Western Blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30119219 | 2018 |
| NORAD | prostate cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31342822 | 2019 |
| NORAD | epithelial ovarian cancer | qPCR, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31250987 | 2019 |
| NORAD | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31207175 | 2019 |
| NORAD | Breast Cancer | RNA immunoprecipitation;Western blot;RNA immunoprecipitation; | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 34190442 | 2021 |
| NPCCAT1 | nasopharyngeal cancer | qPCR, Western blot, in vitro knockdown, etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30481541 | 2018 |
| NR-104098 | acute lymphoblastic leukemia | Microarray, qPCR, Western blot, Luciferase reporter assay, RIP etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32296698 | 2020 |
| NR027113 | gastric cancer | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31210301 | 2019 |
| NR2F1-AS1 | esophageal squamous cell carcinoma | qPCR, Western blot etc | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32329844 | 2020 |
| NR2F1-AS1 | thyroid cancer | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31304680 | 2019 |
| NR2F2-AS1 | colorectal cancer | qPCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32210626 | 2020 |
| NR2F2-AS1 | nasopharyngeal cancer | RT-qPCR, Western blotting | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31966043 | 2020 |
| NR4A1AS | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31253658 | 2019 |
| NRAD1 | triple negative breast cancer | Microarray, qPCR, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31197235 | 2019 |
| NRON | hepatocellular carcinoma | qPCR, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✘ | ✘ | 29772429 | 2018 |
| NRON | bladder cancer | qPCR, Western blot etc | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 32194786 | 2020 |
| NR_026860 | renal cell carcinoma | microarray, qPCR etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 24905231 | 2014 |
| NR_036484 | colorectal cancer | microarray, qPCR etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 27165481 | 2016 |
| NR_045617 | colorectal cancer | microarray, qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 26847923 | 2016 |
| OCC-1 | colorectal cancer | qPCR, Western blot, in vitro knockdown, RIP | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29931370 | 2018 |
| OECC | colorectal cancer | qPCR, Western Blot, luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30126634 | 2018 |
| OGFRP1 | hepatocellular carcinoma | qPCR, Western blot, in vitro knockdown, RNAi | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 29997441 | 2018 |
| OGFRP1 | endometrial cancer | qRT-PCR , Luciferase reporter assay , Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | 31131636 | 2019 |
| OIP5-AS1 | pancreatic cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32157498 | 2020 |
| OIP5-AS1 | gastric cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32147682 | 2020 |
| OIP5-AS1 | hepatocellular carcinoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32042127 | 2020 |
| OIP5-AS1 | laryngeal squamous cell cancer | RT-qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32009213 | 2020 |
| OIP5-AS1 | lung cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29897167 | 2018 |
| OIP5-AS1 | colon cancer | Western blot, Luciferase reporter assay etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32308348 | 2020 |
| OIP5-AS1 | thyroid cancer | qPCR, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32193154 | 2020 |
| OIP5-AS1 | gastric cancer | qRT-PCR, Western blot analysis, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31959478 | 2020 |
| OIP5-AS1 | cervical cancer | western blot, RT-qPCR, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31939597 | 2020 |
| OIP5-AS1 | osteosarcoma | qPCR, RIP, Luciferase Reporter Assay, Western Blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30119217 | 2018 |
| OIP5-AS1 | oral squamous cell carcinoma | qPCR, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31369989 | 2019 |
| OIP5-AS1 | gastric cancer | qPCR, Western blot, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31219209 | 2019 |
| OIP5-AS1 | Endometrial Cancer | Flow Cytometry assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34368370 | 2021 |
| onclncRNA-626 | gastric cancer | PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31720086 | 2019 |
| OPI5-AS1 | gastric cancer | qRT-PCR, Luciferase Reporter Gene Assay, Western Blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31858545 | 2019 |
| OR3A4 | osteosarcoma | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32346295 | 2020 |
| OR3A4 | non small cell lung cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31378892 | 2019 |
| OSER1-AS1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31635804 | 2019 |
| OTUB1-isoform2 | gastric cancer | qPCR, Western blot, Cell proliferation assay, Cell invasion assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 27019636 | 2016 |
| OXCT1-AS1 | bladder cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30609030 | 2019 |
| p4516 | gastric cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31354346 | 2019 |
| P5848 | Hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30541900 | 2018 |
| P7 | Hepatocellular carcinoma | qPCR, Western blot, in vitro knockdown, etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | 30546827 | 2018 |
| pancEts-1 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29773901 | 2018 |
| PANDAR | retinoblastoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29778422 | 2018 |
| PANDAR | oral squamous cell carcinoma | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31938389 | 2018 |
| PANDAR | melanoma | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31938355 | 2018 |
| PANDAR | breast cancer | qRT-PCR, Western blotting, in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31104011 | 2019 |
| PANDAR | pancreatic ductal adenocarcinoma | qPCR, western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28886528 | 2017 |
| PANDAR | retinoblastoma | qPCR, ChIP etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 29778422 | 2018 |
| PAPAS | papillary thyroid cancer | qPCR etc | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32194727 | 2020 |
| PAPAS | gastric cancer | qRT-PCR, Dual-Luciferase Reporter Gene Assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31858543 | 2019 |
| PAR5 | Anaplastic thyroid cancer | qRT-PCR, RIP, Luciferase Assay, Western Blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31963578 | 2020 |
| PAR5 | glioma | qPCR, RIP, Western blotting etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29048683 | 2017 |
| PARROT | non small cell lung cancer | qPCR, RNAi, Western blot, Luciferase reporter assay etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 27129154 | 2016 |
| PART1 | glioma | RT-qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32099409 | 2020 |
| PART1 | colorectal cancer | luciferase assay, RIP, RT-PCR | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31898365 | 2020 |
| PART1 | colorectal cancer | qRT-PCR, Western Blot.Luciferase Reporter Assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31669140 | 2020 |
| PART1 | Bladder Cancer | Microarray, qPCR | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31311442 | 2019 |
| PART1 | colorectal cancer | qPCR, Western blot, luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28619512 | 2017 |
| PAS1 | breast cancer | qPCR, Western blot, RIP, Luciferase reporter assay, Microarray etc | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32312833 | 2020 |
| PAX8-AS1 | Osteoporosis | RT-qPCR; Western blot; dual luciferase reporter assays | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | 34012023 | 2021 |
| PAXIP1-AS1 | Ovarian cancer | ChIP;qPCR;RT-qPCR; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 34108034 | 2021 |
| PBB12 | osteosarcoma | Luciferase assay, RT-PCR, Western blotting | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31894336 | 2020 |
| PCA3 | choriocarcinoma | qRT-PCR, Dual-luciferase reporter assay, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31933978 | 2019 |
| PCA3 | prostate cancer | RNA-seq, qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 22349460 | 2012 |
| PCAT-1 | tongue squamous cell carcinoma | qPCR, Western blot etc | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | 32218838 | 2020 |
| PCAT-1 | multiple myeloma | qPCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31777580 | 2019 |
| PCAT-1 | epithelial ovarian cancer | RT-qPCR, Western blotting | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31934037 | 2019 |
| PCAT-1 | esophageal squamous cell carcinoma | Luciferase Reporter Assay, Western Blot, qRT-PCR | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31920393 | 2020 |
| PCAT-1 | acute myeloid leukemia | RT-qPCR, RIP, dual-luciferase assay, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31814913 | 2019 |
| PCAT-1 | head and neck squamous cell carcinoma | qRT-PCR , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30987615 | 2019 |
| PCAT-1 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30569478 | 2019 |
| PCAT-1 | ovarian cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31210290 | 2019 |
| PCAT-1 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31646561 | 2019 |
| PCAT-1 | non small cell lung cancer | qPCR, RNAi, Cell proliferation assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 26770456 | 2015 |
| PCAT1 | clear cell renal cell carcinoma | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32286142 | 2020 |
| PCAT1 | non small cell lung cancer | PCR | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30980423 | 2019 |
| PCAT1 | prostate cancer | qPCR, RNA-seq, RIP | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | 30773595 | 2019 |
| PCAT1 | endometrial cancer | qRT-PCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31927050 | 2020 |
| PCAT1 | oesophageal squamous cell carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✔ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31273188 | 2019 |
| PCAT1 | osteosarcoma | qRT-PCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29430187 | 2018 |
| PCAT1 | Diffuse large b-cell lymphoma | CCK-8 assay;Dual-luciferase reporter assay;qPCR;RT-qPCR;Western blot;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33829443 | 2021 |
| PCAT18 | gastric cancer | qRT-PCR, Western Blot Analysis, Dual-Luciferase Reporter Assay | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31853187 | 2019 |
| PCAT19 | non small cell lung cancer | RT-qPCR, Western blotting | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31819778 | 2019 |
| PCAT19 | prostate cancer | qPCR, Western blot, luciferase reporter assay | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30033362 | 2018 |
| PCAT19 | Glioma | Dual-luciferase reporter assay;RIP assay;Western blot;Flow Cytometry assay;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32980991 | 2020 |
| PCAT6 | cervical cancer | qRT-PCR, Western blot, RIP | H | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32103984 | 2020 |
| PCAT6 | hepatocellular carcinoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32064636 | 2020 |
| PCAT6 | gastric cancer | RT-qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 32039820 | 2020 |
| PCAT6 | gastrointestinal stromal tumor | qPCR, Western blot, RIP, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32339330 | 2020 |
| PCAT6 | triple negative breast cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32308433 | 2020 |
| PCAT6 | hepatocellular carcinoma | qPCR | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30968586 | 2019 |
| PCAT6 | osteosarcoma | qRT-PCR, Western blotting, Luciferase reporter assays | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31676070 | 2020 |
| PCAT6 | gastric cancer | qPCR, Luciferase reporter assay, Western Blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30178843 | 2018 |
| PCAT6 | non small cell lung cancer | qPCR, Luciferase reporter assay, Other | H | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30464520 | 2018 |
| PCAT6 | non small cell lung cancer | qPCR, RIP, Western blot, Other | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30314898 | 2018 |
| PCAT6 | ovarian cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31646553 | 2019 |
| PCAT6 | cholangiocarcinoma | qPCR, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31632586 | 2019 |
| PCAT6 | Liver cancer | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33907581 | 2021 |
| PCAT7 | prostate cancer | qRT-PCR, Western blotting, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31925912 | 2020 |
| PCED1B-AS1 | glioblastoma | qPCR, Western blot etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32326742 | 2020 |
| PCED1B-AS1 | glioma | qRT-PCR, Luciferase reporter assay, RIP, Western blot assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31680313 | 2020 |
| PCGEM1 | ovarian cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29949791 | 2018 |
| PCGEM1 | renal cancer | qRT-PCR, Microarray, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31958075 | 2020 |
| PCGEM1 | cervical cancer | Western blot analysis, qRT-PCR, RIP, Luciferase reporter assays | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31832017 | 2019 |
| PCGEM1 | prostate cancer | Northern blot etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 16569192 | 2006 |
| PCGEM1 | prostate cancer | qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 16515751 | 2006 |
| PCGEM1 | prostate cancer | RNA-seq, qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 25744782 | 2015 |
| PCNA-AS1 | non small cell lung cancer | qPCR, Western blot etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32194807 | 2020 |
| PCNAP1 | Hepatocellular carcinoma | qRT-PCR | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34007276 | 2021 |
| PCSEAT | prostate cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29803673 | 2018 |
| PCSEAT | prostate cancer | qPCR, Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29803673 | 2018 |
| PCTST | pancreatic cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29978472 | 2018 |
| PDIA3P | breast cancer | qRT-PCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31933942 | 2019 |
| PEG10 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29940767 | 2018 |
| PEG10 | malignant melanoma | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31318088 | 2019 |
| PEG10 | glioma | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31241046 | 2019 |
| PENG | clear cell renal cell carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32341409 | 2020 |
| PGM5-AS1 | colorectal cancer | qPCR, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32354224 | 2020 |
| PGM5-AS1 | esophageal squamous cell carcinoma | qRT-PCR , Luciferase reporter assay , Western blot etc. | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31185143 | 2019 |
| PICART1 | Lung cancer | qPCR, Western blot, etc. | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 30662662 | 2018 |
| PICART1 | colorectal cancer | qPCR, Cell transfection, Western blot, Cell proliferation assay etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28339031 | 2017 |
| PICART1 | lung cancer | qPCR, Western blot, etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29940776 | 2018 |
| PiHL | colorectal cancer | RIP, RNA-seq, qRT-PCR, Western blot | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31903119 | 2020 |
| PIK3CD-AS2 | lung adenocarcinoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32165621 | 2020 |
| PITPNA-AS1 | hepatocellular carcinoma | qRT-PCR, Luciferase Reporter Assay, RIP, Western Blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31700026 | 2019 |
| PLAC2 | oral squamous cell carcinoma | qPCR, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30720068 | 2019 |
| PLACT1 | pancreatic cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32085715 | 2020 |
| PLK4 | hepatocellular carcinoma | Microarray, qPCR, Luciferase reporter assay etc. | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32243714 | 2020 |
| PlncRNA-1 | retinoblastoma | qPCR, Western Blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30096220 | 2018 |
| POU3F3 | hepatocellular carcinoma | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29906746 | 2018 |
| POU3F3 | cervical cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31252264 | 2019 |
| POU6F2-AS2 | colon cancer | RT-qPCR | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32100443 | 2020 |
| PRAL | multiple myeloma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | L | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29944867 | 2018 |
| PRAL | non small cell lung cancer | qPCR, Other | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30274002 | 2018 |
| PRCAT38 | prostate cancer | qPCR, Western blot, Luciferase reporter assay, RNAi, Other | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31405024 | 2019 |
| PRKCQ-AS1 | Colorectal Cancer | Rescue assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32619070 | 2020 |
| PRKCZ-AS1 | lung adenocarcinoma | RT-qPCR, Western blot assay, RIP, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31939714 | 2020 |
| PRKG1-AS | oral squamous cell carcinoma | qPCR, Western blot etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 31788859 | 2019 |
| PRLH1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RNAi, RIP, etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31486214 | 2019 |
| PRNCR1 | breast cancer | qPCR, Western blot etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31798697 | 2019 |
| PRNCR1 | non small cell lung cancer | qRT-PCR, Western blot, Dual-luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31912882 | 2020 |
| PROX1-AS1 | prostate cancer | qPCR, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32271411 | 2020 |
| PROX1-AS1 | papillary thyroid cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30061172 | 2018 |
| PRRT3-AS1 | prostate cancer | RT-qPCR, Western blot, microarray | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | 32086850 | 2020 |
| PSLNR | Prostate cancer | qPCR, Western blot, RNAi | L | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31269242 | 2019 |
| PSMA3-AS1 | esophageal cancer | RT-qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32005028 | 2020 |
| PSMB8-AS1 | glioblastoma | RT-qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32151711 | 2020 |
| PSMB8-AS1 | glioma | qRT-PCR, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31812014 | 2020 |
| PSMG3-AS1 | breast cancer | RT-qPCR, Western blot analysis | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31661146 | 2020 |
| PTAR | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31485653 | 2019 |
| PTCSC3 | gastric cancer | RT-qPCR | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31849528 | 2019 |
| PTCSC3 | cervical cancer | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31814920 | 2019 |
| PTCSC3 | cervical cancer | qRT-PCR , Luciferase reporter assay , Western blot etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31587336 | 2019 |
| PTENP1 | glioma | qPCR, Luciferase reporter assay etc | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31799671 | 2020 |
| PTENP1 | multiple myeloma | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31338886 | 2019 |
| PTENP1 | osteosarcoma | qPCR, Western blot etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29805503 | 2018 |
| PTENP1-AS | gastric cancer | qPCR, RNAi etc. | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29719612 | 2018 |
| PTENPL | bladder cancer | qPCR, Luciferase reporter assay etc | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32271413 | 2020 |
| PTPRG-AS1 | breast cancer | RNA-seq, qPCR | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30981459 | 2019 |
| PTPRG-AS1 | nasopharyngeal cancer | qRT-PCR, Western blotting, Microarray data analysis etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30993702 | 2019 |
| PTTG3P | hepatocellular carcinoma | Microarray, qPCR, Western blot, in vitro knockdown | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 29803224 | 2018 |
| PTTG3P | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31340767 | 2019 |
| PURPL | liver cancer | qRT-PCR , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31059022 | 2019 |
| PURPL | gastric cancer | qRT-PCR , Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31606380 | 2019 |
| PVT1 | osteosarcoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32021563 | 2020 |
| PVT1 | oral squamous cell carcinoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32021271 | 2020 |
| PVT1 | non small cell lung cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32021261 | 2020 |
| PVT1 | non small cell lung cancer | qRT-qPCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32002028 | 2020 |
| PVT1 | non small cell lung cancer | RT-PCR | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31707347 | 2020 |
| PVT1 | pancreatic ductal adenocarcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | 30001707 | 2018 |
| PVT1 | hepatocellular carcinoma | qPCR, Luciferase reporter assay, in vitro knockdown, RNAi | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29975928 | 2018 |
| PVT1 | ovarian cancer | qPCR, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29957467 | 2018 |
| PVT1 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32276209 | 2020 |
| PVT1 | endometrial cancer | qPCR, Western blot etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32210576 | 2020 |
| PVT1 | non small cell lung cancer | qPCR, Western blot etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32202906 | 2020 |
| PVT1 | pancreatic ductal adenocarcinoma | qPCR, Western blot, RIP, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32201527 | 2020 |
| PVT1 | non small cell lung cancer | qPCR, Western blot, RIP, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32197208 | 2020 |
| PVT1 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32184617 | 2020 |
| PVT1 | melanoma | qPCR, Western blot, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31770435 | 2019 |
| PVT1 | acute lymphoblastic leukemia | qPCR, Western blot, RNAi | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30930624 | 2019 |
| PVT1 | Non Small Cell Lung Cancer | qPCR, Luciferase reporter assay, RIP, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30861415 | 2019 |
| PVT1 | gastric cancer | qRT-PCR, Dual-luciferase reporter assay | H | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31966056 | 2020 |
| PVT1 | glioma | QRT-PCR, Western Blot, Dual-Luciferase Reporter Assay, RIP | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31957841 | 2020 |
| PVT1 | esophageal cancer | qRT-PCR, Western Blot Analysis, Dual-Luciferase Reporter Assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31951853 | 2020 |
| PVT1 | cervical cancer | qRT-PCR, Western-blot assays | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31943014 | 2020 |
| PVT1 | hepatitis B virus-positive HCC | qRT-PCR, Western blot analysis, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31894346 | 2020 |
| PVT1 | osteosarcoma | Western blot analysis, qRT-PCR, RIP, Luciferase reporter assay | H | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31699956 | 2019 |
| PVT1 | glioma | qRT-PCR, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31696483 | 2019 |
| PVT1 | renal cell carcinoma | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31040699 | 2019 |
| PVT1 | esophageal adenocarcinoma | qRT-PCR , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31601234 | 2019 |
| PVT1 | glioma | qPCR, RIP, Dual Luciferase Reporter Assay, Western Blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30120709 | 2018 |
| PVT1 | bladder cancer | qPCR, Luciferase assay, Western blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30076714 | 2018 |
| PVT1 | endometrial cancer | qPCR, Western blot, luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30031900 | 2018 |
| PVT1 | bladder cancer | qPCR, Western blot, Luciferase reporter assay, Microarray, Other | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30317572 | 2019 |
| PVT1 | laryngeal squamous cell cancer | qPCR, Western blot, Luciferase reporter assay, Microarray, Other | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30304557 | 2019 |
| PVT1 | glioma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30680011 | 2019 |
| PVT1 | nasopharyngeal cancer | qPCR, Western blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31320749 | 2019 |
| PVT1 | ovarian cancer | qPCR, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31222482 | 2019 |
| PVT1 | thyroid cancer | qPCR, Western blot, RIP, ChIP etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 26427660 | 2015 |
| PVT1 | breast cancer | qPCR, Western blotting etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28882595 | 2017 |
| PVT1 | hepatocellular carcinoma | RNAi, Microarray etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 28979669 | 2017 |
| PVT1 | prostate cancer | qPCR, RNAi | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29050519 | 2017 |
| PVT1 | hepatocellular carcinoma | qRT-PCR, Microarray, ect. | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | 29975928 | 2018 |
| PVT1 | Adenomyosis | Dual-luciferase reporter assay;qRT-PCR;etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33728345 | 2021 |
| PVT1 | Ovarian cancer | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33391456 | 2021 |
| PVT1-214 | gastric cancer | qPCR , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31173288 | 2019 |
| PXN-AS1 | glioblastoma | qPCR, Western blot, Luciferase reporter assay, RIP etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32329150 | 2020 |
| PXN-AS1 | pancreatic cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31488171 | 2019 |
| PXN-AS1-L | nasopharyngeal cancer | qPCR , Luciferase reporter assay , Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31173488 | 2019 |
| RAB11B-AS1 | osteosarcoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29928484 | 2018 |
| RAB31 | renal cancer | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29901101 | 2018 |
| RAB5IF | hepatocellular carcinoma | RT-qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31717443 | 2019 |
| RAD51-AS1 | hepatocellular carcinoma | qPCR, Other | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30201872 | 2018 |
| RBM5-AS1 | oral squamous cell carcinoma | RT-qPCR, Luciferase activity assays, Western blot assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31869662 | 2020 |
| RBM5-AS1 | Hepatocellular carcinoma | qRT-PCR;RIP assay;RNA immunoprecipitation;Western blot;RNA immunoprecipitation; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34019714 | 2021 |
| RBMS3-AS3 | prostate cancer | RT-qPCR, Western blot, RIP | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31712637 | 2019 |
| RC3H2 | oral squamous cell carcinoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32163895 | 2020 |
| RCCRT1 | renal cell carcinoma | qPCR, RNAi etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 25168566 | 2014 |
| RGMB-AS1 | gastric cancer | RT-qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 32064882 | 2019 |
| RGMB-AS1 | glioma | qRT-PCR, Luciferase Reporter Assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31819505 | 2019 |
| RGMB-AS1 | laryngeal squamous cell cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 31351424 | 2019 |
| RHPN1-AS1 | epithelial ovarian cancer | qRT-PCR, Western blot, microarray | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32163372 | 2020 |
| RHPN1-AS1 | hepatocellular carcinoma | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32065447 | 2020 |
| RHPN1-AS1 | breast cancer | RT-qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32003509 | 2019 |
| RHPN1-AS1 | gastric cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31982726 | 2020 |
| RHPN1-AS1 | hepatocellular carcinoma | qRT-PCR, Western Blot, Luciferase Reporter Assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31692433 | 2020 |
| RHPN1-AS1 | breast cancer | qRT-PCR , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31089812 | 2019 |
| RHPN1-AS1 | breast cancer | Microarray, qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31312362 | 2019 |
| RHPN1-AS1 | Retinoblastoma | qRT-PCR;RIP assay;RNA immunoprecipitation;etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33426053 | 2020 |
| RMRP | hepatocellular carcinoma | Luciferase reporter assay etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32308432 | 2020 |
| RMRP | non small cell lung cancer | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31050363 | 2019 |
| RMRP | papillary thyroid cancer | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31564913 | 2019 |
| RMRP | lung adenocarcinoma | qPCR, Cell transfection, Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 27906963 | 2016 |
| RNA-14327.1 | endometrial cancer | RIP, Western Blotting, qRT-PCR | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31819513 | 2019 |
| RNA00887 | non small cell lung cancer | qPCR, RNAi | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31322230 | 2019 |
| RNCR2 | Melanoma | qPCR;Western blot;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 33724862 | 2021 |
| RNCR2 | Melanoma | CCK-8 assay;qPCR;Western blot;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 33724862 | 2021 |
| RNCR3 | prostate cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29887969 | 2018 |
| RNCR3 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, RIP etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 32239427 | 2020 |
| RNCR3 | glioma | qPCR, Western blot etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31788110 | 2019 |
| ROR | gastric cancer | RT-PCR, Western blot | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32019330 | 2020 |
| ROR | breast cancer | qPCR, Western blot, Luciferase reporter assay etc | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✘ | ✘ | 32335998 | 2020 |
| RoR | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32273727 | 2020 |
| ROR | colorectal cancer | qPCR, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32196591 | 2020 |
| ROR1-AS1 | colon cancer | qPCR, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32096171 | 2020 |
| ROR1-AS1 | cervical cancer | qPCR, Western blot etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 32271410 | 2020 |
| ROR1-AS1 | bladder cancer | RT-qPCR, Luciferase reporter gene assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31929567 | 2020 |
| ROR1-AS1 | colorectal cancer | RT-qPCR, Western blot analysis | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31693094 | 2019 |
| ROR1-AS1 | colorectal cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31389604 | 2019 |
| ROR1-AS1 | Cervical cancer | qPCR;RT-qPCR;Western blot;Rescue assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | 33081599 | 2020 |
| RP1 | breast cancer | qRT-PCR , Luciferase reporter assay , RIP , Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31073122 | 2019 |
| RP1-163G9.1 | gastric adenocarcinoma | qRT-PCR etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31002370 | 2019 |
| RP1-93H18.6 | cervical cancer | qRT-PCR, Western Blot Analysis | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31877407 | 2020 |
| RP11-159K7.2 | laryngeal squamous cell cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | 32363688 | 2020 |
| RP11-166P13.3 | ovarian cancer | qRT-PCR, Western Blot Analysis, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31920390 | 2019 |
| RP11-181G12.2 | gastric cancer | qPCR, Western blot etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | 31766099 | 2019 |
| RP11-19E11.1 | breast cancer | RNA-seq, Western blot, qRT-PCR | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31934613 | 2020 |
| RP11-284F21.9 | oral squamous cell carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31397491 | 2019 |
| RP11-284P20.2 | hepatocellular carcinoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32100822 | 2020 |
| RP11-334E6.12 | breast cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 32104091 | 2020 |
| RP11-342M1.7 | acute myeloid leukemia | RNA-seq, qPCR | H | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31356197 | 2019 |
| RP11-361F15.2 | osteosarcoma | qRT-PCR, Western blot analysis, Dual luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31904478 | 2020 |
| RP11-363E7.4 | gastric cancer | qRT-PCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 32141108 | 2020 |
| RP11-381N20.2 | cervical cancer | qPCR, Western blot | L | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29863245 | 2018 |
| RP11-422N16.3 | hepatocellular carcinoma | qRT-PCR, Dual-Luciferase Reporter Assay, Western Blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31849497 | 2019 |
| RP11-468E2.5 | colorectal cancer | RT-qPCR, Western blot, RIP | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31718693 | 2019 |
| RP11-480I12.5 | cervical cancer | RT-qPCR, Western blotting | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31897160 | 2020 |
| RP11-547D24.1 | papillary thyroid cancer | qRT-PCR , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31044550 | 2019 |
| RP11-573G6.10 | acute myeloid leukemia | RNA-seq, qPCR | L | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31356197 | 2019 |
| RP11-598D14.1 | hepatocellular carcinoma | qPCR, Western blot analysis, RIP, etc. | L | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30718359 | 2019 |
| RP11-732M18.3 | glioma | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31202814 | 2019 |
| RP11-789C1.1 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 29991048 | 2018 |
| RP11-79H23.3 | bladder cancer | microarray, qPCR, Dual-Luciferase Reporter Assay, RIP, Western Blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30149689 | 2018 |
| RP11-81H3.2 | hepatocellular carcinoma | qPCR, Western Blotting, Luciferase Reporter Assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31858324 | 2019 |
| RP11-874J12.4 | oral squamous cell carcinoma | qRT-PCR, Western blot | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32004389 | 2020 |
| RP3-439F8.1 | Glioblastoma multiforme | Cell cycle assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33991848 | 2021 |
| RP5-1024C24.1 | papillary thyroid cancer | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29783666 | 2018 |
| RP5-833A20.1 | hepatocellular carcinoma | qRT-PCR, Western Blot, Luciferase Reporter Assay | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31827329 | 2019 |
| RPPH1 | esophageal cancer | qPCR, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 32351293 | 2020 |
| RPPH1 | colorectal cancer | RNA-seq | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31685807 | 2019 |
| RPPH1 | acute myeloid leukemia | qPCR, Luciferase reporter assay | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31645843 | 2019 |
| RPSAP52 | pituitary adenoma | qRT-PCR , Luciferase reporter assay , Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31076808 | 2019 |
| Rs11655237 | cervical cancer | real-time PCR, luciferase assay, Western-blot analysis | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31957869 | 2020 |
| RUNX1-IT1 | hepatocellular carcinoma | qRT-PCR, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 32024815 | 2020 |
| RUNX1-IT1 | hepatocellular carcinoma | qPCR, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31646558 | 2019 |
| RUSC1-AS1 | breast cancer | qPCR, Western blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31378902 | 2019 |
| SAMD12-AS1 | glioma | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31646576 | 2019 |
| SAMMSON | glioblastoma | qPCR | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31283714 | 2019 |
| SAMMSON | Intracranial aneurysm | qPCR;RT-qPCR;RNA pull-down assay;RNA pull-down; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34113109 | 2021 |
| SATB2-AS1 | Colorectal cancer | qPCR, RIP | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30858153 | 2019 |
| SATB2-AS1 | osteosarcoma | microarray, qPCR, RNAi, Western blot, Cell proliferation assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28190168 | 2017 |
| SBF2-AS1 | pancreatic cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown etc. | L | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32301277 | 2020 |
| SBF2-AS1 | esophageal squamous cell carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 32229486 | 2020 |
| SBF2-AS1 | breast cancer | RT-qPCR, Western blot analysis, Dual luciferase reporter gene assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31952549 | 2020 |
| SBF2-AS1 | non small cell lung cancer | Dual luciferase reporter gene assay, Rt-qPCR, Western blot analysis | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31928130 | 2020 |
| SBF2-AS1 | lung adenocarcinoma | qRT-PCR , Luciferase reporter assay , RNA-seq , RIP , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31071530 | 2019 |
| SBF2-AS1 | small cell lung cancer | qRT-PCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31050364 | 2019 |
| SBF2-AS1 | hepatocellular carcinoma | qPCR, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30115383 | 2018 |
| SChLAP1 | glioblastoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31492748 | 2019 |
| SDHAP1 | ovarian cancer | qPCR, Western blot etc | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32211849 | 2020 |
| SDPR-AS | non small cell lung cancer | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31352804 | 2019 |
| SDPR-AS | papillary thyroid cancer | qPCR, Western blot, RNAi | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31334828 | 2019 |
| SDPR-AS | renal cell carcinoma | qPCR etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 28790838 | 2017 |
| SEMA3B-AS1 | hepatocellular carcinoma | qPCR, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31251699 | 2019 |
| SERTAD2-3 | osteosarcoma | qPCR | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | 31999493 | 2020 |
| SH3BP5-AS1 | Neuroblastoma | qPCR, RNA-seq | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | 30886518 | 2019 |
| SIK1-lnc | lung cancer | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30050311 | 2018 |
| Skp2 | non small cell lung cancer | qPCR, Western blot etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 26482610 | 2015 |
| SLC16A1-AS1 | non small cell lung cancer | Microarray, qPCR, vWestern blot | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31371390 | 2019 |
| SLC16A1-AS1 | Hepatocellular carcinoma | qRT-PCR,Western blot,Luciferase reporter assay,RIP etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32748357 | 2020 |
| SLC16A1-AS1 | Cervical cancer | qPCR;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33603475 | 2021 |
| SLC16A1-AS1 | Glioblastoma | CCK-8 assay;qPCR;RT-qPCR; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33603467 | 2021 |
| SLC25A5-AS1 | gastric cancer | qPCR | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30793479 | 2019 |
| SLC2A1-AS1 | hepatocellular carcinoma | qRT-PCR, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32174012 | 2020 |
| SLC2A1-AS1 | Lung cancer | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33580997 | 2021 |
| SLCO4A1-AS1 | bladder cancer | qPCR, Luciferase reporter assay | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30863101 | 2019 |
| SLCO4A1-AS1 | colorectal cancer | qRT-PCR, Western blotting | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31853225 | 2019 |
| SLCO4A1-AS1 | colorectal cancer | RNA-seq, qPCR | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30039525 | 2018 |
| SLCO4A1-AS1 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | 31308265 | 2019 |
| SLCO4A1-AS1 | Lung cancer | qRT-PCR,FISH,RIP,Western blot,luciferase reporter assay etc. | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32762035 | 2020 |
| SLCO4A1-AS1 | Acute lymphocytic leukemia | qPCR;RT-qPCR;RNA pull-down assay;Western blot;Flow Cytometry assay;Rescue assay;RNA pull-down; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 33683013 | 2021 |
| SLCO4A1-AS1 | Lung Adenocarcinoma | Rescue assay; | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32762035 | 2020 |
| SlncR | melanoma | RNA-seq , RIP , in vitro knockdown etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31116991 | 2019 |
| SMAD5-AS1 | nasopharyngeal cancer | RT-qPCR, Dual Luciferase Reporter Gene Assay, RIP, Western Blot Analysis | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31921616 | 2019 |
| SNAI3-AS1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31264769 | 2019 |
| snaR | ovarian cancer | qPCR, Western Blot | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30093110 | 2018 |
| SNHG1 | esophageal squamous cell carcinoma | qRT-PCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32021418 | 2020 |
| SNHG1 | cholangiocarcinoma | RNA-seq, qPCR, Western blot, in vitro knockdown, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29970899 | 2018 |
| SNHG1 | breast cancer | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32323846 | 2020 |
| SNHG1 | gastric cancer | qPCR, Western blot etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32277646 | 2020 |
| SNHG1 | papillary thyroid cancer | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31791587 | 2019 |
| SNHG1 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31788970 | 2019 |
| SNHG1 | cholangiocarcinoma | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30764893 | 2019 |
| SNHG1 | pancreatic cancer | RT-qPCR, Western blot analysis, Dual-luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31933880 | 2019 |
| SNHG1 | neuroblastoma | qRT-PCR, Western Blot Analysis, Luciferase Reporter Assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31696485 | 2019 |
| SNHG1 | meningioma | RT-qPCR, Western blot assay, Luciferase reporter assays, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31692066 | 2020 |
| SNHG1 | pancreatic ductal adenocarcinoma | qPCR, Western Blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30087712 | 2018 |
| SNHG1 | colorectal cancer | qPCR, Luciferase reporter assay, RNAi, RIP, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30266084 | 2018 |
| SNHG1 | gastric cancer | qPCR, Western blot, RIP, Luciferase reporter assay, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✔ | ✘ | 30391432 | 2019 |
| SNHG1 | pancreatic cancer | qPCR, Western blot, in vitro knockdown, etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30520072 | 2018 |
| SNHG1 | laryngeal cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31378897 | 2019 |
| SNHG1 | breast cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31354360 | 2019 |
| SNHG1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31330233 | 2019 |
| SNHG1 | acute myeloid leukemia | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31298340 | 2019 |
| SNHG1 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31288529 | 2019 |
| SNHG1 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31276207 | 2019 |
| SNHG1 | osteosarcoma | qPCR, Luciferase reporter assay, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29115574 | 2017 |
| SNHG1 | esophageal cancer | qPCR, Western blot, northern blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 28423738 | 2017 |
| SNHG11 | hepatocellular carcinoma | RT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | 32021286 | 2020 |
| SNHG11 | lung cancer | qPCR, Western blot, Luciferase reporter assay, RIP etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 32239719 | 2020 |
| SNHG11 | colorectal cancer | qPCR, Western blot | L | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31633800 | 2019 |
| SNHG11 | Gastric cancer | Dual-luciferase reporter assay;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33816469 | 2021 |
| SNHG11 | Triple-Negative Breast Cancer | qPCR;RT-qPCR;RIP assay;Western blot;Flow Cytometry assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34257707 | 2021 |
| SNHG12 | esophageal squamous cell carcinoma | qRT-PCR | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32086782 | 2020 |
| SNHG12 | glioblastoma | qRT-PCR, Western blot | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32039732 | 2020 |
| SNHG12 | osteosarcoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31743769 | 2019 |
| SNHG12 | glioma | qPCR, Western blot, RIP | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30015836 | 2018 |
| SNHG12 | breast cancer | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32269676 | 2020 |
| SNHG12 | esophageal squamous cell carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32239639 | 2020 |
| SNHG12 | prostate cancer | qPCR, Luciferase reporter assay, Western blot | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30945357 | 2019 |
| SNHG12 | cervical squamous cell carcinoma | qRT-PCR, Western blot analysis | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31943193 | 2020 |
| SNHG12 | prostate cancer | qPCR;Western blot;etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | 31933941 | 2019 |
| SNHG12 | clear cell renal cell carcinoma | qRT-PCR, Dual-Luciferase Assay, RIP, Western Blot Assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31824846 | 2019 |
| SNHG12 | gastric cancer | qRT-PCR, microarray, Western blot assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31808752 | 2019 |
| SNHG12 | renal cell carcinoma | RT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31114448 | 2019 |
| SNHG12 | papillary thyroid cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31355416 | 2019 |
| SNHG12 | colorectal cancer | qPCR, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31316616 | 2019 |
| SNHG12 | prostate cancer | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | 31267540 | 2019 |
| SNHG12 | gastric cancer | qPCR, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31258654 | 2019 |
| SNHG12 | colorectal cancer | qPCR, RNAi, Western blot, Flow cytometry assay, MTT assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 28225893 | 2017 |
| SNHG12 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29207106 | 2017 |
| SNHG14 | non small cell lung cancer | RT-PCR | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32153123 | 2020 |
| SNHG14 | prostate cancer | RT-qPCR, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32016964 | 2020 |
| SNHG14 | colorectal cancer | PCR, Western blot | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31704614 | 2020 |
| SNHG14 | breast cancer | qPCR, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30964172 | 2019 |
| SNHG14 | pancreatic ductal adenocarcinoma | RT-qPCR, Western blot analysis, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31929143 | 2020 |
| SNHG14 | lung adenocarcinoma | RT-qPCR, Luciferase Reporter Gene Assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31858549 | 2019 |
| SNHG14 | ovarian cancer | qRT-PCR , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31173283 | 2019 |
| SNHG14 | diffuse Large B-Cell Lymphoma | qRT-PCR , Luciferase reporter assay , Western blot , RIP , Microarray , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31570691 | 2019 |
| SNHG14 | breast cancer | qPCR, Western blot, ChIP | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30063126 | 2018 |
| SNHG14 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31273190 | 2019 |
| SNHG14 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31632558 | 2019 |
| SNHG14 | Breast cancer | qRT-PCR,Luciferase reporter assay,etc.. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32744648 | 2020 |
| SNHG14 | Preeclampsia | Dual-luciferase reporter assay;qPCR;RT-qPCR;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 33161910 | 2021 |
| SNHG14 | Colorectal Cancer | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34234865 | 2021 |
| SNHG15 | non small cell lung cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 29771418 | 2018 |
| SNHG15 | prostate cancer | qPCR | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 30981837 | 2019 |
| SNHG15 | colorectal cancer | qPCR, Luciferase reporter assay, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30945457 | 2019 |
| SNHG15 | colorectal cancer | qRT-PCR , Western blot , RIP , RNA-seq , in vitro knockdown etc. | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31014355 | 2019 |
| SNHG15 | papillary thyroid cancer | qPCR, Western blot, Luciferase reporter assay, RIP, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30237435 | 2018 |
| SNHG15 | hepatocellular carcinoma | qPCR, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31310393 | 2019 |
| SNHG15 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31636472 | 2019 |
| SNHG16 | multiple myeloma | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32025219 | 2020 |
| SNHG16 | neuroblastoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | 32021273 | 2020 |
| SNHG16 | esophageal squamous cell carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29949155 | 2018 |
| SNHG16 | breast cancer | qPCR, Luciferase reporter assay, RIP etc. | H | ✘ | ✔ | ✔ | ✔ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32345959 | 2020 |
| SNHG16 | prostate cancer | qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32210616 | 2020 |
| SNHG16 | cervical cancer | qPCR, Western blot, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31774223 | 2019 |
| SNHG16 | pancreatic cancer | qPCR | H | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30981105 | 2019 |
| SNHG16 | colorectal cancer | qPCR, Luciferase reporter assay, RIP, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30962265 | 2019 |
| SNHG16 | glioma | qPCR, Luciferase reporter assay, RIP, Western blot | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30743215 | 2019 |
| SNHG16 | non small cell lung cancer | qRT-PCR, Dual-luciferase reporter assay, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31953899 | 2020 |
| SNHG16 | neuroblastoma | qRT-PCR, Western Blot, Luciferase Reporter Assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31919621 | 2020 |
| SNHG16 | endometrial cancer | qRT-PCR, Western blot, Dual-luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31814916 | 2019 |
| SNHG16 | hepatocellular carcinoma | qRT-PCR, Dual luciferase reporter assay, Western blot analysis, RIP | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31696971 | 2020 |
| SNHG16 | pancreatic cancer | Dual-luciferase reporter assay, RT-qPCR, , Western blotting | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31664866 | 2019 |
| SNHG16 | neuroblastoma | RT-qPCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31180520 | 2019 |
| SNHG16 | bladder cancer | qPCR, Western Blot | H | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30132983 | 2018 |
| SNHG16 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, RIP, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30287374 | 2019 |
| SNHG16 | colon cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31502038 | 2019 |
| SNHG16 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31306653 | 2019 |
| SNHG16 | Hepatocellular Carcinoma | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31293662 | 2019 |
| SNHG16 | hepatocellular carcinoma | Microarray, qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31256427 | 2019 |
| SNHG16 | retinoblastoma | qPCR, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31234025 | 2019 |
| SNHG16 | glioma | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31226483 | 2019 |
| SNHG16 | ovarian cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29461589 | 2018 |
| SNHG16 | Colorectal cancer | Western blot,qRT-PCR,Luciferase reporter assay,RIP etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 32859986 | 2020 |
| SNHG16 | Clear cell renal cell carcinoma | RNA immunoprecipitation;Western blot;Flow Cytometry assay;RNA immunoprecipitation;Rescue assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 33901578 | 2021 |
| SNHG17 | breast cancer | qRT-PCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32042267 | 2020 |
| SNHG17 | glioma | RT-qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32009853 | 2020 |
| SNHG17 | prostate cancer | qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32351538 | 2020 |
| SNHG17 | breast cancer | RNA-seq, qPCR | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30981459 | 2019 |
| SNHG17 | melanoma | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31599425 | 2019 |
| SNHG17 | gastric cancer | qPCR, Western blot, RIP, Other | H | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30256413 | 2019 |
| SNHG17 | non small cell lung cancer | RNA-seq, qPCR, Western blot, RNAi | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31310946 | 2019 |
| SNHG17 | Oral squamous cell carcinoma | ChIP;RIP assay;Rescue assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33531646 | 2021 |
| SNHG17 | Esophageal Squamous Cell Carcinoma | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34429400 | 2021 |
| SNHG20 | epithelial ovarian cancer | qPCR, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✔ | ✘ | 30846486 | 2019 |
| SNHG20 | esophageal squamous cell carcinoma | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30767270 | 2019 |
| SNHG20 | non small cell lung cancer | qRT-PCR, Western Blotting | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 31957836 | 2020 |
| SNHG20 | bladder cancer | qPCR, Western Blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30106094 | 2018 |
| SNHG20 | oral squamous cell carcinoma | qPCR, Western blot, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30655853 | 2019 |
| SNHG20 | prostate cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31497231 | |
| SNHG20 | glioma | qPCR, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31298384 | 2019 |
| SNHG20 | colorectal cancer | qPCR, RNAi, Western blot, Flow cytometry assay, Cell proliferation assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 27543107 | 2016 |
| SNHG20 | Retinoblastoma | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34080033 | 2021 |
| SNHG20 | Colorectal cancer | Luciferase reporter assay;Rescue assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33179110 | 2021 |
| SNHG20 | Ovarian Cancer | CCK-8 assay;Dual-luciferase reporter assay;qRT-PCR;RIP assay;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34302635 | 2021 |
| SNHG3 | papillary thyroid cancer | qRT-PCR, Western blot, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32048306 | 2020 |
| SNHG3 | papillary thyroid cancer | qPCR, Western blot etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32284745 | 2020 |
| SNHG3 | prostate cancer | qPCR, Western blot, Luciferase reporter assay, RIP etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 32248648 | 2020 |
| SNHG3 | colorectal cancer | qPCR, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32187965 | 2020 |
| SNHG3 | oral squamous cell carcinoma | qPCR, Western blot, RIP etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31762107 | 2019 |
| SNHG3 | osteosarcoma | qPCR, Luciferase reporter assay, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | 30791797 | 2019 |
| SNHG3 | breast cancer | Real-Time QPCR, Western Blot, Luciferase Reporter Assay | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31956955 | 2020 |
| SNHG3 | hepatocellular carcinoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31692508 | 2019 |
| SNHG3 | breast cancer | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31586299 | 2019 |
| SNHG3 | Lung Adenocarcinoma | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30154938 | 2018 |
| SNHG3 | glioma | qPCR, Western blot, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30042166 | 2018 |
| SNHG3 | acute myeloid leukemia | qPCR, Western blot, Luciferase reporter assay, RNAi, Other | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31452272 | 2020 |
| SNHG3 | clear cell renal cell carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31505165 | 2019 |
| SNHG3 | laryngeal cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31238052 | 2019 |
| SNHG3 | Breast cancer | qRT-PCR,Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32883233 | 2020 |
| SNHG4 | prostate cancer | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31608997 | 2019 |
| SNHG4 | cervical cancer | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31590627 | 2019 |
| SNHG4 | lung cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RNAi | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31220419 | 2019 |
| SNHG4 | Colorectal cancer | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33744866 | 2021 |
| SNHG4 | Gastric cancer | Dual-luciferase reporter assay;Flow cytometry assay;Western blot; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 33236157 | 2021 |
| SNHG5 | hepatocellular carcinoma | qPCR, Western blot etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32329834 | 2020 |
| SNHG5 | clear cell renal cell carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32281285 | 2020 |
| SNHG5 | acute myeloid leukemia | qPCR, Western blot, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32266420 | 2020 |
| SNHG5 | endometrial cancer | qRT-PCR, Western Blot Analysis, Luciferase Assays | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31885582 | 2019 |
| SNHG5 | glioblastoma | qRT-PCR, Luciferase reporter assay, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31657621 | 2019 |
| SNHG5 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✔ | ✘ | 30166525 | 2018 |
| SNHG5 | osteosarcoma | qPCR, Western Blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30114643 | 2018 |
| SNHG5 | osteosarcoma | qPCR, Western blot, Luciferase reporter assay, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30250399 | 2018 |
| SNHG5 | chronic myelogenous leukemia | qPCR, Western blot, etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31506418 | 2019 |
| SNHG5 | Breast Cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31255976 | 2019 |
| SNHG5 | Oral squamous cell carcinoma | qPCR;RT-qPCR;Western blot;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33093919 | 2020 |
| SNHG6 | non small cell lung cancer | RT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | 32147945 | 2020 |
| SNHG6 | glioma | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 29799357 | 2018 |
| SNHG6 | pancreatic cancer | qPCR, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32265427 | 2020 |
| SNHG6 | cholangiocarcinoma | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32226515 | 2020 |
| SNHG6 | breast cancer | qPCR, RNAi | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30826970 | 2019 |
| SNHG6 | esophageal squamous cell carcinoma | qRT-PCR, Western Blot, Luciferase Reporter Assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31853782 | 2019 |
| SNHG6 | ovarian clear cell carcinoma | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31119871 | 2019 |
| SNHG6 | colorectal cancer | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31118686 | 2019 |
| SNHG6 | osteosarcoma | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | 30988663 | 2019 |
| SNHG6 | lung adenocarcinoma | qPCR, Western blot, Luciferase reporter assay, RNAi, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30257360 | 2018 |
| SNHG6 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30254467 | 2018 |
| SNHG6 | colorectal cancer | qPCR, Western blot, in vitro knockdown, RIP, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30626446 | 2019 |
| SNHG6 | breast cancer | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31387807 | 2019 |
| SNHG6 | colorectal cancer | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31322251 | 2019 |
| SNHG6 | hepatocellular carcinoma | Microarray, qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31258024 | 2019 |
| SNHG6 | wilms tumor | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31257923 | 2019 |
| SNHG6 | glioblastoma | qPCR, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29579705 | 2018 |
| SNHG6 | Colorectal cancer | qRT-PCR;luciferase reporter assays;Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32840014 | 2020 |
| SNHG7 | cervical cancer | RT-qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32161467 | 2020 |
| SNHG7 | uveal melanoma | RT-qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32002036 | 2020 |
| SNHG7 | bladder cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30003751 | 2018 |
| SNHG7 | osteosarcoma | qPCR, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 29989838 | 2018 |
| SNHG7 | colorectal cancer | Microarray, qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29970122 | 2018 |
| SNHG7 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 29915311 | 2018 |
| SNHG7 | esophageal cancer | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29771415 | 2018 |
| SNHG7 | malignant melanoma | qPCR, Western blot, in vitro knockdown, , Luciferase reporter assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32365219 | 2020 |
| SNHG7 | nasopharyngeal cancer | qPCR, Western blot etc | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32218823 | 2020 |
| SNHG7 | lung adenocarcinoma | qPCR, Western blot, RIP, Luciferase reporter assay etc | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32201260 | 2020 |
| SNHG7 | cervical cancer | qPCR, Western blot etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 31773679 | 2019 |
| SNHG7 | bladder cancer | qPCR, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30719150 | 2019 |
| SNHG7 | nasopharyngeal cancer | RT-qPCR, Western blot analysis, Dual luciferase reporter gene assay | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31944163 | 2020 |
| SNHG7 | breast cancer | qRT-PCR, Western blotting, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31897328 | 2019 |
| SNHG7 | renal cell carcinoma | RT-qPCR, Western Blot Analysis | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31841178 | 2019 |
| SNHG7 | breast cancer | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 31132353 | 2019 |
| SNHG7 | breast cancer | qPCR, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31378900 | 2019 |
| SNHG7 | nasopharyngeal cancer | qPCR, Western blot, in vitro knockdown | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31364118 | 2019 |
| SNHG7 | prostate cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31324390 | 2019 |
| SNHG7 | thyroid cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31210313 | 2019 |
| SNHG7 | Glioma | Western blot; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34113393 | 2021 |
| SNHG8 | cervical cancer | qRT-PCR, Western blot assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31961005 | 2020 |
| SNHG8 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | 30537734 | 2018 |
| SNHG8 | gastric cancer | qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29736176 | 2018 |
| SNHG8 | Triple-Negative Breast Cancer | qPCR;RT-qPCR;RIP assay;Western blot;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34362407 | 2021 |
| SNHG9 | glioblastoma | qPCR, Luciferase reporter assay, etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31504670 | 2019 |
| SOCAR | Ovarian cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31299360 | 2019 |
| SOCS2-AS1 | prostate cancer | RNA-seq, qPCR, RIP, ChIP etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 27342777 | 2016 |
| SOX2 | Ewing sarcoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31312393 | 2019 |
| SOX2 | breast cancer | qPCR, Western blotting etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 28882595 | 2017 |
| SOX2-OT | laryngeal cancer | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32266028 | 2020 |
| SOX2-OT | lung squamous cell carcinoma | qRT-PCR , Western blot etc. | H | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30986097 | 2019 |
| SOX2-OT | nasopharyngeal cancer | qRT-PCR, RIP etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31099048 | 2019 |
| SOX21-AS1 | glioma | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | 31973536 | 2019 |
| SOX21-AS1 | hepatocellular carcinoma | qPCR, Western blot, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 29772433 | 2018 |
| SOX21-AS1 | triple negative breast cancer | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 32277517 | 2020 |
| SOX21-AS1 | neuroblastoma | qRT-PCR, Western blotting, in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30992391 | 2019 |
| SOX21-AS1 | oral squamous cell carcinoma | qPCR, Cell migration and invasion assay, In vitro methylation etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 27933111 | 2016 |
| SOX2OT | bladder cancer | PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 32019566 | 2020 |
| SOX2OT | oesophageal squamous cell carcinoma | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29849506 | 2018 |
| SOX2OT | gastric cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29782828 | 2018 |
| SOX2OT | cervical cancer | qPCR, Western blot etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32286144 | 2020 |
| SOX2OT | multiple myeloma | qPCR, RIP etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32198978 | 2020 |
| SOX2OT | pancreatic ductal adenocarcinoma | qRT-PCR, RIP, western blotting | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31837005 | 2020 |
| SOX2OT | gastric cancer | qPCR, RNAi, Cell proliferation assay, Cell migration and invasion assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 27904704 | 2016 |
| SOX2OTV7 | osteosarcoma | qPCR, Luciferase reporter assay, RIP etc | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32302291 | 2020 |
| SOX2OTV7 | osteosarcoma | qPCR, Western blot, in vitro knockdown | L | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | 29475441 | 2018 |
| SOX9-AS1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31402556 | 2019 |
| SPRY4-IT1 | osteosarcoma | RT-qPCR, Western blot, RNAi | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31746422 | 2019 |
| SPRY4-IT1 | non small cell lung cancer | qPCR, Western blot etc. | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 32308413 | 2020 |
| SPRY4-IT1 | hepatocellular carcinoma | qRT-PCR, Western blot, RNA-seq, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31943198 | 2020 |
| SPRY4-IT1 | melanoma | qRT-PCR, Dual luciferase reporter assay, Western blot analysis | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31933852 | 2019 |
| SPRY4-IT1 | breast cancer | qPCR, Western Blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30104400 | 2018 |
| SPRY4-IT1 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31330497 | 2019 |
| SPRY4-IT1 | pancreatic cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29489909 | 2018 |
| SPRY4-IT1 | pancreatic ductal adenocarcinoma | qPCR etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29551494 | 2018 |
| SPRY4-IT1 | testicular germ cell tumor | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29410498 | 2018 |
| SPRY4-IT1 | glioma | qPCR, RNAi, Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 26464658 | 2015 |
| SPRY4-IT1 | esophageal squamous cell carcinoma | qPCR, RNAi etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 24810925 | 2014 |
| SRA | melanoma | PCR, Western blot, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31945347 | 2020 |
| SRA | endometrial cancer | qRT-PCR, Luciferase reporter assay, Western blot analysis | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31892849 | 2020 |
| SRA1 | cervical squamous cell carcinoma | qPCR | L | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31371629 | 2019 |
| SRRM2-AS | nasopharyngeal cancer | Western blot, microarray | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31742692 | 2019 |
| SSATX | melanoma | RNA-seq, qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31352009 | 2019 |
| SSTR5-AS1 | laryngeal squamous cell cancer | Microarray, qPCR, Western blot, RIP | L | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31196171 | 2019 |
| ST8SIA6-AS1 | breast cancer | qPCR | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30150751 | 2018 |
| STARD13-AS | colorectal cancer | qRT-PCR, Western Blotting | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31807011 | 2019 |
| STCAT16 | gastric cancer | qPCR | L | ✔ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | 30957180 | 2019 |
| STXBP5-AS1 | cervical cancer | qPCR, Western blot, Luciferase reporter assay, RIP | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31212131 | 2019 |
| SUMO1P3 | hepatocellular carcinoma | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29905911 | 2018 |
| SUMO1P3 | hepatocellular carcinoma | qRT-PCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31970876 | 2020 |
| SVUGP2 | non small cell lung cancer | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 31401873 | 2019 |
| TALAM1 | breast cancer | qPCR, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31382922 | 2019 |
| TAPIR | prostate cancer | Microarray , RNA-seq, qPCR, Western blot, in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32365858 | 2020 |
| TATDN1 | hepatocellular carcinoma | qPCR, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31378885 | 2019 |
| TATDN1 | breast cancer | qPCR, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31298381 | 2019 |
| TATDN1 | Triple negative breast cancer | Cell proliferation assay;Cell transfection;Cell transfection;microarray;qPCR;RT-qPCR; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33192097 | 2020 |
| TBILA | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 29908210 | 2018 |
| TCAM1P-004 | hepatocellular carcinoma | qPCR, Western blot analysis, RIP, etc. | L | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30718359 | 2019 |
| TCL6 | hepatocellular carcinoma | qRT-PCR, Western blot | L | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32020591 | 2020 |
| TCL6 | retinoblastoma | RT-PCR, Luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31680766 | 2019 |
| TCONS_00814106 | High-fecundity sow ovarian | Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 33091558 | 2021 |
| TDRG1 | cervical cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 32106739 | 2020 |
| TDRG1 | non small cell lung cancer | qRT-PCR, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31742752 | 2019 |
| TDRG1 | gastric cancer | qRT-PCR, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31726370 | 2020 |
| TDRG1 | endometrial cancer | qPCR, Western blot, in vitro knockdown, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29920344 | 2018 |
| TDRG1 | endometrial cancer | RT-qPCR, Western Blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31849490 | 2019 |
| TDRG1 | cervical cancer | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31164797 | 2019 |
| TDRG1 | Breast cancer | Flow cytometry assay;qRT-PCR;Western blot;Flow Cytometry assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33822672 | 2021 |
| TFAP2A-AS1 | breast cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30768589 | 2019 |
| THAP9-AS1 | gastric cancer | qRT-PCR | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32021238 | 2019 |
| THAP9-AS1 | pancreatic ductal adenocarcinoma | RIP, qRT-PCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31831555 | 2020 |
| THAP9-AS1 | Esophageal Squamous Cell Carcinoma | Luciferase reporter assay;RNA immunoprecipitation;etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34273804 | 2021 |
| THOR | nasopharyngeal cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29959065 | 2018 |
| THOR | retinoblastoma | qPCR, RIP, Western Blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30119193 | 2018 |
| THOR | hepatocellular carcinoma | qPCR, Western Blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | 30098425 | 2018 |
| THOR | nasopharyngeal cancer | qPCR, Western blot, in vitro knockdown, RIP, etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30503558 | 2019 |
| THOR | tongue squamous cell carcinoma | qPCR, Western blot, in vitro knockdown, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31220513 | 2019 |
| THRIL | osteosarcoma | RT-qPCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 32021260 | 2020 |
| TINCR | hepatocellular carcinoma | RT-qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31994189 | 2020 |
| TINCR | hepatocellular carcinoma | qPCR, Western blot analysis | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31900116 | 2020 |
| TINCR | prostate cancer | qPCR, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30154672 | 2018 |
| TINCR | cervical squamous cell carcinoma | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31388923 | 2019 |
| TINCR | gastric cancer | RNA-seq, qPCR, RNAi, Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 25728677 | 2015 |
| TMEM87A | Gastric cancer | Dual-luciferase reporter assay;qRT-PCR;etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 33155080 | 2021 |
| TMPO-AS1 | retinoblastoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32139259 | 2020 |
| TMPO-AS1 | bladder cancer | qRT-PCR, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32087328 | 2020 |
| TMPO-AS1 | lung adenocarcinoma | RT-qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32062549 | 2020 |
| TMPO-AS1 | cervical cancer | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32184662 | 2020 |
| TMPO-AS1 | osteosarcoma | Microarray, RT-qPCR, Western blot assay, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31680323 | 2020 |
| TMPO-AS1 | prostate cancer | qPCR, ChIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | 30105831 | 2018 |
| TMPO-AS1 | breast cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc. | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31501276 | 2019 |
| TMPO-AS1 | non small cell lung cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31230752 | 2019 |
| TMPO-AS1 | Hepatocellular carcinoma | qRT-PCR,Western blot,Luciferase reporter assay etc | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32462698 | 2020 |
| TNRC6C-AS1 | thyroid cancer | RIP, RT-qPCR, Western blot analysis | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | 31657132 | 2020 |
| TNRC6C-AS1 | papillary thyroid cancer | mircoarray, qPCR, Western Blot, Luciferase Reporter Assay | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30038597 | 2018 |
| TOB1-AS1 | gastric cancer | qPCR, Western blot etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31799657 | 2019 |
| TOB1-AS1 | cervical cancer | qPCR, Western blot, Luciferase reporter assay, Other | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 30210918 | 2018 |
| TONSL-AS1 | gastric cancer | qRT-PCR, Western blot assay etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31158361 | 2019 |
| TP53TG1 | pancreatic ductal adenocarcinoma | qPCR, Western blot, Luciferase reporter assay, RNAi, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31325400 | 2019 |
| TP73-AS1 | retinoblastoma | RT-qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 32067207 | 2020 |
| TP73-AS1 | lung adenocarcinoma | RT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 32009796 | 2019 |
| TP73-AS1 | non small cell lung cancer | RT-PCR | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31749884 | 2017 |
| TP73-AS1 | renal cell carcinoma | RNA-seq, qPCR, Western blot, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30016766 | 2018 |
| TP73-AS1 | cholangiocarcinoma | qPCR, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29966969 | 2018 |
| TP73-AS1 | ovarian cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29904939 | 2018 |
| TP73-AS1 | osteosarcoma | Microarray, qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29864904 | 2018 |
| TP73-AS1 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29803931 | 2018 |
| TP73-AS1 | cervical cancer | qRT-PCR, RIP, Dual-luciferase reporter assay, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31663517 | 2019 |
| TP73-AS1 | medulloblastoma | qRT-PCR , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31081944 | 2019 |
| TP73-AS1 | gastric cancer | qPCR, Western Blot | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30127981 | 2018 |
| TP73-AS1 | gastric cancer | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30118890 | 2018 |
| TP73-AS1 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30279010 | 2018 |
| TP73-AS1 | hepatocellular carcinoma | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31210297 | 2019 |
| TP73-AS1 | bladder cancer | qPCR, Western blot etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 29625110 | 2018 |
| TP73-AS1 | glioma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29412778 | 2018 |
| TP73-AS1 | cholangiocarcinoma | qPCR, Flow cytometry assay, etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29966969 | 2018 |
| TP73-AS1 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, RIP, etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30472379 | 2018 |
| TPT1-AS1 | epithelial ovarian cancer | qPCR, Luciferase reporter assay, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✔ | ✘ | 30941821 | 2019 |
| TPT1-AS1 | cervical cancer | qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30045766 | 2018 |
| TPT1-AS1 | Glioblastoma | qRT-PCR,Western blot,Luciferase assays | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32783743 | 2020 |
| TPT1-AS1 | Breast cancer | qRT-PCR;Western blot;Flow Cytometry assay;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33999360 | 2021 |
| TPTE2P1 | hepatocellular carcinoma | qRT-PCR , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31114999 | 2019 |
| TPTEP1 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32323798 | 2020 |
| TPTEP1 | hepatocellular carcinoma | qRT-PCR , Luciferase reporter assay , RNA-seq , Western blot etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31072375 | 2019 |
| TRERNA1 | non small cell lung cancer | qRT-PCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32096153 | 2020 |
| TRERNA1 | Hepatocellular carcinoma | RNA sequencing; | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33839325 | 2021 |
| TRG-AS1 | glioblastoma | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31196742 | 2019 |
| TRPM2-AS | gastric cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32123162 | 2020 |
| TRPM2-AS | breast cancer | RNA-seq, qPCR, Luciferase reporter assay, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30810442 | 2019 |
| TRPM2-AS | colorectal cancer | RT-qPCR, Western blot, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31887411 | 2020 |
| TRPM2-AS | gastric cancer | qRT-PCR, Western blotting, in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31104318 | 2019 |
| TRPM2-AS | glioma | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31637708 | 2019 |
| TSlnc8 | non small cell lung cancer | qRT-PCR , Western blot etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31601776 | 2019 |
| TSlnc8 | breast cancer | qPCR, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31646574 | 2019 |
| TSPAN12 | hepatocellular carcinoma | RNA-seq, qPCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | 32222644 | 2020 |
| TTN-AS1 | breast cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 32100921 | 2020 |
| TTN-AS1 | ovarian cancer | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32049388 | 2020 |
| TTN-AS1 | ovarian cancer | qRT-PCR, Western blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32006899 | 2020 |
| TTN-AS1 | colorectal cancer | RT-qPCR, Western Blot Analysis, Dual-Luciferase Reporter Assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31920341 | 2019 |
| TTN-AS1 | prostate cancer | RT-qPCR, Dual-Luciferase Reporter Gene Assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31858535 | 2019 |
| TTN-AS1 | lung adenocarcinoma | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31173403 | 2019 |
| TTN-AS1 | colorectal adenocarcinoma | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31610194 | 2019 |
| TTN-AS1 | osteosarcoma | qPCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31600142 | 2019 |
| TTN-AS1 | cervical cancer | qPCR, Western Blot, Luciferase assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30135013 | 2018 |
| TTN-AS1 | lung adenocarcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31363080 | 2019 |
| TTTY15 | prostate cancer | qPCR, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30527798 | 2018 |
| TTTY15 | non small cell lung cancer | qPCR, Western blot, RIP | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31311130 | 2019 |
| TUBA4B | colorectal cancer | qPCR, Western blot etc | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32271419 | 2020 |
| TUBA4B | gastric cancer | qPCR, Western blot, Luciferase reporter assay | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31198405 | 2019 |
| TUC338 | tongue squamous cell carcinoma | qPCR, RNAi, Cell proliferation assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 27637778 | 2016 |
| TUC338 | hepatocellular carcinoma | microarray, qPCR, RNAi, Western blot, Northern blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 21187392 | 2011 |
| TUC339 | hepatocellular carcinoma | qPCR, RNAi etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 24167654 | 2013 |
| TUG1 | esophageal squamous cell carcinoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32139664 | 2020 |
| TUG1 | prostate cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 32057513 | 2020 |
| TUG1 | prostate cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 32016963 | 2020 |
| TUG1 | esophageal squamous cell carcinoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 31742924 | 2019 |
| TUG1 | prostate cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RNAi | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 29967294 | 2018 |
| TUG1 | hepatocellular carcinoma | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31949695 | 2018 |
| TUG1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29791864 | 2018 |
| TUG1 | prostate cancer | qPCR, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32256083 | 2020 |
| TUG1 | osteosarcoma | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31799645 | 2019 |
| TUG1 | bladder cancer | qPCR, Luciferase reporter assay, Western blot | H | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30925453 | 2019 |
| TUG1 | ovarian cancer | qRT-PCR, Luciferase activity assay, Western blotting | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31930662 | 2019 |
| TUG1 | hepatocellular carcinoma | RT-qPCR, Dual luciferase reporter assay, Western blot assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31920462 | 2020 |
| TUG1 | esophageal squamous cell carcinoma | qRT-PCR, Dual-luciferase reporter assays, Western blot analysis, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31918742 | 2020 |
| TUG1 | acute myeloid leukemia | qRT-PCR, Dual-Luciferase Reporter Gene Assay, Western Blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31819520 | 2019 |
| TUG1 | glioma | RT-qPCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31809214 | 2019 |
| TUG1 | colon cancer | Dual luciferase reporter assay, Western blot analysis, RT-qPCR | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 31697952 | 2019 |
| TUG1 | renal cell carcinoma | qPCR, Western Blot, Dual-luciferase activity assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30132963 | 2018 |
| TUG1 | osteosarcoma | qPCR, Western Blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30116332 | 2018 |
| TUG1 | breast cancer | qPCR, Western Blot, Dual-luciferase reporter assay | L | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30098551 | 2018 |
| TUG1 | hepatocellular carcinoma | qPCR, Western Blot, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30092578 | 2018 |
| TUG1 | lymphoma | qPCR, Western blot, in vitro knockdown, RNAi, RIP | H | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31338678 | 2019 |
| TUG1 | Renal cell carcinoma | qPCR, Luciferase reporter assay, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31310753 | 2019 |
| TUG1 | bladder cancer | qPCR, Western blot, in vitro knockdown | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31308746 | 2019 |
| TUG1 | osteosarcoma | qPCR, Western blot, in vitro knockdown | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31305159 | 2019 |
| TUG1 | prostate cancer | qPCR | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31210308 | 2019 |
| TUG1 | prostate cancer | qPCR | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31210296 | 2019 |
| TUG1 | malignant melanoma | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29543785 | 2018 |
| TUG1 | small cell lung cancer | qPCR, RNAi, Western blot, RIP, ChIP, Flow cytometry assay, Cell migration and invasion assay etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 28069000 | 2017 |
| TUG1 | hepatocellular carcinoma | qPCR, RNAi, Western blot, RIP, Flow cytometry assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 26336870 | 2015 |
| TUG1 | breast cancer | qPCR, Western blotting etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 28950664 | 2017 |
| TUG1 | oral squamous cell carcinoma | qPCR, RNAi, Western blot, Luciferase reporter assay, MTT assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 28119088 | 2017 |
| TUG1 | osteosarcoma | qPCR, etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29970697 | 2018 |
| TUG1 | Hepatocellular carcinoma | Western blot;qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32821161 | 2020 |
| TUG1 | Ewings sarcoma | CCK-8 assay;Dual-luciferase reporter assay;qPCR;RT-qPCR;Western blot;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33780263 | 2021 |
| TUG1 | Colorectal cancer | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32985219 | 2021 |
| TUSC7 | endometrial cancer | qPCR, Western blot, Luciferase reporter assay, RIP | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31200002 | 2019 |
| TUSC7 | osteosarcoma | qPCR, Western blot, Luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31652435 | 2019 |
| TUSC8 | breast cancer | RT-PCR, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32039833 | 2020 |
| u50535 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29970882 | 2018 |
| UASR1 | breast cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31205563 | 2019 |
| UBE2CP3 | hepatocellular carcinoma | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29866133 | 2018 |
| UBE2R2-AS1 | glioma | qRT-PCR , Luciferase reporter assay , Western blot etc. | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31123407 | 2019 |
| Uc.63+ | gastric cancer | qPCR, Western blot, in vitro knockdown etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32323025 | 2020 |
| uc002jit.1 | acute myeloid leukemia | Microarray, qPCR, Luciferase reporter assay etc | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32259522 | 2020 |
| uc003pxg.1 | Coronary Artery Disease | Dual-luciferase reporter assay;qPCR;RT-qPCR;Western blot;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 34212983 | 2021 |
| uc061hsf.1 | esophageal squamous cell carcinoma | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31743955 | 2019 |
| UCA1 | oral squamous cell carcinoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✔ | ✘ | ✘ | 32130788 | 2019 |
| UCA1 | ovarian cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32016960 | 2020 |
| UCA1 | renal cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31996265 | 2020 |
| UCA1 | gastric cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31982772 | 2020 |
| UCA1 | retinoblastoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31702387 | 2019 |
| UCA1 | papillary thyroid cancer | qPCR | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30015945 | 2018 |
| UCA1 | anaplastic thyroid cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30015867 | 2018 |
| UCA1 | lung cancer | qPCR, Western blot | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30001775 | 2018 |
| UCA1 | breast cancer | qPCR, Western blot, in vitro knockdown | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29980791 | 2018 |
| UCA1 | colorectal cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 29948578 | 2018 |
| UCA1 | non small cell lung cancer | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31938341 | 2018 |
| UCA1 | cervical cancer | qPCR, Luciferase Reporter Assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32329829 | 2020 |
| UCA1 | gastric cancer | qPCR, Western blot, RIP | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 32328192 | 2020 |
| UCA1 | acute myeloid leukemia | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32286143 | 2020 |
| UCA1 | breast cancer | RNA-seq, qPCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30981459 | 2019 |
| UCA1 | prostate cancer | qPCR, Luciferase reporter assay, RIP, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30940776 | 2019 |
| UCA1 | adrenocortical carcinoma | qPCR, Luciferase reporter assay, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30935924 | 2019 |
| UCA1 | colorectal cancer | qPCR, Western blot, RIP | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✔ | ✘ | 31558855 | 2019 |
| UCA1 | colorectal cancer | Western Blotting, Luciferase Reporter Assay, RIP, qRT-PCR | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31955010 | 2020 |
| UCA1 | prostate cancer | Western Blotting, Luciferase Reporter Assay, RIP, qRT-PCR | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31954329 | 2020 |
| UCA1 | acute myeloid leukemia | qRT-PCR, western blot, luciferase reporter assays | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | 31953866 | 2020 |
| UCA1 | non small cell lung cancer | Western Blotting, qRT-PCR, Luciferase Reporter Assay, RIP | H | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31951852 | 2020 |
| UCA1 | acute myeloid leukemia | qRT-PCR, Luciferase reporter analysis, RIP, Western blot assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31916649 | 2020 |
| UCA1 | breast cancer | qRT-PCR, Western blot, Luciferase reporter gene assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31695578 | 2019 |
| UCA1 | gastric cancer | qPCR, RNA-Seq, RIP, Western Blot Assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31689615 | 2019 |
| UCA1 | glioma | qRT-PCR, Western blot analysis, Luciferase assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31680311 | 2020 |
| UCA1 | ovarian cancer | qRT-PCR , Microarray etc. | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31011626 | 2019 |
| UCA1 | glioma | qRT-PCR , Western blot etc. | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31596734 | 2019 |
| UCA1 | hepatocellular carcinoma | qPCR, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30070319 | 2018 |
| UCA1 | cervical cancer | microarray, qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31949782 | 2018 |
| UCA1 | bladder cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✔ | 30666128 | 2019 |
| UCA1 | colon cancer | qPCR, Western blot, Luciferase reporter assay, RIP, etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30652355 | 2019 |
| UCA1 | Epithelial Ovarian Cancer | RNA-seq, qPCR, Western blot, RIP | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31307004 | 2019 |
| UCA1 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✔ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31272462 | 2019 |
| UCA1 | intrahepatic cholangiocarcinoma | qPCR, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31258634 | 2019 |
| UCA1 | Ovarian Cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✔ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31234009 | 2019 |
| UCA1 | cholangiocarcinoma | qPCR, Western blot etc. | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 29221199 | 2017 |
| UCA1 | osteosarcoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29328452 | 2018 |
| UCA1 | liver cancer | qPCR, Western blot, RIP, ChIP, ISH etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 26513297 | 2015 |
| UCA1 | liver cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29523218 | 2018 |
| UCA1 | hepatocellular carcinoma | qPCR, RNAi, Western blot, RIP, ChIP, Flow cytometry assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 27009634 | 2016 |
| UCA1 | bladder cancer | qPCR, RNAi, Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 25015192 | 2014 |
| UCA1 | bladder cancer | qPCR, RNAi, Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 24648007 | 2014 |
| UCA1 | breast cancer | microarray, qPCR, RNAi, ISH etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 26439035 | 2015 |
| UCA1 | bladder cancer | microarray, qPCR, Northern blot etc. | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 18501714 | 2008 |
| UCA1 | Cervical cancer | qRT-PCR;luciferase reporter assays;Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32835591 | 2020 |
| UCA2 | osteosarcoma | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31011522 | 2019 |
| UCC | gastric cancer | qPCR etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32194743 | 2020 |
| UFC1 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 29970131 | 2018 |
| UFC1 | cervical cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29790665 | 2018 |
| UFC1 | non small cell lung cancer | qPCR, Western blot, RIP etc. | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 32242003 | 2020 |
| UFC1 | breast cancer | qPCR, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31544897 | 2019 |
| UICC | cervical cancer | mircoarray, qPCR, Western Blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30094092 | 2018 |
| UNC5B-AS1 | prostate cancer | Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32196578 | 2020 |
| UNC5B-AS1 | ovarian cancer | RT-qPCR, Western blot, Dual-Luciferase reporter analysis, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31903696 | 2020 |
| Unigene56159 | glioblastoma | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31789416 | 2019 |
| UPAT | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30008828 | 2018 |
| UPF1 | glioma | qPCR, RIP etc. | L | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31799670 | 2019 |
| UPF1 | Hepatocellular Carcinoma | qRT-PCR, Western blotting, in vitro knockdown, RIP etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31040354 | 2019 |
| UPK1A-AS1 | esophageal squamous cell carcinoma | qPCR, Luciferase reporter assay etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32368143 | 2020 |
| UPK1A-AS1 | Hepatocellular carcinoma | qRT-PCR;RIP assay;RNA immunoprecipitation;etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33121524 | 2020 |
| URRCC | clear cell renal cell carcinoma | qPCR, microarray, Western blot, Luciferase reporter assay | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30953521 | 2019 |
| VCAN-AS1 | gastric cancer | qPCR, Western blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31637706 | 2019 |
| VPS9D1-AS1 | prostate cancer | RT-qPCR, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31918265 | 2020 |
| VPS9D1-AS1 | Acute lymphoblastic leukemia | qRT-PCR;luciferase reporter assays;Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32808668 | 2020 |
| VPS9D1-AS1 | Hepatocellular carcinoma | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33627127 | 2021 |
| WDFY3-AS2 | lung adenocarcinoma | qPCR, Western blot, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32275336 | 2020 |
| WDFY3-AS2 | ovarian cancer | qPCR, Western blot, Luciferase reporter assay, RIP | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31347170 | 2019 |
| WEE2-AS1 | triple negative breast cancer | qPCR, Luciferase reporter assay, RIP etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32307083 | 2020 |
| WFDC21P | hepatocellular carcinoma | other | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31959898 | 2020 |
| WT1-AS | papillary thyroid cancer | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32021456 | 2020 |
| WT1-AS | Cervical Cancer | qPCR, Luciferase reporter assay | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30720155 | 2019 |
| WT1-AS | cervical squamous cell carcinoma | RT-qPCR, Western-blot | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31694597 | 2019 |
| WT1-AS | cervical cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30666161 | 2019 |
| WT1-AS | Non-small cell lung cancer | Flow cytometry assay;qPCR;RT-qPCR;Western blot;Flow Cytometry assay;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 33603394 | 2021 |
| XIAP-AS1 | colon cancer | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 30892955 | 2019 |
| XIST | glioma | RT-qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32104215 | 2020 |
| XIST | melanoma | qRT-PCR, Western blot, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32103995 | 2020 |
| XIST | colorectal cancer | qRT-PCR, Western blot, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 32061057 | 2019 |
| XIST | glioma | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32036410 | 2020 |
| XIST | cervical cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 29909347 | 2018 |
| XIST | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 29812958 | 2018 |
| XIST | retinoblastoma | qPCR, Western blot, Luciferase reporter assay, etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32329826 | 2020 |
| XIST | glioma | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32271437 | 2020 |
| XIST | non small cell lung cancer | qPCR, Western blot, RIP etc | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32209729 | 2020 |
| XIST | breast cancer | qPCR etc | L | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32198770 | 2020 |
| XIST | nasopharyngeal cancer | qPCR, Western blot, luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32196601 | 2020 |
| XIST | hepatocellular carcinoma | qPCR , in vitro knockdown, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31799653 | 2019 |
| XIST | epithelial ovarian cancer | qPCR | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | 31564909 | 2019 |
| XIST | lung adenocarcinoma | qRT-PCR, Dual-luciferase reporter assay, RIP, Western blot analysis, | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31968395 | 2020 |
| XIST | osteosarcoma | qRT-PCR, Western blot, Luciferase assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | 31933968 | 2019 |
| XIST | ovarian cancer | qPCR, Dual-luciferase reporter assay, Western blotting | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31930432 | 2019 |
| XIST | laryngeal squamous cell cancer | RT-PCR, luciferase reporter assays, Western blot analysis | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31894287 | 2020 |
| XIST | nasopharyngeal cancer | RT-qPCR, Western blot assay, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31810117 | 2020 |
| XIST | glioma | qRT-PCR, Western blot analysis, Luciferase assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31680298 | 2020 |
| XIST | non small cell lung cancer | RT-qPCR, Western blot, Luciferase reporter assay, RIP | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31659146 | 2019 |
| XIST | pancreatic cancer | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31163263 | 2019 |
| XIST | laryngeal squamous cell cancer | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31071316 | 2019 |
| XIST | pancreatic cancer | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31013436 | 2019 |
| XIST | bladder cancer | qRT-PCR , Luciferase reporter assay , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31602223 | 2019 |
| XIST | retinoblastoma | qPCR, Western Blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30114638 | 2018 |
| XIST | breast cancer | qPCR, Luciferase reporter assay | L | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30092355 | 2018 |
| XIST | hepatocellular carcinoma | qPCR, Dual luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30091314 | 2018 |
| XIST | breast cancer | microarray, qPCR | L | ✔ | ✔ | ✔ | ✔ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30026327 | 2018 |
| XIST | thyroid cancer | qPCR, Luciferase reporter assay, RIP, Other | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30463570 | 2018 |
| XIST | colorectal cancer | qPCR, Luciferase reporter assay, Western blot, Other | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30439718 | 2018 |
| XIST | renal cell carcinoma | Western blot assay, Luciferase reporter assays, in vitro knockdown, qPCR, etc. | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30717973 | 2019 |
| XIST | osteosarcoma | qPCR, Western blot, in vitro knockdown, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30655762 | 2019 |
| XIST | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31384173 | 2019 |
| XIST | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31292221 | 2019 |
| XIST | pancreatic cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31213574 | 2019 |
| XIST | neuroblastoma | qPCR, Western blot, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31208278 | 2019 |
| XIST | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31646569 | 2019 |
| XIST | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31632587 | 2019 |
| XIST | gastric cancer | qPCR, Western blot , RIP, Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29212249 | 2017 |
| XIST | osteosarcoma | qPCR, Western blotting, Luciferase reporter assay etc. | L | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29048648 | 2017 |
| XIST | nasopharyngeal cancer | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 27461945 | 2016 |
| XIST | gastric cancer | qPCR, RNAi, Western blot, RIP, Luciferase reporter assay, MTT assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 27911852 | 2017 |
| XIST | breast cancer | qPCR, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29550489 | 2018 |
| XIST | hepatocellular carcinoma | qPCR, RNAi, Western blot, RIP, Luciferase reporter assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 28231734 | 2017 |
| XIST | Aneurysm | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 33501488 | 2021 |
| XIST | Colorectal cancer | Dual-luciferase reporter assay;qRT-PCR;Western blot;Flow Cytometry assay;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33298041 | 2020 |
| XIST | Colorectal cancer | RT-PCR;Western blot;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33666372 | 2021 |
| XIST | Glioblastoma | Luciferase reporter assay;RNA immunoprecipitation;etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33325210 | 2020 |
| XIST | Nasopharyngeal cancer | qPCR;Western blot; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33664820 | 2021 |
| XIST | Breast cancer | Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33510942 | 2020 |
| XIST | Ovarian cancer | Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33510942 | 2020 |
| XIST | Pancreatic cancer | Dual-luciferase reporter assay;qRT-PCR;etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33336734 | 2020 |
| XLOC_001659 | esophageal squamous cell carcinoma | RT-qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31754291 | 2019 |
| XLOC_006390 | pancreatic cancer | PCR, Western blot, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31734356 | 2019 |
| XLOC_006390 | cervical cancer | qPCR, Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 28534991 | 2017 |
| XLOC_006753 | gastric cancer | qPCR, Western blot, etc. | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30481766 | 2018 |
| YIYA | breast cancer | qPCR, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | 29967256 | 2018 |
| YWHAE | colorectal cancer | qPCR, Western blot, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31238337 | 2019 |
| YY1 | medulloblastoma | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31986414 | 2020 |
| ZEB1 | esophageal squamous cell carcinoma | qPCR, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31401160 | 2019 |
| ZEB1-AS1 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29886791 | 2018 |
| ZEB1-AS1 | glioma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29863254 | 2018 |
| ZEB1-AS1 | prostate cancer | qPCR, Western blot etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32275162 | 2020 |
| ZEB1-AS1 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32190742 | 2020 |
| ZEB1-AS1 | bladder cancer | qPCR, Luciferase reporter assay, RIP, Western blot | H | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30823924 | 2019 |
| ZEB1-AS1 | triple negative breast cancer | qRT-PCR, RIP, Dual-luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31922280 | 2020 |
| ZEB1-AS1 | colon adenocarcinoma | qRT-PCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31828845 | 2020 |
| ZEB1-AS1 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30626729 | 2019 |
| ZEB1-AS1 | oesophageal squamous cell carcinoma | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31638344 | 2019 |
| ZEB1-AS1 | gastric cancer | qPCR, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29215918 | 2018 |
| ZEB2-AS1 | colorectal cancer | qPCR, Luciferase reporter assay etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32277632 | 2020 |
| ZEB2-AS1 | colon cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31698657 | 2019 |
| ZEB2-AS1 | non small cell lung cancer | qRT-PCR, Western blot analysis, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31695021 | 2019 |
| ZEB2-AS1 | gastric cancer | qRT-PCR , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31128021 | 2019 |
| ZEB2-AS1 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 30705594 | 2019 |
| ZEB2-AS1 | pancreatic cancer | qPCR, Western blot, Luciferase reporter assay, RIP etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29753015 | 2018 |
| ZFAS1 | prostate cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 32104094 | 2020 |
| ZFAS1 | nasopharyngeal cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 29917194 | 2018 |
| ZFAS1 | breast cancer | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32189153 | 2020 |
| ZFAS1 | hepatoblastoma | qPCR, Western blot, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | 31781561 | 2019 |
| ZFAS1 | esophageal squamous cell carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31775815 | 2019 |
| ZFAS1 | Cervical Cancer | qPCR | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30738960 | 2019 |
| ZFAS1 | nasopharyngeal cancer | microarray, qRT-PCR, Dual-luciferase reporter assay, Western blot analysis | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31851778 | 2020 |
| ZFAS1 | osteosarcoma | RT-qPCR, Western blot analysis, Dual luciferase reporter gene assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31827400 | 2019 |
| ZFAS1 | acute promyelocytic leukemia | RT-qPCR, RNAi, Western blot assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31807158 | 2019 |
| ZFAS1 | non small cell lung cancer | qRT-PCR, Western blot analysis, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31692094 | 2019 |
| ZFAS1 | T cell acute lymphoblastic leukemia | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31096997 | 2019 |
| ZFAS1 | osteosarcoma | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31081072 | 2019 |
| ZFAS1 | papillary thyroid cancer | qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31571903 | 2019 |
| ZFAS1 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, RIP, RNAi, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 30250022 | 2018 |
| ZFAS1 | nasopharyngeal cancer | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | 31403940 | 2019 |
| ZFAS1 | non small cell lung cancer | qPCR, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31378891 | 2019 |
| ZFAS1 | nasopharyngeal cancer | qPCR, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31307201 | 2019 |
| ZFAS1 | Colorectal Cancer | qPCR, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31295229 | 2019 |
| ZFAS1 | acute myeloid leukemia | qPCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 28672980 | 2017 |
| ZFAT-AS1 | glioma | qRT-PCR, Western Blot, RIP | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31813799 | 2020 |
| ZFHX4-AS1 | breast cancer | qPCR, Western blot, Luciferase reporter assay, etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30546116 | 2018 |
| ZFPM2-AS | small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, RIP etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32280300 | 2020 |
| ZFPM2-AS1 | esophageal squamous cell carcinoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32065218 | 2020 |
| ZFPM2-AS1 | gastric cancer | qPCR, Western blot, in vitro knockdown, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29985481 | 2018 |
| ZFPM2-AS1 | lung adenocarcinoma | qRT-PCR, Luciferase reporter assay, RIP, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 31919993 | 2020 |
| ZFPM2-AS1 | lung adenocarcinoma | qRT-PCR, Western blot analysis, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31692047 | 2020 |
| ZFPM2-AS1 | renal cell carcinoma | qPCR, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31298319 | 2019 |
| ZFPM2-AS1 | lung adenocarcinoma | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31297866 | 2019 |
| ZFPM2-AS1 | Hepatocellular carcinoma | qRT-PCR,Western blot,Luciferase reporter assay,FISH etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32744687 | 2020 |
| ZFPM2-AS1 | Thyroid cancer | ChIP;ELISA;Chromatin immunoprecipitation;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33976749 | 2021 |
| ZFPM2-AS1 | Melanoma | qPCR;RT-qPCR;RNA immunoprecipitation;Flow Cytometry assay;RNA immunoprecipitation; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33406278 | 2021 |
| ZNF205-AS1 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30556283 | 2019 |
| ZNF281 | gastric cancer | qPCR etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32194679 | 2020 |
| ZNF667-AS1 | esophageal squamous cell carcinoma | qRT-PCR, Luciferase reporter constructs and dual-luciferase reporter assay, Western blot analysis, RIP | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31804468 | 2019 |
| ZNF674-1 | nasopharyngeal cancer | qPCR, in vitro knockdown | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29805695 | 2018 |
| ZNF710-AS1-202 | clear cell renal cell carcinoma | qPCR, Western blot etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32236626 | 2020 |